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Zusammenfassung
Diese Arbeit beschäftigt sich mit der Analyse von Softwarephantomen für die medizinis-
che Bildverarbeitung. Dazu werden neue Verfahren in zwei unterschiedlichen Aufgaben-
gebieten vorgestellt: (1) Die Entwicklung von Phantomen und deren Anwendung sowie (2)
die Validierung von Phantomen.
Ein wichtiger erster Schritt für die Entwicklung von Softwarephantomen ist die Betra-
chtung der Phantomart und der zugrundeliegenden Anwendung. Die ersten Kapitel dieser
Arbeit geben daher zunächst einmal einen Überblick über Designmethoden. Darüber hin-
aus werden Parameter untersucht, die man häufig für die Phantomerstellung verwendet.
Basierend auf den Ergebnissen dieser Betrachtung erfolgt dann die Entwicklung eines mod-
ularen Designs für Phantome. Unser Ziel ist eine Art Baukasten, der eine formalisierte
Beschreibung von Parametern nutzt. Dies ermöglicht den Austausch einzelner Parameter
durch neue Modelle.
Basierend auf unserer Designmethode, entwickeln wir im nächsten Schritt Phantome für
unterschiedliche Anwendungen. Besonders die Entwicklung von Multiple Sklerose (MS)
Läsionsphantomen sowie von Gehirntumorphantomen stehen im Vordergrund. Dabei wer-
den verschiedene Aspekte untersucht, wie etwa das Objektvolumen. Darüber hinaus wird
eine makroskopische Simulation vonWachstumsprozessen basierend auf einem physikalisch
motivierten, elastischenModell, vorgeschlagen, das bereits für die Erfassung von Formverän-
derungen während neurochirurgischer Eingriffe verwendet wurde. Da für die entwickelten
Phantome ein hoher manueller Aufwand notwendig ist, ist die Zahl der verfügbaren Phan-
tomdatensätze für eine Anwendung typischerweise sehr klein. In einem weiteren Schritt
schlagen wir daher eine vollautomatisierte Methode vor, mit der eine große Zahl an Phan-
tomen erstellt werden kann. Die zugehörigen Parametermodelle werden dabei aus Patien-
tendaten abgeleitet. Mit Hilfe unseres Baukastenprinzips haben wir zusätzlich einen inter-
aktiven Software-Assistenten für die Erstellung von Phantomen implementiert, der den En-
twicklungsaufwand für ein Phantom stark reduziert. Eine Reihe von Phantomen aus dieser
Arbeit wurden mit dem Assistenten entwickelt.
Unsere Phantome bieten eine gute Grundlage für die Evaluierung von Algorithmen, die
häufig in der klinischen Routine oder in Studien auftreten. Zum Beispiel analysieren wir
die Qualität einer rein visuellen Bewertung von Läsionen im Rahmen einer Studie mit mehr
als 20 Teilnehmern. Weiterhin werden neue Ansätze für eine genaue und reproduzierbare
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Volumetrie von Läsionen untersucht. Der Fokus liegt dabei vor allem auf kleinen Läsionen,
wie sie beispielsweise bei Patienten mit MS auftreten. Für die Evaluierung werden mehr als
50 Datensätze mit Läsionsphantomen unterschiedlicher Volumina und Formen erzeugt und
manuell von mehreren neuroradiologischen Experten ausgewertet. Darüber hinaus nutzen
wir unsere Phantome für die Bewertung von Segmentierungsalgorithmen.
Der Schwerpunkt im zweiten Teil der Arbeit liegt auf der Analyse der Phantomqual-
ität. Auf Grund der bekannten Ground Truth für alle modellierten Parameter sind Phantome
heute ein weit verbreitetes Werkzeug. Trotzdem gibt es praktisch keine Methoden, die eine
Bewertung dieser Phantome ermöglichen. Unser erster Schritt in diese Richtung ist daher
zunächst einen Untersuchung von Methoden verwandter Gebiete im Bereich der medizinis-
chen Bildverarbeitung. Danach wird schließlich ein neues Verfahren für die Validierung
von Phantomen vorgestellt, das Verbindungen mit dem Designansatz aus dem ersten Teil
dieser Arbeit aufweist. Unsere Methode ermöglicht sowohl eine standardisierte Analyse
einzelner Phantome als auch den Vergleich einer Menge von Phantomen. Darüber hinaus
wird mit dem sogenannten Analytischen Hierarchieprozess eine Methode verwendet, die
eine Bestimmung des Eignungsgrades für alle verwendeten Parameter ermöglicht.
Bis ein Phantom eine akzeptable Konfidenz für eine bestimmte Anwendung aufweist
sind viele Schritte notwendig. Diesen Aspekt bilden wir auch auf die Phantomvalidierung
ab und schlagen einen iterativen Prozess vor, der aus vielen einzelnen Validierungsmetho-
den besteht. Den übergeordneten Prozess teilen wir in drei Schritte ein: Methodenauswahl,
Methodenvalidierung und Phantomvalidierung. Jede betrachtete Methode vergrößert bzw.
verkleinert die Konfidenz in ein Phantom. Dazu müssen zwei Merkmale bewertet werden:
die Eignung und die Korrektheit einer Methode. Für die Methodenvalidierung schlagen wir
eine Funktion vor, die beide Merkmale miteinander kombiniert. Eine multiplikative Fusion
der Ergebnisse aller Methoden liefert schließlich die finale Phantombewertung. Die Qualität
eines Phantoms wird mit diesem Ansatz also durch eine Zahl beschrieben.
Für eine konkrete Bewertung der vorgestellten Phantomvalidierung werden die MS Lä-
sionsphantome aus dem ersten Teil dieser Arbeit verwendet. Fünf verschiedene Validierungs-
methoden werden dazu untersucht und kombiniert. Anhand einer Studie mit vier Experten
bewerten wir beispielsweise die Detektionsleistung von Läsionsphantomen in Patienten-
daten mit echten Läsionen. Eine weitere Methode nutzt den Vergleich von Segmentierungs-
ergebnissen zwischen Phantomen und Patientendaten. Die Analyse jeder Methode besteht
dabei aus einer kurzen Beschreibung der zugrunde liegenden Daten und einer Diskussion
der Ergebnisse.
Summary
The validation of algorithms is an important aspect in medical image analysis. Today, a
validation study serves as a major decision factor of a method’s value to the user. Thereby,
phantoms have become a widely accepted tool. This thesis deals with the analysis of soft-
ware phantoms in medical image processing. New approaches are proposed in two areas:
(1) Phantom development and applications and (2) phantom validation.
The first step towards developing a phantom is to decide what kind of phantom is re-
quired for the targeted application. Therefore, we start our investigation with a general
overview of design approaches and examine parameters used in phantom development.
Based on the knowledge of the underlying application domain and the phantom type, we
then focus on the actual design. Our goal is a modular phantom design based on a set of
components. To this end, we formalize the overall development process and propose mod-
els for major parameters used in medical image analysis such as object position, shape, or
intensity values. After modeling all relevant parameters for an application, we combine
them to our final phantom.
Several phantoms are developed using our new design approach. We focus on applica-
tions in the field of neurology and neurosurgery, including lesion phantoms that appear in
patients with Multiple Sclerosis (MS) as well as brain tumor phantoms. Several character-
istic properties are investigated such as the object volume or the selected intensity values.
A macroscopic simulation of growth-induced deformations based on a linear elastic model
is proposed, which was previously used to capture shape changes of the brain during neu-
rosurgery. Instead of developing only a small amount of hand-crafted phantoms, we also
present a fully automatic method to build an arbitrary number of MS phantoms. Thereby,
our parameter models such as the lesion shape and the lesion position are based on actual
patient data.
Based on the modular design process, we propose a new interactive software assistant
for the development of software phantoms. Several phantoms developed in this work are
generated with the software assistant, reducing the time to build a phantom from hours to a
fewminutes. The developed software phantoms provide an excellent basis for the evaluation
of typical algorithms that frequently occur in clinical practice and trials. We investigate the
quality of visual assessment in MS lesion volumetry based on a study with more than 20
participants. Furthermore, new methods for an accurate and reproducible volumetry are
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presented. Here, the focus is on small lesions that appear in patients with MS. More than
50 software phantoms with different lesion shapes and volumes are generated, and both
manual and semi-automatic approaches are analyzed. Finally, our phantoms are used for
the evaluation of segmentation methods. Several algorithms ranging from manual to fully-
automatic are analyzed.
In the second part of this work, we focus on the analysis of the phantom quality. Phan-
toms are a widely used tool, since the ground truth is known for all modeled parameters.
However, algorithms for phantom validation are widely unknown. Therefore, our first step
towards an analysis of the phantom quality consists of a survey of work in related fields of
medical image analysis. We then propose an approach that is closely related to the phantom
design process. It enables the analysis of a single phantom as well as the comparison of
phantoms. A multi-criteria decision making technique is applied to evaluate the suitability
of the modeled parameters.
Several steps are required to reach a reasonable confidence in a phantom. Therefore, we
define phantom validation as an iterative process that comprises several validation methods.
Three steps are distinguished: method selection,method validation, and phantom validation.
Each method increases or decreases the confidence in the phantom. Thereby, an analysis of
the method’s suitability and correctness is performed. A validation function is introduced
that fuses these two features.
A multiplicative combination of all validation methods is used to compute the final
phantom validation. In other words, the phantom quality is expressed by a single value.
To evaluate our phantom validation approach, we use the MS lesion phantoms proposed
in the first part of this thesis. Different validation methods are analyzed such as a user study
to assess the detection performance of lesion phantoms in patient data sets with several
real MS lesions. We also propose a comparison of segmentation overlap measures between
phantoms and patient data using the results obtained in the first part of this thesis. For each
validation method, a short description of the underlying data and a discussion of the results
is given.
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1. Introduction
Medical image processing has become a powerful tool for analyzing normal and patholog-
ical processes in the human body. With the growing amount of data per case acquired by
medical imaging devices, the variety and complexity of post-processing algorithms are in-
creasing. Today, image segmentation and quantification of anatomical structures are integral
parts of virtually any image analysis system for basic research and for clinical applications
in surgical planning and therapy monitoring. Therefore, each algorithm has to be evaluated
carefully with respect to advantages and drawbacks.
Unfortunately, each quantitative analysis is subject to errors or uncertainties. There
are errors related to the acquisition process such as a limited spatial resolution or motion
artifacts. Other errors are related to anatomical and pathological variability. Therefore, ac-
curacy and reproducibility of a proposed method are fundamental issues. To reach clinical
acceptance, and to understand the intrinsic characteristics and behavior of a method, dedi-
cated validation strategies are required.
Patient data can provide a realistic evaluation basis for novel methods. However, a
large data pool is often required to account for major anatomical variations and pathologies.
Furthermore, the lack of common reference data sets with an exactly known ground truth
for the underlying application makes validation and comparison a difficult task. Today,
researchers usually have their own small pool of patient data sets for the evaluation of new
image analysis techniques.
Publicly available databases have been proposed in different fields of medical image
analysis such as computer aided detection of calcifications in mammograms. Today, several
workshops at major conferences use a set of patient data with manual expert segmentations
for an analysis of new algorithms e.g., the ’Grand Challenge’ workshops at the MICCAI
conference. Two major requirements for a validation tool are accomplished: A number
of data sets for the development, training, and evaluation of new algorithms, plus a com-
mon basis for the comparison of performance between different approaches. One of the
most popular databases in this area has been introduced by Karssemeijer (1993), containing
40 digitized film-screen mammograms of different clinically relevant cases with associated
ground truth. Another, much larger, public database is the Digital Database for Screening
Mammography (DDSM), maintained by the University of Florida. The DDSM database
contains approximately 2.500 studies (Heath et al. 1998). In the field of lung cancer de-
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tection, a cooperative effort known as the Lung Image Database Consortium (LIDC) was
launched in year 2000 to construct a database that contains CT scans from both diagnostic
and screening studies (Armato et al. 2004). Various information is stored for each data set
in addition to the actual image data including technical scan parameters, patient informa-
tion, and nodule features (McNitt-Gray et al. 2007). The assessment of lesion boundaries
is based on manual outlining performed by expert radiologists.
Although such image databases provide a common source of clinically relevant images
for researchers around the world, a quantitative analysis is rarely possible due to the lack of
a ground truth. The exact object parameters such as boundaries and tissue quantities within
a voxel are simply unknown, and a manual object labeling suffers from intra- and inter-
observer variability. Therefore, phantom data are a useful tool for developing, training, and
evaluating new segmentation and quantification methods.
Early approaches to simulate human anatomy in medicine were developed in the 1960’s
for dosimetry calculations in radiography and radiotherapy (Fisher and Snyder 1966). To-
day, new algorithms are often accompanied by a phantom-based evaluation study. One of
the most popular digital phantoms in medical image analysis is the freely available brain
phantom from the BrainWeb project (Collins et al. 1998). More than 100 groups have al-
ready used the associated data sets for various image analysis and evaluation tasks (Aubert-
Broche et al. 2006). Unfortunately, there are only few other publicly available software
phantoms, and a common repository or database has not yet been established. One reason
might be the large manual effort required during phantom development. Fully automatic
approaches could prove helpful here. Furthermore, it is important to understand and to
evaluate intrinsic characteristics and behavior of the data sets, used as a surrogate ground
truth. In other words, we need a structured decision process that can be documented and
replicated. Today, most phantoms are accompanied by at least some kind of evaluation.
However, a proper approach beyond an expert-based rating is still missing. Formalizing the
overall development process is a first step towards this goal.
1.1. Objectives
A frequent argument against the use of phantoms is their lack of complexity and struc-
tures encountered under clinical conditions. A phantom typically has only a reduced set of
modeled parameters, putting in question the reliability of drawn conclusions as well as the
overall data quality. Two main aspects are analyzed in this work: Phantom development
and phantom validation. We address the following questions:
Phantom Development
• How to develop phantoms for medical image analysis?
• What are the benefits of our phantoms?
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Phantom Validation
• Why is an analysis of the phantom quality required?
• What are the benefits of our phantom validation?
1.2. Contributions and Publications
This work contains several novel contributions. Our overall aims are the development of
phantoms, applications associated with these phantoms, and an assessment of the phantom
quality. We focus on two clinical applications in the field of neuroimaging: Lesions that
appear in patients with Multiple Sclerosis (MS) and the analysis of brain tumors. Magnetic
resonance imaging (MRI) is used as underlying imaging modality. In detail, the following
novelties have been presented:
• A modular approach for the development of software phantoms, which provides a
formalization of the phantom design process. A general overview has been published
in (Rexilius and Tönnies 2014a).
• Software phantoms for Multiple Sclerosis based on an overall manual design have
been developed in (Rexilius et al. 2003; Rexilius et al. 2005). An extension using
a fully automatic method to build an arbitrary number of MS data sets was later
published in (Rexilius and Tönnies 2014b).
• A software phantom for brain tumors has been published in (Rexilius et al. 2004).
Tumor growth is simulated based on a linear elastic model. Initially, we developed
this model to capture shape changes of the brain during neurosurgery (Rexilius et al.
2001; Rexilius et al. 2002). An overview of our approach together with other meth-
ods can be found in (Warfield et al. 2002). Furthermore, our non-linear registration
method has been used for a multi-modal analysis (Verhey et al. 2002; Verhey et al.
2005).
• To provide an easy-to-use tool for manual phantom design, we developed an interac-
tive software assistant. The results have been published in (Rexilius et al. 2008).
• The implemented MS lesion software phantoms have been used for several applica-
tions. In (Rexilius et al. 2003; Rexilius et al. 2005), we used them to evaluate lesion
volumetry algorithms including manual and semi-automatic methods. A phantom-
based evaluation of a well-known segmentation method has been published in (Rexil-
ius and Tönnies 2014b).
• Similar to MS lesion phantoms, we also used our brain tumor phantoms for the eval-
uation of a segmentation algorithm. Our current brain tumor phantom consists of
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only a single sequence. A multispectral extension will enable the analysis of our own
segmentation algorithm (Rexilius et al. 2007), which is part of future work.
• Today, only few approaches are used for phantom validation in medical imaging. We
propose an iterative approach based on an evaluation of different validation methods.
Our long term goal is a standardization of phantom validation. Therefore, the formal-
ization of the validation process proposed in this work is an important step. Initial
results of our work have been published in (Rexilius and Tönnies 2014b). The itera-
tive validation method has been presented in (Rexilius and Tönnies 2014a).
1.3. Thesis Structure
The rest of this thesis is organized as follows:
Chapter 2. Chapter 2 provides a general overview of phantom design approaches and pro-
poses a new classification scheme. Furthermore, we introduce design requirements,
which each phantom should reflect to a certain extent. Since our work focuses on
software phantoms, we propose an additional categorization for this phantom type
into stylized phantoms, voxel phantoms, and hybrid phantoms.
Chapter 3. In this chapter, we perform a detailed examination of parameters used in phan-
tom development. Furthermore, we propose a classification into different groups,
each modeling a certain aspect of a phantom.
Chapter 4. In this chapter, we introduce a modular design approach that is suited to de-
scribe any phantom. Based on a formalized description for each parameter, we pro-
pose several methods for parameter modeling. Furthermore, an easy-to-use software
assistant is presented that enables an interactive design of software phantoms.
Chapter 5. After discussing how to design a phantom and the underlying parameters, we
introduce three example phantoms. For each of them, the template sheet introduced
previously is used to provide a brief overview. Two phantoms are based on a manual
object design, targeting Multiple Sclerosis lesions as well as brain tumors. Object
deformations affecting the background data are modeled to describe tumor growth
based on a linear elastic model. The third example extends the above methods to
a fully automatic approach. A statistical map of object positions and an automatic
selection of other parameters such as shape or volume enable the generation of an
arbitrary number of phantom data sets.
Chapter 6. In Chapter 6, the phantoms developed so far are used for the evaluation of al-
gorithms that frequently occur in clinical practice and trials. First, we analyze the
quality of visual assessment in MS lesion volumetry. Further applications are the
evaluation of current algorithms for lesion volumetry as well as an analysis of seg-
mentation methods.
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Chapter 7. This chapter concludes the first part of our work. We discuss the main ob-
jectives related to phantom development and recapitulate our contributions. This es-
tablishes the basis for an in-depth analysis of the phantom quality in Part II of this
work.
Chapter 8. Chapter 8 gives an overview of validation approaches used in medical image
analysis and summarizes important characteristics. Furthermore, we discuss current
validation strategies, which can be applied to phantoms.
Chapter 9. This chapter is dedicated to the validation of phantoms. In the first part, we
recapitulate major challenges of phantom validation and identify a link to the overall
requirements for phantom development already addressed in Chapter 2. To assess the
phantom quality, we then propose a novel iterative validation approach. Each iteration
consists of a separate validation approach, that increases or decreases the confidence
in the phantom.
Chapter 10. In Chapter 10, we apply the proposed phantom validation approach to validate
the MS lesion phantoms introduced in Chapter 5.
Chapter 11. Finally, Chapter 11 concludes this thesis. We reflect the main challenges of
phantom validation and our contributions in this field. The thesis is completed with a
discussion of future work.
6 1. Introduction
2. Related Work
What is a phantom? In this chapter, we provide a general overview of today’s phantom
design approaches and outline early and more recent work. A principal definition of a
phantom and general requirements are given. Furthermore, we propose a categorization
into different layers that abstract the core functionality from the actual application: the
phantom type, the simulation approach, and the overall phantom appearance. Since our own
work largely focuses on software phantoms, we present a comprehensive survey on software
phantom design. A common classification scheme into stylized and voxel phantoms as well
as the combination of both, so-called hybrid software phantoms, is considered in this work.
2.1. Phantoms – Principles and Definitions
In manufacturing and engineering, quality control (QC) or quality assurance (QA) have
become an important requirement to meet customer requirements. When a newMR scanner
is installed or maintained within a clinical environment, extensive calibration and testing
are necessary to ensure that the system is operating within the demanded specifications
(Chen et al. 2004). Thereby, QA is largely concerned with image quality using specifically
designed phantoms, i.e., test objects with a known ground truth with respect to different
imaging parameters (McRobbie et al. 2003). Such phantoms gain even more importance
for testing and calibration when data is collected and analyzed by different scanners and at
different institutes, e.g., in multicenter trials (Fu et al. 2006).
Besides QA of scanner parameters, the usage of phantoms is also an integral tool during
the design, implementation, and utilization of new image analysis methods. Simulations of
different image acquisition parameters, such as the slice thickness, provide a standardized
way to generate data with known ground truth. Realistic simulations of anatomical struc-
tures further allow a dedicated performance characterization and evaluation of segmentation
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and registration methods. Even education and training of medical students and professionals
in medical disciplines involving anatomy and radiology are now common applications for
simulation environments (Hoehne et al. 2003). Furthermore, surgical training with differ-
ent normal and pathological cases can benefit from phantoms based on anatomical models
(Petersik et al. 2003).
Unfortunately, not all effects of an MR system or of an examined pathology can be
simulated with a phantom in a sufficient way; simplifications of the geometry or of the ac-
quisition parameters are inevitable. Human control subjects, on the other hand, yield com-
pletely realistic images and could thus provide a basis for parameter evaluation. However,
a known ground truth is usually not available and reference measurements are computed by
software or by human observer, e.g., manual segmentations by a radiologist. Furthermore,
large multispectral image acquisition protocols can be tedious for a subject, and there may
be ethical issues concerning (repeated) injection of contrast agent. Healthy and patholog-
ical structures and organs also show high variability with respect to appearance, size, or
shape, complicating the generation of established and representative data sets. Therefore, a
method to generate different phantoms with a known ground truth constitute a general tool
for an initial analysis and a quantitative validation of both new image analysis methods and
scanner parameters.
2.1.1. General Requirements
Besides the different tasks a phantom should be able to perform, the actual design process
raises several questions. How can we build a phantom? How can we measure the quality of
a phantom? And what is a good phantom anyway? General requirements for phantoms are
suitability, flexibility, and correctness (cf. Fig. 2.1).
Suitability. In our definition we already highlighted a known ground truth for a phan-
tom as a central aspect. Thus, the first requirement is a preferably complete modeling of
all features of real image data. Unfortunately, it is not possible to model all features of
an image, because some of them might not even be known or very complex to model. A
reasonable compromise could be to model only aspects, relevant for the application in mind.
For example, analyzing a lesion segmentation based on global thresholding will not require
a phantom with exact positions for each lesion.
An alternative strategy could be the utilization of post-mortem images of histological
sections such as cryosection images of representative male and female cadavers (Spitzer
and Whitlock 1998), applied to the confirmation of in-vivo data. However, various nonlin-
ear deformation artifacts such as shrinkage, tearing, or partial loss of tissue are introduced
within the tissue, and suitable correction methods must be applied. Moreover, physical
changes within the observed tissue may result in modifications of magnetic characteristics
and thus in different tissue intensity contrast.
Correctness. After deciding on the required parameters of a phantom, each parame-
ter should be generated from a correct model and in an appropriate parameter distribution.
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Figure 2.1. General design properties of a phantom.
Anatomically detailed properties allow for a plausible design with respect to examined struc-
tures of the human body. Especially parameters such as a known size and volume are an
important step towards representative data sets for a quantitative analysis.
However, characterizing the quality of a parameter or even of the whole phantom is
difficult and heavily depends on the considered task. While phantoms used for QA usually
do not depend on a mixture of components or complicated structures, a sophisticated design
with complex shape assumptions and several different tissue classes is often required for
phantoms. Common measurement tools comprise visual assessment of the acquired images
by medical experts. Other approaches try to ensure anatomical and functional correctness
by adapting the phantom to a given patient data set (Prastawa et al. 2009). For example,
a heart phantom based on intensity-averaged MR series of a single healthy volunteer is
proposed by Moore et al. (2003).
Flexibility. The third requirement for a phantom is a flexible design approach. Each
parameter should be easily changeable, resulting in the ability to generate phantoms of
arbitrary shape, appearance, structure, or contrast behavior. Furthermore, simulation of
dynamic processes including contrast enhancement or deformations due to tissue growth
and shrinkage respectively would allow for a broad range of different applications.
2.1.2. The ’Perfect’ Phantom
After discussing general design requirements in the previous section, what would be a per-
fect phantom? Generally, such a phantom should reflect all requirements (suitability, correct-
ness, flexibility) to a certain extent. However, each application will have its own definition
of what is needed for evaluation. A scanner calibration procedure does not need a phantom
shaped like a real organ. Therefore, an object as shown in Figure 2.2 (a) could be described
as a perfect phantom to control certain imaging parameters of an MR scanner.
In the field of medical image analysis on the other hand, a different approach is required.
Here, a simple shape is often not enough to model anatomical variability of a real patient
data set (cf. Fig. 2.2 (b)). For example, validating a new liver segmentation method requires
a phantomwith an appropriate shape model of the liver. A following quantification approach
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(a) (b) (c)
Figure 2.2. From simple phantoms to actual patient data sets — the perfect phantom for an appli-
cation. (a) Physical phantom (from General Electrics) used for scanner calibration, (b) simple
software phantom consisting of two circles for initial algorithmic evaluations, (c) CT patient data
set of the liver without known ground truth.
Figure 2.3. Categorization of the phantom design process.
would also require a known object volume of the phantom. Here, a perfect phantom consists
of a data set that is not distinguishable from a patient data set. Additionally, the ground truth
should be known for each parameter and should be easily changeable.
2.2. A Categorization Scheme for Phantoms
In addition to basic requirements for a phantom, a taxonomy should be established catego-
rizing the design process. In this work, we propose a partition into different layers that are
separated from the actual application. Figure 2.3 gives an overview of the proposed cate-
gories. Three main layers are identified, each employing certain constraints to determine
the properties of a phantom.
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2.2.1. Physical vs. Software
The first design decision in the phantom development process includes the choice of the
required QA procedure for the system in mind, and thus the general phantom type. Testing
of medical imaging devices requires real objects to be placed in the scanner, which are thus
denoted physical phantoms. Physical phantoms were introduced into medicine for radio-
logical use in the 1910’s (Lee and Lee 2006). At that time, water tanks and wax blocks
were usually applied for x-ray experiments. Although some are still in use in certain appli-
cations, technology has evolved along with radiological imaging equipment since. Today,
physical phantoms are manufactured using a variety of available materials and processes.
Tanks filled with water, oil, or other liquids are commonly used for acceptance testing of
MR systems. Incorporated geometric objects based on acrylic compounds such as plastic
allow for an examination of a broad range of imaging parameters.
Physical phantoms can also be generated from actual tissue. For example, Sekhar et al.
(2014) propose a bovine–porcine tissue phantom for liver biopsy simulations. A model that
allows to simultaneously capture internal images of a working heart and to record physio-
logical parameters of both mammalian and human beating hearts has been proposed as well
(Visible Heart Project ). Another interesting approach is proposed by Klink et al. (2014).
In their work, the authors develop a brain phantom from segmented MR and CT data of a
patient. Different rapid prototyping methods such as a 3D printer are used to generate the
modeled tissue classes.
If the development and testing of a new system is very complex or even too expensive to
be implemented at every design stage, computerized models and simulations are an advanta-
geous alternative in many areas including engineering, physics, and biology. Such software
phantoms provide a flexible, reproducible, and cost-effective way for the evaluation of new
methods and systems. Medicine as well as medical image analysis have also become an
established field for the utilization of software phantoms. Early approaches for the simula-
tion of human anatomy in medicine were used for planning of radiotherapy, developed in
the 1960’s (Caon 2004). Evaluations of modern segmentation and quantification methods
are commonly based on both simple artificial objects such as a square or a sphere (Noe and
Gee 2001; Warfield et al. 2004), as well as on models of anatomical structures (Collins et al.
1998; Kazemi et al. 2011).
The different approaches to represent human anatomy have led to a further specializa-
tion of software phantoms into three classes: stylized phantoms, voxel phantoms, and a com-
bination of both, so-called hybrid phantoms (cf. Fig. 2.4). Each of these, also called com-
putational anthropomorphic phantoms, differ in their basic design properties (cf. Fig. 2.1).
An extensive review of the three software phantom classes can be found in (Caon 2004; Lee
and Lee 2006). An example for each software phantom category is shown in Figure 2.5. A
comparable categorization could also be established for physical phantoms.
A more detailed overview of parameters used in both physical and software phantom
design along with their targeted applications is given in the next chapter.
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Figure 2.4. Categorization of software phantoms.
Stylized Phantoms
Stylized or mathematical phantoms describe the shape of a considered structure using sim-
ple mathematical representations such as planes, cylinders, spheres, or combinations thereof,
i.e., the underlying ground truth is defined by mathematical equations. One of the first mod-
els was developed for dosimetry calculations in radiography and radiotherapy at the Oak
Ridge National Laboratory (ORNL) (Fisher and Snyder 1966; Cristy 1980). These phan-
toms, also known as ’MIRD’ phantoms (after the Medical Internal Radiation Dose Com-
mittee), assemble the major body sections and principal organs from simple equations. For
example, the brain is represented by an ellipsoid, and the liver by an elliptical cylinder cut
by a plane. In medical image analysis, stylized phantoms are an important step in validation
studies of new segmentation and registration algorithms, e.g., (Drexl et al. 2004). Espe-
cially during early development stages, simple shapes with known geometries provide an
excellent testing environment.
Voxel Phantoms
With the advances of modern tomographic imaging technology such as MR and CT, high-
resolution 3-dimensional digital images of anatomical structures can be acquired, facilitat-
ing a better representation of the human body. Concomitantly, software phantoms con-
structed from such data sets have gained importance for different applications. These
voxel or tomographic phantoms typically consist of a patient data set with manual or semi-
automatic segmentations of different tissues or organs. Voxel phantoms may even comprise
images from more than one individual.
The Zubal phantom offers a precisely labeled segmentation of different organs and other
internal structures from a CT data set of a single subject. Furthermore, T2-weighted MR
images of the brain were outlined, resulting in 62 designated neurological and taxonomical
structures (Zubal et al. 1994). One of the most popular digital phantoms in medical image
analysis is the brain phantom proposed by Collins et al. (1998). Due to its quality and its free
availability from the Montreal Neurological Institute (MNI), it is often used in validation
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(a) (b) (c)
Figure 2.5. Examples of stylized, voxel, and hybrid software phantoms. (a) Stylized phantom:
combination of geometric primitives, (b) voxel phantom: slice of the BrainWeb phantom (T1-
weighted data set), (c) hybrid phantom: slice of the BrainWeb phantom with MS lesions (T2-
weighted data set).
studies (Hahn et al. 2004; Cuadra et al. 2005), or as template in atlas-based segmentation
and quantification methods (van Leemput et al. 1999).
Hybrid Phantoms
An approach that takes advantage of the flexibility of stylized phantoms and the anatomi-
cal correctness of patient-based voxel phantoms are hybrid phantoms. An interesting ap-
proach has been implemented by Segars et al. (1999). In their work, smooth surfaces are
constructed from segmentations of a cardiac MR data set based on non-uniform rational
B-splines (NURBS) technology. This enables the development of a model of the human
heart. Similar approaches for modeling respiratory mechanics (Segars et al. 2001) as well
as simulation of dynamic respiratory models for individual lung lobes and the airway tree
are proposed by the same group (Garrity et al. 2003).
Burgess et al. (2003) propose a software phantom for mass discrimination in mammo-
grams. In their work, masses extracted from digitized surgical specimen radiographs are
added to regions of digitized normal mammograms. A similar technique has been applied
to study the effect of wavelet-based data compression on lesion detection in digital mam-
mograms (Suryanarayanan et al. 2005). A software phantom consisting of two concentric
ellipsoidal surfaces with varying sizes and levels of segmentation error, and missing surface
information for the segmentation of radiofrequency ablation induced thermal lesions is pro-
posed by Lazebnik et al. (2002). Furthermore, a physical phantom using in vivo lesion
images obtained from an animal model is used in their work.
2.2.2. Static vs. Dynamic
Once we have decided on the required phantom type, the next step is to determine what
to simulate. Here we consider structural or static approaches and dynamic approaches that
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simulate processes. The typical static method includes a certain object used for testing
purposes, and the examined QA parameters largely denote morphological measurements
such as the size and the volume of a lesion or an organ. A more complex task is to simulate
a dynamic process within a phantom. Recent approaches include biomechanical modeling
of deformations due to tissue growth and infiltration of brain tumors, as well as simulating
treatment strategies for therapy planning (Swanson et al. 2003). A simulation of contrast
enhancement characteristics is proposed in (Brix et al. 1999). A phantom that combines
different organ models of the torso with cardiac and respiratory motion simulations has
been developed in (Segars et al. 1999; Garrity et al. 2003).
2.2.3. Artificial vs. Realistic
A further design decision is the actual appearance of the phantom and its complexity. Ar-
tificial objects based on simple geometric primitives such as a cube or a sphere provide an
easy-to-handle test framework with a known ground truth based on simple mathematical
expressions (Cinti et al. 2004; Warfield et al. 2004). Moreover, they present a cost-effective
design strategy for physical phantoms. For example, an inexpensive tissue-equivalent breast
phantom consisting of lard (a solid cooking fat) surrounding a commercial jelly product is
proposed by Liney et al. (1999). Nevertheless, anatomical correctness is favored in many
cases. Especially image analysis methods that make use of anatomical prior information
require realistic phantoms tailored to the considered application. Common design schemes
consist of complex representations of anatomical structures using plastic cutouts (Hoffman
et al. 1990), or use data sets from patients and/or healthy volunteers (Zubal et al. 1994).
To take advantage of features from both, standardized mathematical equations and anatomi-
cal realism, hybrid phantoms have also been proposed by some investigators (Garrity et al.
2003).
2.3. Discussion
This chapter introduced two aspects we focus on in this work. The first part was dedicated to
the question: What is a phantom? The second part provided an overview over common ap-
proaches in medical image analysis that will be further discussed in the context of phantom
design in the upcoming chapters.
So, what is a phantom? Creating a model before creating a product has become a com-
mon technique in many engineering disciplines. Automobile designers build scale models
of a new car and create 3D computer visualizations in order to provide a visible, early so-
lution of their design. Such prototypes allow designer and customer to validate the require-
ments and design specifications. Phantoms in medical imaging are designed to achieve sim-
ilar goals: The development of a phantom is concerned with the evaluation of new analysis
approaches or the calibration and testing of imaging devices. Thereby, phantoms provide a
cost-effective and time-saving approach in comparison to an analysis based on actual patient
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Figure 2.6. Degree of agreement of the three software phantom types with the general design
requirements introduced in Section 2.1.1. Good (+), average (◦), low (−).
data. Furthermore, they allow focusing on the really important features of a testing proce-
dure. For example, analyzing the field inhomogeneity of an MR scanner does not require a
shape of a human organ. However, the quality and importance of the modeled parameters
are essential issues for the applicability of the whole phantom, and the following chapters
will discuss this aspect in detail.
Software Phantoms
Besides a general overview of design requirements we also proposed a categorization scheme
that partitions a phantom into three categories, namely the phantom type, the simulation ap-
proach, and the phantom appearance (cf. Fig. 2.3). Especially software phantoms were
surveyed, because they present the main category in this work. They provide a flexible and
more reproducible design approach and an advantageous alternative to physical phantoms
for many applications, e.g., applications that require a detailed object shape.
We divided software phantoms into three groups (cf. Fig. 2.4): stylized phantoms, voxel
phantoms, and hybrid phantoms, each having their own advantages and drawbacks. Figure
2.6 illustrates the degree of agreement with the proposed design properties for each group.
A similar categorization could also be used for physical phantoms.
Stylized Phantoms. The simple mathematical description of each object in stylized
phantoms allows for a flexible and simple adaptation of imaging parameters. Furthermore,
changing the volume or position of an object can be easily achieved. However, geometrical
models based on mathematical equations alone inherently limit exact modeling of complex
shapes, resulting in a low degree of agreement with respect to suitability and correctness of
the considered parameters.
Voxel Phantoms. Although voxel phantoms offer the ability to create appropriate mod-
els of the human anatomy that surpass stylized phantoms (suitability & correctness), several
limitations still exist. An important drawback is the missing ground truth of the scanned
anatomical structures. For example, the amount of white matter in the brain or the volume
of a tumor is not known and can only approximated, which makes an analysis of new quan-
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tification techniques difficult. Furthermore, a limited data pool and a limited resolution can
not account for all anatomical variations and pathologies. The phantom construction can
also be time consuming due to the required segmentation task for each structure. Moreover,
small structures in the order of the voxel dimension may not be accurately segmented, and
extensive acquisition protocols with long scanning times or repeated injection of contrast
agents often prevent from scanning patients or probands in the preferred way. Therefore,
this approach results in a limited flexibility.
Hybrid Phantoms. Hybrid phantoms are most suitable for the analysis of newmethods
and systems, since they combine the advantages of the two other categories. The resulting
data sets provide a suitable model for several parameters plus a flexible handling of them.
A main feature is the separation between object and background. An example of a hybrid
phantom could be as follows: An object with a suitable shape incorporated into a patient
data set. In other words, we focus on the development of objects with relevant parameter
models, and assume the background to be already available. This approach provides great
flexibility and suitability during object modeling. However, this approach results into a
phantom design with only moderate correctness, since some parameters may not result from
actual patient or volunteer data and have a rather simple layout. To this end, a careful
selection of the important features has to be taken by the developer. The following chapters
will present a survey on how different parameters can be modeled, and present our approach
to phantom development. Furthermore, an analysis of possible applications and limitations
is provided.
Part I.
Phantom Development
17

3. Parameters in Phantom Development
The development of phantoms in medical imaging is a challenging task. Important aspects
are the complexity of the underlying problem domain and the difficulty of modeling all re-
quired parameters in a sophisticated way. The previous chapter has given a general overview
of design approaches and proposed a categorization into different layers. Now, we present
a more detailed examination of parameters used in phantom development. We propose a
categorization into different groups: The first group contains morphological and topolog-
ical parameters associated with the appearance of an object such as shape or volume (cf.
Sec. 3.1). The second group includes parameters related to the acquisition process, such as
noise, uniformity, or spatial resolution (cf. Sec. 3.2). The last two groups contain a general
scanner parameter and the modeling of processes such as tumor growth (cf. Sec. 3.3). See
Figure 3.1 for an overview.
For each group we present a general description of examined parameters. Furthermore,
we give an overview of typical phantom examples from literature, that model the consid-
ered parameters as well as associated applications. Thereby, the description of phantoms
is divided into physical and software phantoms. Each section concludes with a compact
summary of the presented modeling approaches, again divided into physical and software
phantoms.
3.1. Morphological and Topological Parameters
The initial design decision in phantom development is typically related to the appearance
where important aspects are the morphology and the topology of the generated objects.
This includes parameters such as shape, orientation, or volume. For example, a muscle has
a different imaging characteristic than the liver. Normal tissue has a different appearance
than pathological tissue.
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Figure 3.1. Overview of parameter groups presented in this chapter.
3.1.1. Parameter Description
Shape
The shape of a structure is an integral part of many clinical applications forming a rela-
tionship between visual appearance and function. Each organ has a characteristic shape,
and pathologies are often related to an abnormal shape of the analyzed structure. Using
shape related parameters has also become a common approach in medical image analysis.
Many segmentation methods incorporate specific knowledge about the morphology of an
organ to constrain the approximation of the object contour, e.g., by using a statistical shape
model which provides a parametric description of object variations based on a set of aligned
training data.
For example, Liney et al. (2006) propose a number of shape features such as convexity
or circularity to differentiate benign and malignant breast lesions. Thereby, a common
challenge is the typically large variability of anatomy within a shape population.
Structure
Another parameter to describe the appearance of an object is related to its underlying struc-
ture, i.e., the different components or tissue classes. Such a classification plays an important
role in diagnosis and therapy planning, and multispectral acquisition protocols are often re-
quired. For example, a brain tumor can consist edema, active tumor, or necrosis. Here, a
differentiation is essential of these tissue classes for treatment planning such as resection or
radiation therapy.
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Volume
The volume of an object is another important descriptor. Several studies have reported the
clinical use of volumetric measurements as a surrogate marker for different applications and
body parts. For example, brain atrophy as well as atrophy of certain brain structures such
as the hippocampus have emerged as sensitive predictive markers for disease progression
in Multiple Sclerosis and in Alzheimer disease (Miller et al. 1998; Henneman et al. 2009).
A volumetric growth assessment of lesions is also an essential task in many applications
including oncological therapy monitoring (Ko et al. 2003), estimation of total lesion load
in Multiple Sclerosis (Molyneux et al. 1998), or the computation of residual tumor volume
as a predictive survival rate after brain surgery (Wood et al. 1988).
Topology
Besides the general appearance of an examined object, its topology has to be considered for
an in-depth analysis. We relate the topology to the location or position of an object within
the background, as well as the position in relation to other objects. Although anatomical
structures have their pre-defined positions or at least a reference range of typical locations,
deviations can give insight into potential pathologies. Furthermore, the location of a patho-
logical structure such as a lesion is an important feature for diagnosis and treatment plan-
ning: A tumor deep inside the brain is more difficult to access for surgical removal than one
at the surface. In liver surgery, a tumor close to a large vessel can have major impact on
the remaining liver volume, since a surgeon removes the tumor with a lap of surrounding
healthy tissue.
3.1.2. Phantoms
After discussing common parameters related to morphology and topology, we now present
a survey of phantoms modeling these features. The same categorization as above is used to
group the referenced publications. Of course, the discussed phantoms in this section only
present a subset of possible applications. We focus on common examples including brain,
breast, heart, or liver.
Shape
Shape is an important spatial property of a phantom. Unfortunately, complex anatomical
and pathological shapes are difficult to model, especially for physical phantoms. Further-
more, these phantoms have to cope with the problem of long-term physical stability. Nev-
ertheless, several physical phantoms with a realistic anatomical appearance have been pro-
posed, and some are even commercially available, e.g., via CIRS, Norfolk, USA. The Hoff-
man brain phantom (Hoffman et al. 1990) comprises a representation of the outer edge of
the human brain, of the interface of white and gray matter, as well as of the ventricle region.
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Nineteen independent plastic plates that can be stacked in a plastic cylinder, facilitate com-
plex simulations of radioisotope distributions found in the brain. User-defined defects can
be added to simulate clinical abnormalities. A related approach is presented in (Pupi et al.
1990).
Other groups use rather simple shapes such as spheres or ellipsoids to model their phan-
toms. Ko et al. (2003) use a realistically shaped chest phantom composed of different
materials simulating bone, lung, muscle, and fat to study quantification methods for small
pulmonary nodules. The actual nodules are acrylic spheres placed into small wells drilled
into the material of each lung. A physical phantom of the upper abdomen consisting of 17
synthetic lymph nodes of ten different sizes is proposed in (Keil et al. 2009). A related, how-
ever much simpler phantom consisting of wells within a Plexiglas cylinder is presented by
Drexl et al. (2004) for the analysis of vessel segmentation approaches. Physical phantoms
for many other anatomical structures and applications have been proposed as well (Timinger
et al. 2006; Mattila et al. 2007; Tofts et al. 1997; Cinti et al. 2004).
Similar to their physical counterpart, software phantoms have been proposed with a
wide range of different shapes, each shape again being on a scale of simple geometric
objects to realistic anatomical appearance. One approach to model anatomically realistic
shapes within a software phantom is to use digitized real lesions, e.g., obtained after biopsy.
A software phantom for mammograms is proposed by Burgess et al. (2003). Here, digitized
masses from patient data sets are incorporated into normal mammograms. However, digi-
tized real lesions are often not available, and other representations of these structures are
required. A common method is to extract the shape from segmented volunteer or patient
data sets. A popular example is the BrainWeb phantom by Collins et al. (1998). In a related
approach, Kauffmann et al. (2003) use segmentations of the tibia and the femur geometries,
as well as of cartilage for the quantification of cartilage thickness and volume changes.
Several simple geometric software phantoms have been proposed as well. Stylized phan-
toms are a common approach for dosimetry calculations in radiotherapy (Fisher and Snyder
1966; Lee and Lee 2006). Schlüter et al. (2005) propose a phantom for the analysis of
fiber tracking algorithms on diffusion tensor data. Synthetic fiber bundles based on mathe-
matical equations as well as clinical data serve as basis for evaluation. A spherical lesion
phantom is added to assess the robustness of fiber tracking methods to fiber disturbance. A
software phantom consisting of two concentric ellipsoidal surfaces with varying sizes and
levels of segmentation error is proposed by Lazebnik et al. (2002) for the segmentation of
radiofrequency ablation induced thermal lesions.
Structure
Developing phantoms that consist of several components is a challenging task, especially
for physical phantoms. Each structure requires its own anatomical shape and imaging pa-
rameters such as contrast or noise. Therefore, common physical phantoms consist of one
or more geometric structures and of a single material. Depending on the targeted applica-
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tion, this can be an acceptable solution, e.g., for quality assurance of MR systems (Price
et al. 1990). However, analyzing anatomical or functional patterns within the human body
requires phantoms with a more detailed underlying structure. To give an example, a suitable
phantom to examine brain tissue deformations during neurosurgery should include a model
of all important structures such as different tissue types as well as blood vessels. A first step
in this direction is presented in (Reinertsen and Collins 2006). Several physical phantoms
of more than one component for other structures have been proposed as well (Hoffman et al.
1990; Timinger et al. 2006).
Software phantoms have the ability to be easily composed of different tissue classes, and
phantoms have been proposed for various anatomical structures up to whole body phantoms
(Lee and Lee 2006). Again, the BrainWeb phantom is a prominent example. It consists of
ten tissue classes including gray matter (GM), white matter (WM), and cerebrospinal fluid
(CSF). Furthermore, an extension with additional structures (blood vessels, the dura matter,
marrow, etc.) is proposed by Aubert-Broche et al. (2006). A brain phantom including
tumor and edema is presented in (Prastawa et al. 2005). A diffusion-reaction model is used
to guide edema growth and tumor infiltration. Zhang et al. (2008) propose a breast phantom
including the simulation of skin, adipose tissue, and fibro-glandular tissue.
Volume
Phantoms used to analyze the volume of an anatomical or pathological structure often have
a rather simple geometric shape. Reasons are the associated time and costs for develop-
ing complex objects with known volume plus correct imaging parameters and morphology.
Another aspect is anatomical feasibility. Especially, methods that quantitatively assess the
volume of lesions use roundish or ellipsoidal objects (Luft et al. 1996). Multiple Sclerosis
lesions (Tofts et al. 1997) and pulmonary nodules (Ko et al. 2003; Winer-Muram et al.
2003) are typical examples. Kuhnigk et al. (2006) use a physical lung phantom consisting
of 39 spherical and non-spherical objects of different diameters for a volumetric assessment
of lung nodules.
Nevertheless, a detailed volumetric analysis often requires phantoms with a more com-
plex shape. The BrainWeb software phantom is one of the most common data sets for the
evaluation of methods for brain volumetry, see for example (Shattuck et al. 2001; Hahn
et al. 2004; Cuadra et al. 2005).
Topology
The position of an object within the background structure is seldom explicitly modeled in
physical or software phantoms. Instead, objects incorporated in phantoms are spread ran-
domly or in some pre-defined pattern throughout the underlying background material (Pikus
et al. 2006). Furthermore, a specific object position presumes a surrounding background
related to an anatomical structure, i.e., there is no need for careful positioning if the back-
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ground is made of a single material without any specific anatomical shape (Winer-Muram
et al. 2003).
An approach towards a realistic topology could be to position objects at similar loca-
tions found in patient data sets. Reynolds et al. (2007) propose a direct mapping of 2D
coordinates of melanoma positions onto a 3D anatomical model created from the Visible
Human data set. Ko et al. (2003) place several wells at typical positions of lung nodules
in the periphery of each lung at a pre-defined distance to the pleura and in the center of the
lungs. Phantoms in the field of radiation dose calculation use the shape of a human body
with incorporated objects (Lee and Lee 2006). Each object is shaped as an internal organ
and placed at an approximately correct position.
Summary
This section provides a brief overview of the modeling approaches discussed above. Thereby,
physical phantoms and software phantoms are given for each parameter.
3.2. Imaging Parameters and Artifacts
Besides morphological and topological parameters, imaging parameters and artifacts are
further important aspects in phantom development. Acquiring a data set from an MR or CT
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scanner comprises many features related to the acquisition process and associated artifacts.
Image artifacts are intensity values in an image that do not have a corresponding anatomical
basis, i.e., values that are not present in the imaged object. Thus, they influence the image
appearance such as a hyperintense signal in the background or a drop-out of signal where
there should be something. Each modality causes own artifacts, and considering all will
go beyond the scope here. Therefore, we focus on MRI image data in this work, which
have numerous potential sources of image artifacts and each pulse sequence has its own
problems.
Here we only give a brief overview of common imaging parameters and artifacts. For
an in-depth discussion we refer to standard literature and textbooks such as (McRobbie et al.
2003).
3.2.1. Parameter Description
Contrast/Intensity
To examine normal anatomical or pathological structures within an image, a contrast be-
tween adjacent tissue classes is needed. In MR imaging, an intensity value depends on
several effects influenced by the used pulse sequence. Thereby, altering the local magnetic
field with respect to a voxel position varies the signal intensity in the examined tissue. Fur-
thermore, several new and evolving imaging techniques such as diffusion tensor imaging
(DTI), magnetization transfer imaging (MTI), or MR Spectroscopy (MRS) have opened up
new opportunities in MR imaging. Another possibility to change the contrast between cer-
tain tissue types is to administer a contrast agent to a patient. For example, a contrast agent
based on the paramagnetic gadolinium is used to visualize areas of enhancing brain tumors
with a disrupted blood-brain-barrier.
Noise
Unfortunately, imperfect imaging conditions result in fluctuations in the signal measured
with an MR scanner and thus of the voxel values in an image. The term noise or random
signal is used to describe this component. Different sources of noise arise during an acquisi-
tion such as thermal noise from the imaged subject or the coil temperature, or quantization
artifacts from the analog to digital conversion. However, anatomical variations in a mea-
sured tissue may also result in deviations from the expected signal intensity. See (Sijbers
1998) for a more detailed overview. A noise measure is the Signal to Noise Ratio (SNR) that
quantifies the amount of signal with respect to the amount of noise. A common definition
is given by McRobbie et al. (2003) as
SNR =
µ
σ
(3.1)
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SNR Signal to Noise Ratio
µ mean value of signal
σ standard deviation of noise.
The SNR will be large for areas with a large mean signal value or a low noise level. The
above mentioned spread of possible intensity values is commonly described by a Probability
Density Function (PDF). The complexMR signal noise can be described by a Gaussian PDF
as
p(i) =
1
σ
√
2pi
exp
[
−(xi−µ)
2
2σ2
]
(3.2)
p(i) Gaussian PDF with model parameters θ = (µ,σ)
µ mean value
σ standard deviation.
For magnitude MR images, this PDF transforms into a Rician distribution (Sijbers 1998). In
the special case of low SNR, e.g., in the background of an MR image, this PDF is reduced to
a Rayleigh distribution. For high SNR, the Rician PDF is well approximated by a Gaussian
distribution. This result will be applied in Part II of this work on image segmentation and
classification, where we use a Gaussian PDF to characterize the distribution of brain tissue
classes. Other imaging modalities such as CT or PET have their own noise models.
Resolution
The spatial resolution of an image describes the level of detail, an MR scanner is able to
achieve. Or simply stated, the image resolution is determined by the size of a voxel —
the larger the voxel size, the lower the resolution, and the less accurate an object is imaged.
Thereby, we have to consider the in-plane resolution and the slice thickness, which are often
different. In this work, we typically work with data sets having an in-plane resolution of
1× 1mm2 and a slice thickness of 1− 3mm. Unfortunately, MR resolution is limited with
respect to the amount of SNR. The available scan time is another limiting factor.
Field Inhomogeneities / Nonuniformity
MR scanners seldom have a uniform magnetic field. Therefore, a measured homogeneous
tissue region will often not result in a uniform MR signal intensity, but in variations across
the image. These distortions are typically caused by hardware imperfections, but can also
result from susceptibility of the imaged object.
Motion Artifacts
Another common artifact is caused by motion of the imaged object during the acquisition,
resulting in a blurring of an entire image or parts of it. Two types of artifacts due to motion
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Figure 3.2. Illustration of the partial volume effect. A black object is sampled in a white background,
resulting into voxels with different gray values between black and white at the object boundary.
can be observed: involuntary movements, such as respiration and cardiac motion, and ran-
dom patient movements. A reduction of the first type can be used to gate the acquisition to
the breathing or the cardiac cycle of a patient. Patient movement during the acquisition can
be reduced by immobilizing the imaged body part.
Partial Volume Artifacts
Digitizing a continuous signal into a finite number of data points results into voxels that
contain a mixture of tissue types, which is referred to as Partial Volume (PV) effect. The
intensity values of these PV voxels can be calculated as proportional sum over the individual
tissues. For example, a black object in a white background will result into PV voxels with
mid-range gray values, i.e., the PV effect spreads out the object and it will appear larger
than it actually is. This could for example have influence on treatment planning if the PV
effect is not taken into consideration during measuring the object size. See Figure 3.2 for
an illustration of the PV effect in such an image.
Several parameters have an effect on the PV effect, only some of which can be con-
trolled. PV effects strongly depend on the size of an examined object. For example, the
volume of the liver might be analyzed with a larger voxel size than a lesion with a diameter
of only a few millimeters. A way out of this dilemma could be to increase the resolution and
acquire data with a voxel size that is small enough for the examined object. Unfortunately,
scanner and acquisition protocol, as well as patient acceptance of long scan times limit the
feasible data resolution. Another parameter influencing the amount of PV is the shape of an
object. A large surface area for a given volume will result in a larger amount of PV. Thus,
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an irregular object is more affected than a spherical or cuboidal one, because a larger part
of the object is close to the boundary and thus prone to PV effects.
Further Imaging Artifacts
Besides the above mentioned artifacts, several other can occur as well. Some are mentioned
in this section.
Susceptibility and (metal) artifacts. Magnetic susceptibility describes the degree of mag-
netization of a tissue when placed in an external magnetic field. Different tissue types be-
come magnetized to different extents, causing local distortions that result in a loss of signal.
Similar artifacts occur in the presence of metals, which produce large magnetic field inho-
mogeneities because of their different susceptibility than body tissue.
Gibbs ringing. Truncation or Gibbs ringing artifacts are parallel bright or dark lines
that can occur parallel or adjacent to high-contrast boundaries. The effect can be reduced
by collecting more high-frequency data, i.e., by increasing the resolution. Another approach
is to apply a smoothing filter.
Chemical shift. Chemical shift artifacts refer to signal alternations that result from dif-
ferences in the resonance frequency (Lamor frequency) of nuclear spins between different
body tissues. An important example is the shift between fat and water. Because fat has
a lower Lamor frequency than water, signals from water and fat protons at the same loca-
tion will be assigned different locations when converting from the frequency to the spatial
domain, causing a misregistration.
3.2.2. Phantoms
Other than phantoms related to morphological and topological parameters presented in Sec-
tion 3.1.2, phantoms modeling imaging parameters often do not require a complex appear-
ance or a specific clinical application, Since few publications only model a single parameter,
some phantoms are addressed more than once. An approach to develop phantoms dedicated
to a single imaging parameter is presented by Price et al. (1990). The authors summa-
rize different methods for quality assurance of an MR system and their associated physical
phantoms. Required design criteria including appearance and material are examined, and
applicable sequences and scan conditions are specified. To the best of our knowledge, a
similar approach for software phantoms has not been proposed yet.
Contrast/Intensity
A physical phantom consisting of obliquely positioned cylinders within a plastic container
for the analysis of brain lesion quantification methods has been developed in (Tofts et al.
1997). To obtain lesion-like intensity values, the lesion to white matter contrast is extracted
from a data set of a patient with Multiple Sclerosis. Because these intensities vary over dif-
ferent positions within the white matter, different gray value transformations are proposed
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for a more realistic appearance. Another approach to obtain appropriate intensity values for
a physical phantom is to use material with relaxation times similar to that of human tissue.
For example, Yoshimura et al. (2003) use carrageenan gel, a polysaccharide extracted from
red seaweeds.
A common approach for software phantoms is to use so-called tissue templates, i.e., gray
values extracted from patient data or from healthy volunteers (Burgess et al. 2003; Surya-
narayanan et al. 2005). Other methods such as the popular BrainWeb phantom (Collins et al.
1998) uses an MR simulator based on a simulation of Bloch equations to provide realistic
intensity values (Kwan et al. 1999).
Noise
As described in Section 3.2.1, magnitude MR images have Rician distributed noise within
tissue and Rayleigh distributed noise in the background respectively. The BrainWeb phan-
tom uses these distributions during the simulation of MR signal intensity values (Kwan et al.
1999). Other software phantoms often simplify this approach and model image noise by a
Gaussian distribution (Noe and Gee 2001), which is also a common assumption in many
image analysis methods.
In order to determine the amount of noise, two approaches can be found: MR simulators
compute a distribution from an explicit model (Kwan et al. 1999). On the other hand, noise
can also be measured directly from an MR scan. For example, Gedamu et al. (2008)
estimate the standard deviation of the noise intensity distribution from a mask drawn in the
background of a patient data set. Price et al. (1990) draw a region-of-interest in the data set
of a physical phantom that consists of a uniform signal-producing material.
Resolution
For quality assessment or for the evaluation of new sequences, spatial resolution can be as-
sessed with physical phantoms by bar patterns, i.e., by an array of altering signal-producing
elements and non-signal-producing elements (McRobbie et al. 2003). The length of each
bar should be at least twice the slice thickness (Price et al. 1990). A convenient way for
software phantoms to model spatial resolution is to downsample a high-resolution data set.
Field Inhomogeneities / Nonuniformity
Similar to the analysis of noise or of the signal-to-noise ratio of a scanner, evaluating field in-
homogeneities requires a physical phantom filled with a uniform signal-producing material.
In image analysis, several algorithms use a nonuniformity correction as a pre-processing
step. A software phantom consisting of a cube with a random intensity distribution mul-
tiplied by a parabolic function is used for the evaluation of the popular N3 method (Sled
et al. 1998). A similar approach is used to extend the BrainWeb phantom with intensity
inhomogeneities.
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Motion Artifacts
As described in the previous section, patient motion can have several reasons, including
breathing or heart motion as well as minor patient movement during a scan. Each variant
causes blurring and ghosting artifacts and is difficult to analyze for a phantom. Sophisticated
phantoms for this task should be able to generate a number of motion patterns for each
application.
A common approach for physical phantoms is a movable device that can be controlled
by some software program. For example, Fitzpatrick et al. (2005) developed a movable plat-
form allowing the simulation of different motion patterns. Different objects can be placed
on the device resulting in a range of potential applications. Timinger et al. (2006) propose
an MR compatible ventricle phantom of the heart. Silicon tubes serve as model of the vas-
cular structure. To model arbitrary motion patterns simulating heartbeat and respiration, the
phantom is placed on a rigid plastic frame that can be mechanically controlled. A low-cost
phantom that models cardiac motion is proposed in (Huber et al. 2000).
Instead of actually moving an object within the scanner, software phantoms provide a
computational model of the underlying motion. A generic approach to obtain such a model
is based on markers placed outside a patient’s body during an acquisition that can be easily
tracked. McClelland et al. (2006) propose a patient-specific motion model to describe
deformations of lung tumors and of adjacent tissue classes during an average respiratory
cycle. The model is reconstructed from a patient data set at free breathing by non-rigid
registration of a high-resolution reference data of the same patient. Another approach has
been implemented by Segars et al. (1999). In their work, a set of surface models is created
from gated MR cardiac data of a normal patient and transferred into a 4D software phantom.
Non-uniform rational B-splines (NURBS) are used to model heart motion and to permit the
generation of arbitrary time-points. A similar approach is used by the same group to model
respiratory motion (Segars et al. 2001; Garrity et al. 2003).
Besides the above-mentioned, patient-specific models, several paper propose physiolog-
ical or biomechanical models to simulate involuntary patient movement. Wu et al. (2004)
describe the respiratory motion of patients by a finite state model including three repeating
breathing states, each corresponding to a typical action: exhale, end-of-exhale, and inhale.
An analytical simulation of cardiovascular and respiratory mechanics is presented in (Kaye
et al. 1998).
Partial Volume Artifacts
The size and shape of an object as well as the scan direction are the most prominent pa-
rameters influencing the partial volume (PV) effect, i.e., causing the border between tissue
classes to be blurred. Therefore, a common approach for physical phantoms is to study ob-
jects with differing known volume or scanning them at different spatial resolution. Typical
applications include the analysis of MS lesions (Tofts et al. 1997; Ballester et al. 2002) and
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of lung nodules (Ko et al. 2003), where the lesion size is often small compared to the slice
thickness. A similar approach is presented in (Plewes and Dean 1981). Here, a phantom
consisting of a solid block with several holes of varying diameter is used to study contrast
loss due to partial volume averaging.
A popular software phantom for the analysis of PV effect in image data of the brain is
the BrainWeb phantom (Collins et al. 1998). Other software phantoms use object blurring
or model PV artifacts as a separate layer within an object. For example, Shin et al. (2006)
use Gaussian filtering of a binary object to simulate the decreased intensity values at the
object’s boundary. A square divided into three vertically separated regions is used by Noe
and Gee (2001) to evaluate a segmentation with an explicit model for PVE. Two regions are
considered as pure tissue classes with intensity values drawn from a normal distribution. In
between, the third region is computed by linear interpolation.
Summary
To summarize this section, we give a brief overview for each parameter, divided into physi-
cal and software phantoms.
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3.3. Other Parameters
In the previous sections, we have analyzed parameters affecting the quality of a scanner or
the output of an image processing algorithm. Now, we present two additional parameters
that did not fit so far, namely scanner and process. The first parameter subsumes general
features such as an update of the scanner software or a new sequence setup. The second
parameter describes dynamic processes within a phantom.
3.3.1. Parameter Description
Scanner
Manufacturers of MR scanners offer a range of scanner types for different applications.
Thereby, each scanner has its own hardware and software configuration including different
field strengths, coils, scan sequences, etc. During the life time of a scanner several of
these components will change due to hardware or software upgrades, and modifying such
a parameter can lead to changes in the resulting image data. An example, that shows the
effect of the parameter ’scanner’ is presented in (Han et al. 2006). Here, an evaluation of
the reliability of cortical thickness measurements within as well as across different scanner
platforms is performed. The results show a variability in the global mean of the cortical
thickness across platforms as well as across different field strengths. On the other hand, an
upgrade to a newer scanner version did not have a significant effect on the results. Several
other work also demonstrate the effect of field strength changes on the resulting image data,
e.g., changes from 1.5T to 3T.
Process
Dynamic processes within a phantom comprise a number of different mechanisms. They
can be regarded as a subgroup of the category ’simulation approach’ defined in Section 2.2.2
(cf. also Fig. 2.3). In this work we focus on processes related to enhancement characteristics
after contrast agent injection and on deformations, e.g., due to tissue growth or shrinkage.
Contrast agents are commonly used in MRI to improve the scanned images by alter-
ing relaxation times after injection. Thus, the contrast between different tissue classes is
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increased in various parts of the body where the agent resides. Today, the paramagnetic
gadolinium is one of the most commonly applied contrast agents. Applications include
the evaluation of blood vessels, the analysis of infections and inflammations, diagnosis of
cancer, or the characterization of different lesion types. For example, dynamic contrast en-
hanced MRI of the breast has shown to be a sensitive modality for early detection of cancer.
Thereby, a series of scans is acquired at different time points, enabling an analysis of the
uptake and wash-out characteristics of the tissue. Differences in contrast uptake between
normal and pathological tissue provides a basis for differentiation.
As stated above, the second process analyzed in this section is related to deformations.
In this work, we focus on deformations of pathological structures such as tumors: The pro-
gression of a tumor is a complex process with different stages from an initial avascular phase
to invasion and metastasis. A hallmark is the breakdown of normal cellular interaction and
control of replication. Angiogenesis is another process during tumor development, forming
new blood vessels from existing vasculature in response to chemical signals from a tumor.
See also (Hanahan and Weinberg 2000; Swanson et al. 2003) and references therein for a
more detailed review. Another process resulting in deformations is caused by intraoperative
movement. For example, the brain undergoes deformations during neurosurgery after the
skull has been opened (brain shift).
3.3.2. Phantoms
Scanner
We relate this parameter to the overall process of phantom development rather than to a
specific attribute. Today, no phantoms are known to model these parameters. One reason
might be, that changing the scanner manufacturer or upgrading the hardware or software of
a scanner have only a minor impact on the results as already described above. Furthermore,
no detailed information are available from manufacturers, e.g., about software upgrades in
an MR system.
Process
Simulations of object deformations and contrast enhancements allow the incorporation of
clinical and biological knowledge into the phantom development process. Multi-compartment
models are commonly used to describe the enhancement of macromolecular contrast agent
particles in tissue and thus are an important tool for computer-assisted analysis of dynamic
MRI. The Tofts&Kermode model is a popular approach to generate simulated perfusion
data sets (Tofts and Kermode 1991). A simulation of contrast enhancement characteristics
of different lesion types is proposed in (Brix et al. 1999).
The second investigated aspect in process modeling is related to deformations. In this
work, we focus on tumor growth models, which can be classified into two categories: (1)
cellular and microscopic models, and (2) macroscopic models.
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Cell population models typically start from a small number of proliferating tumor cells
and comprise a set of rules describing the evolution of their state and position. Kansal
et al. (2000) propose a three-dimensional cellular automaton for solid brain tumor growth.
The authors use a delaunay triangulation with a variable grid size for the underlying lattice,
which allows for a tumor growth modeling over several orders of magnitude. A cellular
automaton as well as a particle based tumor growth model are proposed in (Sierra et al.
2006). The authors put special emphasis on a realistic macroscopic appearance of common
pathologies including polyps and myomas, to meet the requirements of a surgical training
simulator for hysteroscopy.
Approaches that simulate tumor growth on a macroscopic level typically model soft tis-
sue deformations Thereby, two main directions can be taken: a biomechanical approach and
a computational discrete approach (Delingette 1998). Common models typically consist of
reaction-diffusion equations (Clatz et al. 2005). Furthermore, models based on continuum
mechanics assuming linear elastic (Wasserman et al. 1996) as well as nonlinear elastic
material (Kyriacou et al. 1999) have been described in literature. Here, tumor growth is in-
fluenced through internal and external forces that deform the underlying anatomy. Several
additional anatomical constraints are introduced to facilitate a realistic tumor expansion and
a deformation of surrounding tissue. In the last few years, these physics-based models have
also gained increasing popularity in medical image registration due to their ability to con-
strain the underlying deformation in a plausible manner (Ferrant et al. 2001; Christensen
et al. 1996). Thereby, an image is treated as a physical entity, either an elastic solid (Bajcsy
and Kovacic 1989) or a viscous fluid (Christensen et al. 1996). The underlying physical
principals, i.e., elasticity theory and fluid dynamics respectively, are a branch of continuum
mechanics. An overview of registration approaches using physics-based models can be
found in (Modersitzki 2004).
Unfortunately, these approaches only model the growth process and thus only one pa-
rameter. Phantoms with a model for tissue deformations plus imaging parameters such as
noise or the correct contrast between tissue classes are hardly available. Sierra et al. (2006)
manually texture the surface of their phantoms with image fragments from previous intra-
operative recordings, to provide an image appearance similar to that of an intra-operative
scene. A phantom for brain-shift simulations, suited for MR and ultrasound imaging, has
been developed by Reinertsen and Collins (2006). This phantom consists of several parts
simulating cerebral falx, brain, and vessel structures. To deform the brain, a catheter balloon
is placed under the phantom and inflated by injecting water.
Summary
Similar to the other modeling groups, we provide an overview of discussed modeling ap-
proaches in tabular form, divided into physical and software phantoms.
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3.4. Discussion
After introducing general aspects of a phantom in the previous chapter, this chapter focused
on parameters used in phantom development. We presented a classification into four groups,
each modeling a certain aspect of a phantom.
1. Morphology and topology
2. Imaging parameters and artifacts
3. Dynamic processes
4. Other scanner characteristics
A description of each parameter was followed by a discussion of characteristic phantoms
proposed in literature.
Today, phantoms are used for many applications, and only some have been discussed
in more detail in this chapter. We concentrated on phantoms for major anatomical and
pathological structures such as brain and heart as well as lesions. Furthermore, phantoms
for the evaluation of segmentation and quantification approaches were presented. This will
be a focus in the upcoming chapters.
General
Both, physical and software phantoms have their own characteristic construction methods,
and both types have been proposed in literature for the parameters presented in this chapter.
Physical phantoms are commonly developed for quality assurance, since they can be placed
in a scanner. Unfortunately, building such a phantom is associated with a large manual
effort. One has to gather all components and assemble them to form the final phantom. This
often results in objects with a simple shape, although realistic anatomical appearances have
been proposed as well and are even commercially available. Another issue is chemical and
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physical long-term stability: A phantom should not change its parameters over time, e.g.,
contrast changes due to different relaxation times.
Software phantoms on the other hand do not need any assembling of hardware objects.
Their strength lies in the flexible and correct parameter modeling, and many different ap-
proaches have been proposed. Nevertheless, building a software phantom is by no means
less challenging or less time consuming. Correct models of the imaging parameters need
to be extracted. Furthermore, data sets of an investigated body region have to be acquired
to extract anatomically realistic morphology and topology, which can require hours of scan
time.
A common approach to software phantom design is a direct simulation of the underly-
ing acquisition process. Thereby, the imaging parameters are controlled via mathematical
equations. For example, Kwan et al. (1999) introduce an MR simulator, that is also used
in the BrainWeb project. Drexl et al. (2004) propose a simplified model of the CT scan-
ning process to generate software phantoms consisting of a homogeneous background with
small vessel-like structures. A more sophisticated software package simulating the process
of projecting X-rays through an object is available from the CTSim project (CTSim 5.1.2 ).
Another method to software phantom development is to simulate a data set from a differ-
ent modality. Kiebel et al. (1997) use high-resolution MR data to generate simulated PET
images. They apply a set of transformations including intensity modifications and smooth-
ing. Furthermore, Gaussian noise and a rigid body transformation are added. The resulting
PET data are then used to evaluate multi-modal image registration methods.
This approach is especially beneficial for the evaluation of registration algorithms, be-
cause both images originate from the same data set with the same artifacts. Moreover, mo-
tion artifacts with known ground truth can be easily added. Unfortunately, such a ground
truth is not available for many other parameters including morphological as well as imaging
parameters.
Although we have discussed major parameters used in phantom design, not all features
of the acquisition process and the considered structures can be investigated. Some might
not be known to have an influence on the results or might even not be known at all. Others,
such as the global parameter scanner are not used because they only have a small impact
on the resulting phantom, and little information is available about parameter changes, e.g.,
changes due to scanner upgrades.
Parameter Selection and Grouping
An important constraint in this chapter was the chosen parameters. But why is this selection
a correct assumption? The parameters related to morphology and topology (cf. Sec. 3.1)
as well as the parameters describing dynamical processes (cf. Sec. 3.3) are selected based
on the examination of published work in the field of medical image analysis. Therein, the
shape or the volume of an anatomical or pathological structure are important markers for
diagnosis and therapy monitoring, as we have already presented in the previous sections.
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The selected imaging parameters in Section 3.2 are commonly used in quality assur-
ance (QA) programs of MR scanners (McRobbie et al. 2003). They have a major effect
on the resulting image quality and are thus key parameters in QA. Firbank et al. (2000)
developed guidelines for QA based on a comprehensive analysis of an MR scanner over
the course of one year. They measured various imaging parameters including the signal
to noise ratio, image uniformity, and resolution using two different physical phantoms. In
a nationwide survey on quality assurance on MR scanners in England with 24 participat-
ing hospitals, Koller et al. (2006) found SNR and image uniformity tests to be among the
most frequently evaluated parameters in QA programs. A similar study was performed by
McRobbie and Quest (2002), monitoring effectiveness and relevance of quality assurance
for 17 MR systems from four manufacturers.
The analysis of different parameters in this chapter has shown that each parameter re-
quires its own modeling approach. Furthermore, it is not only related to the considered
application, but also to the phantom type, i.e., physical vs. software. Thereby, various meth-
ods from physics and biology are used, modeling normal as well as pathological processes
in the human body. Other approaches use statistical methods based on training data sets that
show typical variations of the modeled parameter. To give an example, evaluating a brain
segmentation approach requires a different phantom shape than evaluating a liver segmenta-
tion. Furthermore, a segmentation will focus on different parameters than a quantification
of the same structure.
Nevertheless, parameters can seldom be considered separately, and changing one pa-
rameter will affect others. For example, changing the shape of an object from a cube to a
sphere will also influence the resulting partial volume artifacts. The quality of a phantom
might even worsen if one parameter excessively changes, e.g., large motion artifacts can
impede the analysis of a quantification algorithm or even make it infeasible. Thus, each
parameter has to be described by its individual scope, which can change from application
to application. Unfortunately, a method is still missing that defines such a range for all
application-relevant parameters.
Relation to Design Properties
Even if we might have chosen all relevant parameters for a phantom, the overall perfor-
mance is still unclear. In Section 2.1.1 we defined general design properties for this task,
namely suitability, correctness, and flexibility. But to what extent do the cited phantoms
meet these requirements? To provide a more in-depth analysis of this issue, we discuss
three examples that were frequently used in this chapter. See also Figure 3.3 for examples
of these phantoms.
Tofts et al. (1997). This work proposes a physical phantom for the quantitative analysis
of brain lesion volume estimation schemes. Nine cylinders are placed in a container
at different positions and with different orientations. Adjustments are made to the
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Figure 3.3. Examples of typical phantoms that are frequently referenced in this work. (a) Physical
phantom for analysis of MS lesions proposed by Tofts et al. (1997) (left: whole phantom; right:
zoom of single annulus), (b) physical chest phantom with drilled wells proposed by Ko et al.
(2003), (c) slice of the BrainWeb phantom (T2-weighted data set).
resulting image data to obtain more realistic intensity values. Although the authors
state that the phantom is quick to manufacture (about 2h), especially morphology
related parameters such as a more complex object shape will be difficult to change.
Therefore, the flexibility of the phantom is low. On the other hand, the ground truth
is available for various parameters. Especially for those relevant to the targeted ap-
plication, e.g., PV artifacts, contrast, and resolution. Other parameters can only be
estimated (noise) or are not considered at all (field inhomogeneities, motion). This
results in an average suitability and correctness of the phantom.
Ko et al. (2003). In a related approach, Ko et al. use a physical chest phantom with wells
inside the lungs for the analysis of lung nodules. Each well contains an approximately
spherical nodule object. The selected phantom type again reduces the flexibility of
this approach. Suitability and correctness also receive only average grades. However,
the usage of a chest phantom results in a better quality than the previous approach.
For example, the underlying structure lacks of several components such as vessels or
bronchi that will affect the results in real patient data.
Collins et al. (1998). The BrainWeb phantom is a software phantom of the brain resulting
from a sequence of processing steps. It offers a great flexibility for various parameters
including the amount of noise or the resolution. The phantom also has a good suitabil-
ity and correctness, since its construction is based on a set of scans from one volunteer,
affecting morphological parameters such as shape and structure. Additionally, an MR
simulator is used to predict image contrast, PV artifacts, noise, and nonuniformities.
On the other hand, the phantom is generated from a single individual, reducing the
parameter distribution and thus the flexibility and correctness of this approach. For
example, it is not possible to change the shape of white matter or cerebrospinal fluid.
Unfortunately, the descriptions above and the rather fuzzy terms (good, average, low) pro-
vide only a qualitative analysis of a phantom. An objective discussion including quantitative
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measurements is still missing. This will be addressed in Part II of this work.
Lessons Learned
To conclude, important aspects of parameter modeling for phantoms can be summarized as
follows:
1. Not all parameters can be modeled.
2. Each parameter requires an application-specific modeling.
3. Each parameter has a range of suitable values.
4. Modifying one parameter has also an effect on others.
5. A phantom models more than one parameter.
Based on these aspects, we will propose a new approach for software phantom development
in Chapter 4 that covers several parameters discussed in this chapter. For each parameter,
we present a dedicated model and discuss relations between parameters. An application-
specific modeling with appropriate parameter ranges is then proposed in Chapter 5 and
Chapter 6.
40 3. Parameters in Phantom Development
4. Design and Construction of Software Phantoms
After an overview of current phantom design approaches and modeled parameters in the
previous chapters, we now focus on how to develop our own phantoms. Since we aim at the
design of hybrid phantoms that propose a separation between object and background, we
focus on the parameters required for object design. Our goal is a set of building blocks that
can be easily described and exchanged. This will allow us to efficiently design own phan-
toms, for example within a dedicated software assistant. Therefore, we introduce a modular
approach for the phantom design process in the first part of this chapter. Our novel method
is suited to describe any phantom, including both physical and software phantoms. Three
main tasks are distinguished: object design, background design, and object incorporation,
where each task has its own characteristics and design properties.
In Section 4.2, we then propose models for all major parameters such as object position,
shape, or intensity values. A formalized description for each parameter is given based on
our modular design approach. Based on the developed set of building blocks, we introduce a
software assistant for the development of software phantoms in the third part of this chapter.
We propose an easy-to-use tool that allows us to interactively combine the parameter models
described before.
4.1. Modular Phantom Design
Phantoms have become a standard way to validate the quality of measurements during the
development and evaluation of new imaging devices and algorithms. Especially software
phantoms are an integral part of solid test specifications for new image analysis methods.
However, most approaches today facilitate a merely ad hoc design dedicated to the underly-
ing application. A general design approach is still missing.
In this work, we propose a modular description of the phantom design process, charac-
terized by a set of modules with different functionalities. We aim at a system that enables
an information fusion of several parameters, allowing for a sound analysis and comparison
of different design approaches. Thereby, our goal is to provide a systematic description of
an arbitrary physical or software phantom.
Three main steps are required to determine the overall phantom development process:
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The design of a suitable object, the design of a related background, and the incorporation of
one or more of these objects into the background. Each step consists of a number of process-
ing steps, providing a detailed description of required parameters and modeling schemes.
See Chapter 3 for an overview of characteristic parameters used in phantom design. Fur-
thermore, each phantom has its own targeted application domain consisting of a specific
task, a body region, and an imaging protocol. A similar notation is also used by Udupa et al.
(2006) to specify the application domain of image segmentation evaluation methods.
In this work, the object of a phantom mainly determines the task of the targeted applica-
tion, whereas the background typically specifies the body region. For example a phantom
dedicated to the evaluation of liver tumor (object) segmentation methods using a CT scan
(background). If the background is merely used as image background and consists of a ho-
mogeneous material or a constant gray level, the object already determines the body region.
For example, Reinertsen and Collins (2006) propose a brain-shaped object with a vessel
structure for the simulation of brain-shift. In their work, the brain is placed in a liquid filled
acrylic plastic container.
4.1.1. Modules
To formalize the overall phantom design process, we propose a structured development
based on functional units that contribute to the overall system. Each of these so-called mod-
ules consists of a set of properties and behaviors, allowing to extract or combine information.
We also denote the description of a module a model. A module Mt of type t is then defined
as a tupel
Mt := 〈H,x, f ,θ,y〉 (4.1)
Mt Module of type t, t ∈ {parameter, f usion,state}
H hypothesis
x input value(s), x= {x1, . . . ,xN}
f transition function
θ parameters of transition function
y output value.
The first parameter determines the overall assumptions of the module. In other words, each
module is developed based on a certain hypothesis H. For example, this could be a charac-
teristic object intensity value. Nevertheless, this provides only a description. A discussion
about the correctness of the underlying assumptions is not given, but will be proposed in
Part II. Besides the hypothesis, a module consists of one or more input values x, which
can be image data or other external sources, as well as the output of another module. A
module has one output value y. A transition function f (x,θ) with a set of parameters θ is
used to transform the input. Therefore, it also provides a description of the module’s task.
For example, a module dedicated to the simulation of cardiac motion based on non-uniform
rational B-splines ( f ) is proposed by Segars et al. (1999). Therein, patient data (x) are used
to extract a 4D motion model of the heart (y). A graphical representation of a module is
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Figure 4.1. Illustration of a module. (a) General module layout: Input of a module are parameters
θ as well as input values x such as image data. The transition function f is used to compute the
output y. (b) Differentiation of different module types.
shown in Figure 4.1.
To summarize, our modules are somewhat related to components in component-based
software engineering (Brown and Wallnau 1998; Broy et al. 1998), and can be described as
follows:
In contrast to the definition given in Equation 4.1, our definition above is a rather informal
description similar to the definitions of quantification or segmentation given in Chapter 2.
Nevertheless, it covers the main features of a module, i.e., being a part of a phantom with
a clear interface allowing a common description as well as a flexible replacement. Thereby,
only modules that actually involve a concrete model are used. Parameters that can only be
estimated, e.g., noise or partial volume effects for a physical phantom, are thus not used as
part of the phantom specification (cf. Fig. 4.3-4.5). For example, an explicit noise model is
not specified in the phantom by Ko et al. (2003) and the corresponding module is thus not
given in the phantom description (cf. Fig. 4.4). Tofts et al. (1997) add additional Gaussian
noise to their phantom after image acquisition. In this case, we list the associated module
in brackets (cf. Fig. 4.3).
Three different module types are distinguished (cf. Fig. 4.1):
1. Parameter Module
2. Fusion Module
3. State Module
A parameter module delineates the most elementary module. It represents a parameter
model and can be further divided into groups as proposed in Chapter 3. We distinguish
between imaging parameters, morphological and topological parameters, and other param-
eters such as general scanner properties and the modeling of processes. A fusion module
44 4. Design and Construction of Software Phantoms
Figure 4.2. A modular approach to phantom development.
combines different parts of a phantom. For example, the Incorporation module is supplied
by the two state modules object and background (cf. Fig. 4.2). Finally, a state module
describes one of the three main outputs during phantom development, namely the object,
the background, or the final phantom.
4.1.2. A General Phantom Description
After defining the components required during phantom design as well as their interactions,
we now combine the different modules within a common representational format. The three
main steps, i.e., object and background design and incorporation, are integrated as fusion
modules. Thereby, object and background design consist of several parameter modules. The
result of the design process is a state module, i.e., object or background. The fusion module
Incorporation takes these two states as input and combines them to the final phantom. To
simplify the workflow, no additional parameter modules are used in this stage. However,
please note that more than one object might be involved during object incorporation as
discussed above. Figure 4.2 illustrates our resulting approach with the required modules.
To summarize, our approach offers two ways to describe a phantom: (1) A rather high-
level description providing a quick overview especially including the phantom type, the
targeted application, and the main hypotheses and modeled parameters, and (2) a detailed
analysis of all modules used during phantom development. We have developed an easy-
to-use tabular description based on the high-level description that will be used throughout
this work. To demonstrate the general applicability of our method and to illustrate our
description, we exemplarily show three typical phantoms that were already used in Chapter
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Figure 4.3. Description of the physical phantom proposed by Tofts et al. (1997).
3 to review phantom design properties (cf. Sec. 3.4). Both, physical and software phantoms
are used. See also Section 4.4 for a discussion of our approach.
Figure 4.3 gives a description of the phantom developed by Tofts et al. (1997). The
objects of this physical phantom are several cylinders placed in a container at different po-
sitions and with different orientations. A container filled with water is used as background.
Adjustments are made to the resulting MR images for more realistic intensity values. The
second phantom is based on the work of Ko et al. (2003) and consists of wells drilled into
a chest phantom. Approximately spherical objects are inserted into small wells simulating
lung nodules. See Figure 4.4 for an overview. Finally, Figure 4.5 summarizes the phantom
described by Collins et al. (1998). The BrainWeb software phantom uses a number of pro-
cessing steps to simulate an MR image data set of the brain. Thereby, several parameters
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Figure 4.4. Description of the physical phantom by Ko et al. (2003).
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Figure 4.5. Description of the BrainWeb phantom proposed by Collins et al. (1998).
48 4. Design and Construction of Software Phantoms
are addressed including the spatial distribution of different tissue classes as well as imaging
parameters such as noise or intensity values.
4.2. Parameter Modeling
After introducing a general phantom description, let us now focus on the required parame-
ters. Our component-based phantom description does not make any specific assumption on
the phantom type or appearance and is therefore suited for a large range of applications. Be-
cause we focus on applications in the field of neurology and neurosurgery, some parameter
models are already tailored to meet the requirements of the targeted phantoms within these
areas, e.g., the modeling of object positions. Nevertheless, other applications are possible
and a discussion about potential applications is given at the end of the first part of this work.
We use the categorization introduced in Chapter 3, i.e., first parameters that describe the
overall object appearance (cf. Sec 4.2.1) followed by imaging parameters in Section 4.2.2.
In Chapter 5, we will additionally provide examples on how to model parameters for object
growth and enhancement characteristics.
In the following sections, each parameter model is formalized by a module description
based on the definition given in Equation 4.1.
4.2.1. Morphology and Topology
The first parameter group is related to morphological and topological parameters character-
izing the overall object appearance. In the following sections, we present models for four
different parameters, i.e., shape, structure, volume, and topology.
Object Shape
The first investigated parameter is dedicated to the overall object shape. We propose a
parameter moduleMpshape that can be used to build object appearances of varying complexity,
ranging from simple shapes to complex models that better reflect anatomical reality. A
software assistant that provides a user-controlled design is introduced in Section 4.3.
A commonmethod to shape development is object shapes based on geometric primitives.
Mathematical equations provide a standardized and yet flexible approach that is sufficient
for many applications. Unfortunately, these phantoms can not capture anatomical variability
with typically irregular shapes. An important step towards this goal is to give up this rather
strict object definitions with a smooth and homogeneous surface. In (Rexilius et al. 2003),
we applied a generic approach that allows the construction of objects from a combination of
geometric primitives. Ellipsoids of different size and shape are iteratively placed at random
positions on the initial object surface in an iterative fashion. A schematic overview of this
algorithm as well as exemplary results are given in Figure 4.6 (top row).
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Figure 4.6. Three approaches for object shape design used in this work. (top) Object shape based
on a combination of geometric primitives such as ellipsoids, (middle) geometric primitive that is
subsequently deformed using a WEM data structure, (bottom) object shape from segmentation
mask.
Since an iterative object placement as described above can be time-consuming, we use
a further approach that introduces geometric distortions to a given object surface. The 3D
representation of the current object is based on a boundary representation (also known as
b-Rep), which describes the object as a collection of connected surface elements. Both,
the geometric data of primitive geometric entities such as faces, edges, and vertices, and
the topological data maintaining the connectivity between these entities are stored. We
use a winged-edge mesh representation (WEM) as data structure, allowing a quick traversal
between faces, edges, and vertices in 2D and 3D. An arbitrary viewer position in the vicinity
of a WEM contour can be interactively selected, which influences all nodes within a sphere
around the click point. These nodes will then follow any mouse movement to a certain
degree (cf. Fig. 4.6 (middle row)). A comprehensive review of winged-edge data structures
can be found in (Baumgart 1975).
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(a) (b) (c)
Figure 4.7. Brain tumor phantom with different amount of necrosis. (a) T1gd reference image with
incorporated tumor, (b) tumor phantom with necrosis scaled to maxnecrosis = 50%, (c) examples
for active tumor tissue and necrosis maps.
In (Rexilius et al. 2004), we introduced a third approach to object design for software
phantoms, based on manual segmentations of anatomical structures. Different object shapes
are generated from segmentations of different patient data sets with similar anatomical struc-
tures. For example, Figure 4.6 (bottom row) shows an object resulting from a manual seg-
mentation of a brain tumor. Unfortunately, this method limits anatomical variability to the
number of available data sets. Here, additional geometric deformations of the segmenta-
tion mask might be allowed, e.g. based on an interactive approach as described above. To
summarize, the parameter moduleMpshape is described by
Parameter Description (Mpshape)
H Compact object shape, i.e., all voxels are connected
x Zero or one input data depending on selected approach (cf. Fig. 4.6)
f Manual drawing; deformation of WEM structure; segmentation
y IbinOb j (binary object volume)
Object Structure
If an object consists of more than one component, e.g., a brain with white matter, gray
matter, and cerebrospinal fluid, each structure, i.e., tissue class, requires its own modeling.
This includes a dedicated shape for each tissue class, which can be generated with one of the
methods described above. Furthermore, the amount of tissue per pixel has to be determined
for all components. Similar to the shape module, this can be a user-defined definition done
by an expert. Another approach is to segment an actual patient data set and then define
the portions based on the resulting tissue maps. For example, we will develop brain tumor
phantoms consisting of two overlapping tissue classes, active tumor tissue and necrosis in
Section 5.3. An example is shown in Figure 4.7.
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A related approach to generate reasonable object portions is texture synthesis from a
sample database extracted from patient data, as proposed for brain tumors in (Prastawa et al.
2009). Unfortunately, this method requires a large amount of reference data to model a
sufficient amount of anatomical variability. In this work, we propose a parametric model
based on 3D simplex noise introduced by Perlin (2002) to generate different lesion textures,
which is frequently used for organ surface-like textures in surgery simulators. Instead of
relying on a large pool of reference data, this approach allows us to automatically generate
largely heterogeneous object appearances by changing very few parameters. In Section 5.2,
we will use this approach to develop textured MS lesion objects. See also Figure 5.6 for
a comparison of different real lesions and corresponding phantom results. The resulting
parameter module Mpstructure is given by
Parameter Description (Mpstructure)
H An object consists of N tissue classes ti, i= 1, . . . ,N
x ti ∈ [0,1], ∑Ni=1 ti = 1
f Shape: cf. Mpshape , tissue portion: user-defined, segmentation result
y Iob j,k, for tissue class k (Iob j,k ∈ [0,1])
Approximation of a Continuous Volume Model
After we have decided for an appropriate object shape, we generate a binary object volume
for each considered tissue type. A major focus of the considered applications in the fol-
lowing chapters is on quantitative image analysis. Therefore, an accurate approximation
of the correct object volume often is an indispensable requirement. Our design process
consists of digitized data, so that a good approximation implies a small size of a single
voxel with respect to the whole object volume. We concentrate on medical image data sets
used in clinical routine or in studies, using a voxel size about ten times smaller than the
in-plane resolution, where a typical in-plane resolution is around 1mm. Although this is a
rather heuristic choice, it provides a good trade-off between computational complexity and
accuracy.
A more formal description of our approach can be given as follows: We generate a high-
resolution binary object volume Iob j,k for each tissue type k with signal intensity values
Iob j(u), Iob j(u) = 1 for u ∈ ob ject, and Iob j(u) = 0 otherwise. Thereby, the actual object is
obtained on a lower resolution and is then resampled. Finally, the volume is given by the
sum over all object voxels
VIob j = ∑
Θ
Iob j(u) , (4.2)
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VIob j object volume
Θ object domain
u= (u,v,w)⊤ voxel position, u ∈ Θ
Iob j(u) intensity value Iob j(u) ∈ {0,1} at position u
We typically consider a 5123 grid for object delineation. Different object volumes can then
be easily generated by specifying a different voxel size of Iob j. The resulting parameter
module Mpvolume is
Parameter Description (Mpvolume)
H The volume can be approximated by voxel counting
x High-resolution object
f Voxel counting approach to approximate the object volume
y Volume VIob j
Topology
The position of an object within the background is another parameter that has significant
impact on the later appearance of the phantom data set. Important attributes are the spatial
relation between different objects as well as the actual object position within the background.
For example, Multiple Sclerosis lesions predominantly appear in the white matter of the
brain. Possible object positions could therefore be restricted to this area. For example, a
white matter mask is used for this task in Section 5.2.
In this work, we propose three approaches for object placement. The first method is
based on manual object placement. Here, the user selects the final object position (cf.
Fig. 4.8 (top row)). To provide this functionality in a structured workflow, we have devel-
oped a software assistant, facilitating an interactive manipulation of appropriate positions
by simple user interactions. See Section 4.3 for a detailed description.
Our second approach uses a reference patient data set plus a segmentation mask of the
targeted objects within this data set, e.g., a segmentation of lung nodules. In a first step,
the original patient data are aligned with the background image data using an automatic
registration algorithm. The resulting transformation is then applied to the segmentation
mask so that this information can be used in the coordinate system of the background image.
Finally, the center of mass of the segmented objects is used to position objects within the
background. See Figure 4.8 (middle row) for an illustration of this approach.
The third approach is related to the previous one. Again, we use a patient data set as
reference. However, we do not constrain the segmentation mask to come from a single
patient. Instead, we use a number of data sets with segmentations of the targeted structure
and create a probability map of cross-subject variability. To this end, we register the training
data as well as the segmentations to the reference data. The resulting average map is then
used to constrain the spatial object positioning (cf. Fig. 4.8 (bottom row)). This approach is
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Figure 4.8. Methods for object topology modeling used in this work. (top) User-defined placement
of object position, (middle) Object position obtained from reference patient data via registration,
(bottom) automatic object placement based on probability map.
used in Section 5.2 to place lesion objects at reasonable positions. The associated parameter
module Mptopology is described by
Parameter Description (Mptopology)
H Suitable object positions known a priori
x Objects and background
f User-defined or automatically selected object positions
y List of user-defined object positions within background
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4.2.2. Imaging Parameters
The second parameter group is related to imaging parameters and artifacts. Our phantom
development process includes the following parameter modules: contrast, noise, PV effects,
and resolution.
Determination of Object Intensities
The aim of this parameter module is to generate a volume Igv with intensity values igv(x)
for each modeled tissue type at voxel positions x = (x,y,z)⊤, x ∈ Θ. A common approach
assumes constant gray values for each tissue class throughout the whole object volume.
Although anatomical structures seldom have a uniform intensity on a macroscopic level,
this is often a valid assumption for small structures with a compact local appearance in an
MR scan. Additional object textures can be added using the methods introduced for the
parameter moduleMpstructure .
In this work, we use a different intensity model for each tissue class. The models are
obtained from a number of training data sets based on segmentations of each investigated
tissue class as well as their adjacent anatomical structures. For example, we segment a
lesion in the white matter of the brain as well as the adjacent white matter itself (cf. Sec. 5.1).
To remove smoothly varying intensity values across the image, an intensity normalization
algorithm can be applied to the data, e.g., the N3 algorithm proposed by Sled et al. (1998).
The final gray value map Igv for each structure is then obtained using the mean and the
intersubject variability as descriptors of the object appearance (Rexilius et al. 2005). The
ratio between object and adjacent tissue classes is used as a relative measure for the object
intensity value. For example, a hyperintense lesion in the white matter of the brain will
result in a high ratio. The parameter moduleMpcontrast for intensity values is given by
Parameter Description (Mpcontrast )
H Each tissue class is described by a single intensity value
x Number of training data sets
f Subject-specific mean value of segmented area
y Resulting gray value map Igv
Noise
Object noise is described by a Gaussian PDF (cf. Eq. 3.2), assuming zero-mean and a
standard deviation σ. This results in a new object intensity map I˜gv with intensity values
given as
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Figure 4.9. Diagram of main components to determine the object intensity values.
i˜gv = igv + N(µ= 0,σ) (4.3)
igv initial intensity value
i˜gv final intensity value with added noise
N(µ,σ) Gaussian distribution
µ noise mean value
σ noise standard deviation.
This parameter module Mpnoise is given by
Parameter Description (Mpnoise)
H Noise can be described by a Gaussian PDF
x Number of training data sets
f Combination of intensity value and Gaussian noise (cf. Eq. 4.3)
y I˜gv
Partial Volume Effects
One of the major limiting factors for an accurate quantitative analysis are partial volume
effects. Especially in structures of the same order of magnitude as the slice thickness of the
associated imaging protocol, a dedicated handling of these effects becomes necessary for
an applicable phantom.
In order to generate software phantoms with a correct partial volume handling, we pro-
pose an approach based on changing the resolution of a binary object volume Iob j (Rexilius
et al. 2003). Therein, a high-resolution object is downsampled to the same voxel size as
the background image using trilinear interpolation, and then reformat the object into the
same coordinate system. This results in a probability map I˜ob j : Ω → R with intensity val-
ues λ := i˜ob j(x) ∈ [0,1], defining the amount of partial volume at each voxel. A decreasing
density can be observed starting from the object core, yielding a typical blurring at the ob-
ject border. To ensure the correctness of this step, we verify the exact volume of I˜ob j by
comparing it with the original volume of VIob j . The parameter moduleMppve is given by
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Parameter Description (Mppve)
H PV effects arise from object downsampling
x High-resolution binary object Iob j
f Object downsampling
y Downsampled image I˜ob j
Resolution
A parameter related to the modeling of PV effects presented in the previous section is the
object’s spatial resolution. Similar to this previous approach, the resolution is defined by
object downsampling to the same voxel size as the background image using trilinear inter-
polation. The corresponding moduleMpresolution is described by
Parameter Description (Mpresolution)
H Object resolution is defined by the background resolution
x High-resolution binary object Iob j
f Object downsampling
y Downsampled image I˜ob j
4.2.3. Background Design
In this work, we use volumetric MR data sets Ibg : Ω → R acquired from actual patients or
healthy volunteers as background model. Voxel phantoms such as the BrainWeb phantom
by Collins et al. (1998) are applied as well. Additional noise can be added similar to the
noise model described in Section 4.2.2. A different approach could be a homogeneous back-
ground model with a constant gray value. Although this results in a simplified evaluation
process, the applicability for the evaluation of image analysis methods is rather low. To-
day, many image analysis techniques make use of prior information such as the gray value
distribution of tissue classes or certain structural characteristics of the underlying anatomy.
For example, brain tissue classification schemes are often based on an atlas-based initializa-
tion. Furthermore, segmentation methods typically include prior shape information about
a regarded structure. In these cases, a software phantom with a homogeneous background
model is not an appropriate evaluation tool, due to missing shape and texture information.
4.2.4. Object Incorporation
The final step of our phantom design approach combines the determined object and the
selected background model. More specifically, we incorporate the object volume I˜gv con-
taining appropriate gray values for each tissue class into the background Ibg using a linear
weighting function. The amount of partial volume at each voxel, derived from the high-
resolution binary object volume as described in Section 4.2.2, serves as weighting factor. A
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Figure 4.10. Illustration of incorporation step. Two different resulting phantom images as well as
the corresponding parameter settings are presented with different object positions and volumes.
Please note that the selected object positions can also denote different slices within the data set.
In this example, slice number 21 and 22 are used.
phantom data set Ip is then generated by a convex combination at each voxel defined as:
ip =
K
∑
k=1
(
λk · i˜gv,k
)
+
(
1−
K
∑
k=1
λk
) · ibg , (4.4)
ip intensity value of resulting phantom data set
λk object probability map for tissue class k (cf. Sec. 4.2.2)
i˜gv,k object intensity value for tissue class k
ibg background intensity value
K number of modeled tissue classes
with ∑Kk=1λk = 1. This technique is sometimes also called ’alpha blending’ (Shin et al.
2006).
Figure 4.10 provides an overview of the construction process, showing the original back-
ground and the object image as well as resulting phantom images and their parameter set-
tings. Different object positions and volumes are used to demonstrate flexibility of our
approach.
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4.3. A Software Assistant for Interactive Parameter Modeling
The concretization our hybrid phantom design approach by explicite models for a number of
modules gives us the building blocks required to develop a software assistant for the design
of software phantoms (Rexilius et al. 2008). The following sections provide an overview of
the underlying concepts as well as the different processing tasks.
4.3.1. Design Concepts
Our goal is an easy-to-use tool that can be applied to many different tasks occurring dur-
ing the design and evaluation of new algorithms in medical image analysis. This way,
researchers can generate a data basis for evaluating performance and limitations of their
own algorithms. Moreover, the exchange of data sets between research groups is supported,
enabling a standardized and objective validation with a set of reference data.
An important aspect for the success of such a software assistant is a clear and easily op-
erated graphical user interface. Our software assistant consists of three different processing
steps, related to the design tasks in Section 4.1, namely object design, background design,
and object incorporation. For each step, a separate component has been implemented, facil-
itating a hierarchical encapsulation of the underlying methods. To enable rapid prototyping
of software assistants, our software is designed as part of the modular development platform
MeVisLab (MeVisLab 1.5 ).
In addition to the actual graphical user interface, a common data scheme for the descrip-
tion of the resulting image and meta data is an important requirement, e.g., noise variance,
voxel size, object volume. Our software supports several image data formats including DI-
COM, DICOM/TIFF, or the Analyze file format. Further information, e.g., about object
intensity values or the object volume, are stored in a separate data structure using the Exten-
sible Markup Language (XML).
4.3.2. Processing Steps
Object Design
The main functionality of the first processing step is the definition of object shapes that
are appropriate for the considered application. Ten predefined shapes including spheres
and ellipsoids of different geometries can be used. Object shapes that have been used in
previous work are available as well (Rexilius et al. 2003; Rexilius et al. 2005). This allows
for a direct comparison of new analysis methods with a comparable data pool. Besides the
already available shapes, own object files can be loaded as described below. Furthermore,
new object shapes can be generated by interactively modifying the surface of a currently
selected object. The user interface with an exemplary parameter setting is illustrated in
Figure 4.11.
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Figure 4.11. First step of our software assistant: Object design.
The software assistant provides 2D as well as 3D representation of a selected object
shape. The 3D representation of the current object is based on a winged-edge mesh (WEM)
data structure. An implementation of a comprehensive WEM library is readily accessible
as part of the standard MeVisLab package.
To tailor a given object shape to the application in mind, the software assistant allows
for an intuitive deformation of the object surface. Thereby, the user can interactively select
an arbitrary viewer position close to the surface. All nodes in the neighborhood of this
dragging position are then influenced by subsequent mouse movements to a certain degree.
This way, different local and global object deformations can be achieved, depending on the
set influence radius. See also Figure 4.6 for an example.
Defining new WEM object shapes
An important feature for a broad applicability of our software assistant is the ability to use
not only the predefined objects that come along with the software, but also new ones. These
could be user-defined shapes or even shapes defined by other researchers. So how to import
a new object into the application?
In order to generate a new WEM structure, we developed an additional application that
can be selected via button from the parameter section of the current object definition step.
This application facilitates the design of new shapes from a binary image, e.g., from a man-
ual segmentation of a tumor. We extract an iso surface from the loaded segmentation mask,
which stores the result in a WEM. In a subsequent step, a simplification of the mesh is per-
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Figure 4.12. Integrating own object shapes from binary segmentation masks. (left) User interface,
(right) overview of algorithm steps.
formed, employing a multi-pass edge collapse algorithm. Thereby, all edges are sorted in a
priority queue according to an angle criterion in each pass. Then, a sequence of edge col-
lapse transformations is applied. The resulting WEM preserves visually important features
of a mesh and greatly reduces the required space for saving the data. Finally, an optional
surface smoothing can be applied to the mesh. Figure 4.12 (right) gives an overview of
the performed processing steps. The proposed user interface of this application is shown in
Figure 4.12 (left).
Background Design
We propose two different approaches for the background design: An image with a constant
gray value and predefined image size and voxel size, as well as other, more problem specific
image data. Additional Gaussian noise can be added to a selected background. A screenshot
of the user interface of this step is presented in Figure 4.13.
Object Incorporation
The last processing step of our software assistant combines object and background. There-
fore, the selected object has to be resampled to the same voxel size as the background data
set, allowing for an incorporation into this data set at a suitable position. To enable a flexible
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Figure 4.13. Second step of our software assistant: Background design.
workflow, this step facilitates a number of parameter adjustments. An illustration of the user
interface is given in Figure 4.14.
Two general workflow scenarios can be distinguished: Either both object and back-
ground have been selected in the previous two steps, or an object is selected directly in this
last step. For the first case, we have to define a suitable voxel size first – typically about
ten times smaller than the smallest resolution of the used background image. An isotropic
voxel size that fulfills these demands is automatically computed as a first guess. Then, the
user has to define an object volume and the object is downsampled to meet this value. Be-
cause the object image data has a high resolution, this is the most time consuming step of
the whole application. To avoid any resampling, we added an additional feature that per-
mits the determination of an object shape and volume from previously processed objects.
Thereby, an important prerequisite is an equal voxel size of the background data set and
the downsampled object data set. Otherwise, the incorporated object volume would not be
correct. This constraint is automatically verified for all data sets.
After object downsampling, we can incorporate it into the background. An appropriate
object position within the background can be chosen interactively. The amount of partial
volume at each voxel serves as weighting factor as described in Section 4.2.4. An extra
object shift by up to one voxel within the (x,y,z)-direction can be applied, causing additional
partial volume effects. In a final step, proper object intensity values as well as a suitable
noise level have to be selected by the user. We also added the possibility to integrate more
than one object into the current background.
The resulting software phantom image data can be saved using the MeVisLab-specific
DICOM/TIFF format. Further general as well as data-specific information are stored into
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Figure 4.14. Third step of our software assistant: Object incorporation.
an XML structure. Especially the characteristics of an included object are important. We
retain information about the volume of each object, its exact position within the background,
as well as the gray value and the amount of noise. An evaluation by four field experts with
respect to applicability resulted in an overall good rating.
Processing Time
Our software assistant provides an efficient tool that reduces the total time required for
phantom design from hours to minutes, depending on the lesion complexity and the number
of required lesions in the phantom.
Object Selection For object selection, the user can select an available shape from a list.
Nevertheless, this step can become rather time-consuming, if additional manual shape
deformations are performed. Although the user is supported in this task, adding sev-
eral large and small deformations can take up to five minutes. The object design step
should be repeated several times and the resulting objects should be stored in advance.
Background Selection This step mainly consists in selecting an appropriate background
data set plus additional noise if required. No further processing is done. Therefore,
users typically need less than a minute for this step.
Incorporation Several parameters can be changed in this last step such as the voxel size,
the object intensity value or the noise level. Furthermore, several objects can be accu-
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mulated within one phantom. For a phantom with only a single object, this processing
step takes no longer than 2 minutes.
4.4. Discussion
Standard reference data sets are an important tool for the development and evaluation of
algorithms in medical image analysis. Furthermore, they can serve as basis for discussions
with clinical experts, e.g., about accuracy and precision of current measurement tools. Es-
pecially software phantoms of anatomical and pathological structures provide a flexible and
cost-effective approach for this task.
Our overall goal is an efficient and reusable design of hybrid software phantoms. To
this end, we proposed an approach that allows for a generic specification of phantoms. An
integral part is a set of modules providing an in-depth description of parameters used dur-
ing phantom design. Based on this description, we then presented modeling schemes for
various parameters that will be used in the following chapters for software phantom design.
This provides the building blocks to develop a software assistant that allows us to combine
several parameters in an interactive fashion, adding additional flexibility to the phantom
design process.
4.4.1. Modular Phantom Development
In Chapter 2, we first introduced phantoms based on very general design properties, fol-
lowed by a description of relevant parameters in Chapter 3. Now we focus on how to pro-
vide an easy-to-use phantom description. We developed a template data sheet that provides
an easy-to-use phantom description and allow for a quick overview of the most important
phantom parameters Figures 4.3-4.5 exemplarily illustrate this description for three phan-
toms. Both, physical and software phantoms are presented to show the wide applicability
of our approach.
Our phantom description can be categorized into three basic steps: Object design, back-
ground design, and incorporation. Each step includes a task-specific description of parame-
ters used during phantom development. Thereby, major parts of such a parameter, which we
also call a module, are input and output values as well as a transition function to transform
the input. Furthermore, a module is based on a certain hypothesis presenting an understand-
able description of the underlying assumptions. For example, Ko et al. (2003) assume a
spherical object appearance in their phantom.
Phantoms have become an inevitable tool for algorithm development and evaluation in
medical image processing. Nevertheless, a standardized analysis that allows a comparison
between different design approaches has not been proposed yet. Therefore, some publica-
tions focus on a domain-specific literature survey of phantoms. For example, Lee and Lee
(2006) present a review of phantoms related to radiation dose distribution calculations in
the human body. Price et al. (1990) develop a set of standard physical phantoms dedicated
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(a) (b) (c) (d)
Figure 4.15. Examples of software phantoms for hyperintense brain lesions with wrong or missing
object modules. (a) Oversimplified object shape, (b) unrealistic object volume, (c) wrong object
intensity value, (d) no consideration of partial volume effects.
to the evaluation of a single imaging parameter such as spatial resolution or uniformity. Un-
fortunately, these paper merely provide a summary of recent work. Moreover, related work
in the field of image analysis as well as an explicit categorization of phantoms has not been
proposed yet.
In this work, we present a method that is suited to describe any phantom, and some
examples have been given in this chapter. To the best of our knowledge, we provide the first
approach towards a comprehensive description of phantom design processes in medical
image analysis. Furthermore, we propose a standardized analysis for both physical and
software phantoms, that enables a description of modules and of their interactions. We adopt
a notation proposed by Udupa et al. (2006), where the domain of a segmentation method is
determined by three entities: Task, body region, and imaging protocol (cf. Sec. 8.6.1).
Introducing a general description of the phantom design process also allows direct com-
parison of different phantoms. For example, our approach enables a quantitative analysis,
e.g., about the number of used modules. Furthermore, we can carry out a qualitative anal-
ysis of the modules used for phantom design. Thereby, the enclosed field of application
allows for a domain-specific comparison. To give an example, Figure 4.15 shows four soft-
ware phantoms for small hyperintense brain lesions. In each picture, at least one module is
not within the correct parameter range or is based on wrong assumptions. For example, an
oversized object volume (cf. Fig. 4.15 (b)) or a wrong object intensity value (cf. Fig. 4.15
(c)). Nevertheless, a statement about the actual phantom quality remains difficult. To this
end, we propose a new method for phantom validation in Part II of this work.
4.4.2. Our Phantom Approach
Today, phantoms are often based on simple geometric objects with known volumes, espe-
cially when using physical phantoms. Additionally, these objects usually consist of a single
material or tissue type. In Chapter 2 we introduced three different types of software phan-
toms: stylized phantoms, voxel phantoms, and hybrid phantoms. We found the last category
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to be most suited since these phantoms combine several advantages of the other two classes
(cf. Fig. 2.6). In this chapter, we focused on a hybrid method that incorporates objects into
tomographic image data of a patient or a volunteer. Based on our modular design approach,
we modeled various parameters that are typically used during phantom development. For
example, we propose different methods for the development of a suitable object shape. Fur-
ther aspects of our phantom are an application-specific parameter modeling and a range of
suitable values, which were identified as important issues for phantom parameter modeling
(cf. Sec. 3.4).
Used Modules
In Chapter 3 we already discussed a number of characteristic modules, which are frequently
used in medical image analysis or represent a common choice in scanner quality assurance
programs. Our phantom design uses several of these modules to enhance the acceptance
of our approach. For example, we assume a commonly used noise model described by a
Gaussian PDF. Nevertheless, we also introduce extensions to current modeling approaches
such as an interactive method to deform a given surface that is used to change a given object
shape. Furthermore, we propose different methods to define the object topology. These
are not only based on the common manual object placement at ’typical positions within
the human body’, but also obtain a suitable position from reference data such as patient
data as well as from probability maps of cross-subject variability. Another specific feature
of our phantom is a high-resolution binary object that is used to determine an accurate
volume measurement and to model partial volume effects via downsampling. Other than
the object design, the background does not contain any concrete parameter modules. Here,
we use volunteer image data where the underlying ground truth is not available for most
parameters. A similar difficulty occurs for example for imaging parameters in physical
phantoms as already discussed in this chapter.
To summarize, we developed specific models for eight parameter modules divided into
two categories:
Category Modules
Morphology and Topology Shape, Structure, Volume, Topology
Imaging Contrast, Noise, Resolution, PV Effects
For each module, we provided a detailed analysis plus a tabular summary that consists of
input and output values, applied transition functions, and the underlying hypothesis. Com-
pared to the number of relevant parameters introduced in Chapter 3, only three are not
included in the above list.
Uniformity. A model for intensity nonuniformity will be available for the phantom
proposed in Section 5.2. Therein, we use the bias field available from the BrainWeb project.
Motion. The second imaging parameter not included in our modeling approach is a
module for motion artifacts, because it is simply not required for our targeted applications.
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Process. A general approach for modeling dynamic processes for phantoms is not possi-
ble. However, we propose dedicated modules for growth and a simulation of contrast agent
enhancement characteristics in the context of brain tumors in Section 5.3 of this work.
Several phantom results based on our modeled parameters are shown in Chapter 5. For
example, Multiple Sclerosis lesion phantoms (cf. Fig. 5.2) or brain tumor phantoms in
Figure 5.13. To the best of our knowledge, our approach represents the first hybrid software
phantom with this amount of object modules.
5. Phantom Examples
In the previous chapter, we proposed newmodeling schemes for parameters commonly used
in phantom design. This finally enables us to develop our own phantoms. In this chapter, we
present three examples. For each phantom, the parameter models proposed in the previous
chapter are used to generate a phantom. Extensions are described and examples of the
resulting software phantoms are given. Furthermore, the template sheet introduced in the
last chapter is applied to provide a compact description and a quick overview of the most
important aspects of all phantoms.
Our first example describes the design of phantoms for Multiple Sclerosis (MS) lesions
(cf. Sec. 5.1). Therein, an interactive object design of typical lesion shapes incorporated into
an MR dataset of a healthy volunteer is used. The software assistant proposed in Section
4.3 is used to design the final phantoms. Section 5.2 then introduces an extension of this
manual approach. Here, we propose a fully automatic method to build an arbitrary number
of MS data sets. The BrainWeb phantom (Collins et al. 1998) is used as reference data set.
The third example is a phantom for brain tumors (cf. Sec. 5.3). Here, we introduce
two modeling scheme for process modules. A biomechanical model is used to simulate
tumor growth and the associated deformations inside the brain. Furthermore, a simulation
of contrast agent enhancement characteristics is presented. Compared to the lesion objects
above, we also develop additional tissue classes to model the amount of edema and active
tumor. Again, our software assistant is used to generate the phantoms.
5.1. Interactive Design of MS Lesion Phantoms
Multiple Sclerosis (MS) is a chronic disease affecting the central nervous system (CNS),
which includes the brain and spinal cord. It is one of the most common neurological dis-
eases in Central Europe, predominantly affecting young and middle-age adults. Currently,
approximately 130,000 persons have been diagnosed with MS in Germany. Around 2,5
million people are affected worldwide. The etiology of MS is still unknown, but current
studies point out a multifactorial genesis. A high degree of variability and diversity charac-
terize the clinical signs and symptoms of the disease, that histo-pathologically results from
a progressive demyelination and an axonal loss within the CNS (Lassmann 2002).
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Currently, no predictable pattern is known for presentation of patients with MS, which
makes the diagnosis clinically challenging. Most patients with MS initially have a relapsing-
remitting (RRMS) subtype characterized by episodes of neurological dysfunction followed
by periods, during which a stabilization or a partial to full recovery of the symptoms can
be observed. Over time, the initially relapsing-remitting MS gradually worsens often into
a more progressive course of the disease, called secondary progressive (SPMS). Another
subtype that can be distinguished is the primary progressive MS (PPMS), characterized by
a gradual progression from its onset with no remissions at all (Inglese 2006).
Several therapeutic options are available to patients to treat the disease symptomatically.
However, no curative treatment is available for Multiple Sclerosis today, so that there is a
considerable demand to develop new and more effective drugs.
Diagnosis of MS and the Role of Magnetic Resonance Imaging
Multiple Sclerosis can be very difficult to diagnose at first and there is no simple test be-
cause of the high variability in signs and symptoms that may suggest a number of conditions.
Commonly used methods of quantifying MS are neurological disability scales such as the
Expanded Disability Status Scale (EDSS) (Kurtzke 1983). During the last years, MRI has
become an important imaging modality for understanding and managing several aspects of
MS. Today, it is an integral part of standard diagnostic especially for follow-up examinations
and plays a primary role as a surrogate marker of drug efficacy in clinical trials (Miller et al.
1998). In more than 95% of patients with MS, abnormalities can be seen on MR images
(Compston and Coles 2002). To make use of the advances in MRI techniques, an interna-
tional panel was convened and recommended revised diagnostic criteria for MS, known as
McDonald criteria that formally incorporated MRI (McDonald et al. 2001; Polman et al.
2005).
Typical multispectral image acquisition protocols include proton density (PD-), T2-
weighted, and FLAIR (fluid attenuated inversion recovery) sequences, as well as T1 se-
quences pre and post contrast with a slice thickness of 3-5mm (Traboulsee et al. 2003).
T2- and PD-weighted images are very sensitive in detecting MS lesions, where lesions ap-
pear as areas of increased signal intensities, predominantly in the white matter of the brain.
Chronic abnormalities such as axonal degeneration and the presence of demyelination can
be observed as hypointense lesions on T1-weighted images (’black holes’). Enhancing le-
sions (’active lesions’), found on T1-weighted images after contrast administration, show
the inflammatory stage of the disease. Besides established imaging sequences, a number
of other modalities have gained attention in the last few years, including MR-Spectroscopy
(MRS), functional MRI (fMRI), high-resolution morphometrical imaging combined with
accurate atrophy measurements, or diffusion weighted imaging (DWI) and diffusion tensor
weighted imaging (DTI) (Miller et al. 1998). Each sequence offers a specific view on dif-
ferent aspects of the disease and each radiology department typically has its own standard
protocols.
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(a) (b) (c)
Figure 5.1. Modeling of different lesion types. (a) Standard T2 hyperintense lesion, (b) same
volume and position of lesion as in (a) on a T1-weighted image; (c) same lesion object as in (b),
but now hypointense on T1-weighted image (black hole).
In this section we develop MS lesion phantoms, that we introduced first in (Rexilius
et al. 2003). We propose a manual object design of typical lesion shapes. The lesion objects
are incorporated into an MR dataset of a healthy volunteer. In Chapter 6 we will then
reuse the resulting software phantoms to investigate the quality of visual assessment in MS
lesion volumetry as well as for the evaluation of MS lesion quantification and segmentation
approaches.
5.1.1. Morphology and Topology
Shape and Structure
To cover a variety of realistic-shaped MS lesions, we generate different lesion objects such
as sphere-like objects and ellipsoidal objects with several deformations. Thereby, we as-
sume that a lesion consists of a single homogeneous tissue class. Each object is constructed
from a combination of geometric primitives. To this end, ellipsoids of different size and
shape are placed at manually selected positions on the object surface in an iterative fashion.
A similar approach has also been used for the design of lung nodule phantoms (Shin et al.
2006).
Volume
Each lesion phantom is defined on a 5123 grid, i.e., a lesion volume is defined as the number
of voxels inside this grid. Different volumes then can be easily generated from a lesion
phantom by specifying a different voxel size. We use a voxel size ten times smaller than the
inplane resolution of the available MR scan.
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Position
The lesion objects are generated manually and placed at typical paraventricular positions in
the white matter of the brain. See Figure 5.2 for examples.
5.1.2. Imaging Parameters
Gray value and noise
A lesion object with a reasonable constant intensity value for MS lesions for each available
sequence is created, and Gaussian noise is added. The standard deviation of the Gaussian
noise is set approximately equal to the noise of the brain scans, estimated from unstructured
regions inside the white matter for each available imaging sequence separately. A similar
approach is used to generate appropriate lesion gray values. Mean gray values for white
matter, as well as for lesion tissue, are computed manually from several patient data sets,
and the ratio is used as guideline for the phantom lesion gray values. Different ratios are
computed for the available MR sequence. Furthermore, phantom lesion gray values are
adjusted based on inspections of patient data sets with MS lesions.
Resolution
The spatial resolution of the images is determined by the underlying reference data.
PV Effects
To account for partial volume effects, we resample the lesion mask using trilinear interpo-
lation after modeling all morphological parameters, i.e., shape, structure, and volume. The
resulting probability map defines the amount of partial volume at each voxel.
5.1.3. Background Design and Object Incorporation
The images used as background in this study were acquired from a healthy volunteer (a 28-
year-old male) on a 1.5 T scanner (Magnetom Vision; Siemens, Erlangen, Germany). The
data-acquisition protocol contained axial and coronal PD-, T2-, and T1-weighted images
with an in-plane resolution of 0.449×0.449mm2 and a slice thickness of 3 mm, matrix of
512× 512, and 34 axial and 51 coronal continuous slices, respectively. All images were
acquired in one session with head fixation and without table movement, such that all data
sets are perfectly aligned without visible motion artifacts.
The final phantom values iphantom are computed by linear combining all structures avail-
able within a voxel, i.e., iphantom = λ · ilesion+(1−λ) · iWM,λ ∈ [0,1] (cf. Eq. 4.4).
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Phantom Data Patient Data
Figure 5.2. Examples of different generated phantom MS lesions showing the potential of our ap-
proach on axial PD- and T2-weighted axial images. (Left column) MR scan of a healthy volunteer
used in this work with different incorporated MS lesion phantoms, (Right column) a patient’s MR
scan with several MS lesions.
5.1.4. Resulting Software Phantoms
An summary of the resulting phantom using the proposed template is given in Figure 5.3.
Furthermore, Figure 5.1 and 5.2 illustrate the potential of our approach. A comparison of a
patient MR scan with several MS lesions and a modeled data set with corresponding lesion
types is shown in Figure 5.2. Each lesion object is placed at a position in the volunteer scan
that roughly corresponds to a lesion appearance in the patient scan.
Figure 5.1 demonstrates the flexibility of our phantoms. Different lesion types can be
generated by simply changing the intensity value of an object. A typical hyperintense lesion
within a T2-weighted data set is shown in Figure 5.1 (a). Figure 5.1 (b) and (c) show the
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Figure 5.3. Summary of the developed MS lesion phantoms.
same lesion in a T1-weighted image with varying intensity values resulting in hyper- and
hypointense lesions.
5.2. Automatic Design of MS Lesion Phantoms
A major drawback of the lesion phantoms introduced in the previous section is the overall
manual design. Each object shape is constructed from a single geometric primitive with
manually added ellipsoids at various positions on the object surface. A feasible object
position within the background data is then selected by hand. Furthermore, we assume that
a lesion consists of a single homogeneous tissue class, which does not allow to change the
object texture.
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(a) (b) (c)
Figure 5.4. Visualization of lesion positions within reference data. (a) The center of gravity (red
points) for all reference lesions; (b) statistical position map for one slice; (c) position map overlay
on T1-weighted image slice.
In this section, we introduce an extension of the manual approach (Rexilius and Tönnies
2014b). Instead of developing a small amount of hand-crafted lesions, we present a fully
automatic method to build an arbitrary number of MS data sets. Several parameters are mod-
eled for each lesion such as shape, volume, or position. The BrainWeb phantom (Collins
et al. 1998) serves as reference data set. Our approach can thus be seen as extension of the
BrainWeb data by an additional MS lesion class.
5.2.1. Morphology and Topology
Position
MS lesions have a variety of typical locations. In a pre-processing step, we compute a
statistical map of lesion positions from a list of patient data sets (cf. Fig. 5.4 (a)-(c)). The
BrainWeb data are used as reference coordinate system. The underlying registration process
can be described as follows: In the first step, an automatic brain extraction is performed for
each patient data set based on an evolving deformable model (Smith 2002). This reduces
the degrees of freedom for the following registration steps. Moreover, no information is
eliminated since all lesions are located inside the brain. In the next step, we perform a global
affine registration followed by a local nonrigid B-spline registration (Klein et al. 2010)
to reduce inter-patient shape variabilities. The final map of lesion positions is computed
by applying the resulting transformations to the corresponding manual segmentations. An
example of the registration results shown as overlay on the BrainWeb data is given in Figure
5.5. This map is then used to automatically place a lesion within the BrainWeb data, using
randomly selected positions from the map. Furthermore, a minimum distance between two
lesions can be defined.
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(a) (b) (c)
Figure 5.5. Registration results. (a) Reference data. (b) Reference data with patient data overlay
(affine registration). (c) Reference data with patient data overlay (affine + B-spline registration).
Figure 5.6. Modeling lesion texture using Perlin Noise. (top row) patient data; (middle row)
phantom with incorporated lesion; (bottom row) synthetic lesion mask with texture.
Shape
Similar to the lesion positions, their shape also shows a considerable intra- and inter-patient
variability. Thus, instead of developing a few handmade shapes, a database consisting of
all lesion objects extracted from the registered segmentation masks, as described in the
previous section, is used. To reduce the effect of manual segmentation errors, an isosurface
is computed from each segmentation mask and further modified by applying a smoothing
operation. The result is then transformed back to image space.
Structure
Another important parameter to describe the appearance of an MS lesion is related to its
underlying structure or texture. Histologically, MS is characterized by different processes
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(a) (b) (c) (Patient Data)
Figure 5.7. Example using scaling of lesion texture. Top row: T2-weighted data with incorporated
lesion. Bottom row: corresponding lesion probability mask. (a) Homogeneous lesion; (b) texture
values ∈ [0.3,1]; (c) texture values ∈ [0,1].
including inflammation, myelin breakdown, and gliosis. This results in a large heterogeneity
in appearance, which is further increased by changing imaging and scanner parameters
between data acquisitions. Nevertheless, current methods for MS lesion phantoms use only
a single homogeneous tissue class (Tofts et al. 1997; Rexilius et al. 2005).
One way to generate a reasonable lesion structure is texture synthesis from a sample
database extracted from patient data, as proposed for brain tumors in (Prastawa et al. 2009).
However, we aim at a high-resolution lesion object that is later downsampled to model
partial volume effects during image acquisition. A texture extracted directly from patient
data can hardly meet these requirements.
In this work, we propose a parametric model based on 3D simplex noise introduced
by Ken Perlin (Perlin 2002) to generate different lesion textures. Such an approach is fre-
quently used for example for organ surface-like textures in surgery simulators. Changing
the parameter values, i.e. the number of octaves, frequency, and persistence, results in a
wide range of different texture samples. Figure 5.6 shows a comparison of different real le-
sions and corresponding phantom results. Furthermore, the underlying lesion mask is given
for each example.
After determining an adequate lesion structure, the resulting texture map is scaled to
[vmin,1]. Figure 5.7 shows a lesion with an example texture incorporated into the reference
BrainWeb data. Different values vmin ∈ {1,0.3,0} are used to demonstrate the flexibility of
our design approach.
Volume
The lesion volume is computed by accumulating all segmented voxels within the segmen-
tation mask. The amount of lesion tissue is used as weight at each voxel, accounting for
76 5. Phantom Examples
Figure 5.8. Result of automatic lesion volume selection. (left) Random selection of volume v ∈
[minV,maxV ]. (middle) v= maxV . (right) v= minV .
both partial volume effects and textural changes. Moreover, the final volume is randomly
selected from a range depending on the original volume. Figure 5.8 shows the result of this
approach for different lesions. We use the maximal (Fig. 5.8, middle) and minimal (Fig. 5.8,
right) possible volume as well as a random volume selection (Fig. 5.8, left) within the given
range for each lesion. This way, the same reference lesion will receive slightly different
volumes in different phantom data set. Another approach could be for example to use only
lesions from the database that exceed a certain volume threshold.
5.2.2. Imaging Parameters
Gray value and noise
The lesion gray value is defined via the ratio between mean white matter and lesion gray
values, extracted from the reference patient data sets. This way, a typical range of values
is defined. The final lesion value is then randomly selected from this range. In addition
to a gray value, Gaussian noise is added to each lesion. The noise standard deviation is
set approximately equal to the reference data noise, selected from a homogeneous region
within the white matter.
Resolution and uniformity
The spatial resolution of the images is determined by the underlying BrainWeb reference
data. Several inhomogeneity fields are also available from BrainWeb and can be used to add
further challenges to the phantom data.
PV Effects
We use the same method that was already proposed for the manual lesion design, i.e., re-
sampling the final lesion mask using trilinear interpolation. The resulting probability map
defines the amount of partial volume at each voxel.
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Figure 5.9. Summary of the developed MS lesion phantoms.
5.2.3. Background Design and Object Incorporation
The BrainWeb data are used as background. Several different settings are available for
download from the associated website. We use PD-, T2-, and T1-weighted images with a
slice thickness of 1mm and an in-plane pixel size of 1mm×1mm. Furthermore, a noise level
of 3% is selected. Additional noise levels (0%, 1%, 5%, 7%, 9%) as well as slice thickness
(1mm, 5mm, 7mm, 9mm) are available from the website.
The developed lesion probability map is used as additional tissue class. Due to regis-
tration inaccuracies, it is limited to the white matter mask of the brain. The final lesion
phantoms are then incorporated into the MR data sets using an independently computed
gray value for each lesion.
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PHANTOM1 PHANTOM2 PHANTOM3
Figure 5.10. Examples of the resulting phantom data sets. Row 1-3: T2-, PD-, T1-weighted data of
one phantom.
5.2.4. Resulting Software Phantoms
The tabular phantom description with the most important aspects is given in Figure 5.9. We
developed 16 phantom data sets with varying amount of lesions. The associated total lesion
load (TTL) has a range from 1.12ml to 7.18ml. An overview is given in Table 6.8. Three
examples of the resulting phantoms are shown in Figure 5.10. The overall quality of the
data sets is assessed by a domain expert using a rating scale based on fuzzy terms (poor,
low, average, high, very high). The detailed results for each data set are given in Table 5.1.
Adding a more complex texture model results in a higher rating for all phantoms.
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Table 5.1. Visual assessment of the quality of each phantom data set performed by a domain expert.
See also Sec. 6.3 for additional information about the phantom data sets.
HOMOGENEOUS LESIONS
Data1 Data2 Data3 Data4 Data5 Data6 Data7 Data8
Ranking avg avg avg avg avg avg avg avg
LESIONS WITH TEXTURE
Data1 Data2 Data3 Data4 Data5 Data6 Data7 Data8
Ranking high high high high high high high high
5.3. Brain Tumor Phantoms
Tumors of the central nervous system (CNS) are considered some of the most lethal and
difficult to treat forms of cancer. The main types of treatment are surgery, radiation therapy,
and chemotherapy (Osborn and Tong 1999). Characteristic properties that have to be taken
into account include the anatomy and vascularity of a tumor, its relation to adjacent struc-
tures, as well as neurological functions of underlying areas. Furthermore, a fundamental
issue is the accuracy of the calculated qualitative and quantitative parameters, which can
have direct impact on treatment planning and therapy monitoring.
Today, MRI is often the imaging method of choice in clinical routine due to its high
soft-tissue contrast combined with versatile parameterization alternatives (Thornton et al.
1992). Common acquisition protocols include T2- and FLAIR-weighted sequences, which
are sensitive to edema and to tissue infiltration, providing an indication of the extent of
low malignant tumor parts. Furthermore, T1-weighted sequences pre- and post-contrast
facilitate an estimation of blood-brain barrier dysfunctions, often caused by high malignant
tumor parts.
The boundary of a tumor and its volume are often used as objective parameters. How-
ever, since brain tumors can largely vary in size, shape, amount of edema, and enhancement
characteristics, any analysis used in clinical routine and in multi-center studies has to be
carefully evaluated. Varying acquisition protocols and image quality add to complexity of
this task. Unfortunately, publicly available reference data sets are hardly available. Further-
more, a ground truth is usually not known for brain tumors.
In this section, we develop brain tumor phantoms, which have been introduced in (Rex-
ilius et al. 2004). A biomechanical model enables us to simulate deformations that occur
due to tumor growth inside the brain (cf. Sec. 5.3.3). Additional properties such as the
amount of edema at each voxel (cf. Sec. 5.3.2) as well as a simulation of contrast agent
enhancement characteristics are provided within the software phantom (cf. Sec. 5.3.5). An
extension of our work was proposed by Prastawa et al. (2009). Their phantoms have also
been used as training data at the BRATS challenge at MICCAI 2012.
80 5. Phantom Examples
(a) (b) (c) (d)
Figure 5.11. Examples of tumor phantoms without simulation of edema that differ only in size
and amount of necrosis in comparison to original MR data. (a) Original T1-weighted image post
contrast (T1gd) of healthy volunteer, (b) T1gd image with small tumor, (c) T1gd image with large
tumor, (d) T1gd image with large tumor and necrotic tissue scaled to 5%.
5.3.1. Overall Phantom Design
To develop a realistic object shape and appearance for brain tumors, we use two different
tissue classes: active tumor and necrosis. Furthermore, we introduce an additional class for
edema (cf. Sec. 5.3.2). This approach can be considered as an extension of the one-class
approach proposed for MS lesions in the previous sections of this chapter.
Both, active tumor tissue and necrosis are obtained from segmentation masks of a real
tumor patient, and are resampled onto a high-resolution grid (5123 grid). The amount of
necrosis can be easily changed by appropriate scaling (cf. Fig. 5.11 and 5.12). Suitable
object gray values as well as noise characteristics for both tissue classes are determined
from the patient data set, and are adjusted to the underlying background data set.
Three-dimensional T1-weighted pre and post contrast MR images from a healthy vol-
unteer are used as background data. All data are obtained from a clinical 1.5T scanner
(Siemens Magnetom Vision, Siemens, Erlangen, Germany) with 1.0mm isotropic voxel
size, 256x256 matrix (cf. Fig. 5.11 (a)). A simulation of deformations induced by tumor
growth is performed to provide a more realistic background model. Furthermore, we in-
troduce an additional tissue class, to simulate edema. The following sections give a more
detailed description of these steps. Finally, the objects for each tissue class are incorporated
into the volunteer MR data sets as a linear combination of the deformed MR scan and the
tumor tissue classes.
5.3.2. Modeling of Edema
In addition to the actual tumor tissue, edema is another important structure that should be
taken into account. Brain edema is an inflammatory response to the tumor, which causes
the brain around the tumor to swell, and is mostly located in the white matter (Osborn
and Tong 1999). Because the brain is located in a confined space and cannot expand, and
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(a) (b) (c)
Figure 5.12. Second example of tumor phantoms without simulation of edema, similar to Figure
5.11. (a) T1gd image with small tumor, (b) image with large tumor, (c) necrotic tissue scaled to
5%.
because the fluid that accumulates cannot easily be carried away, an edema can impair the
normal brain functions and cause an increase of intracranial pressure. Therefore, an accurate
segmentation and quantitative analysis could add valuable information for a physician. For
example, a method for tumor segmentation with an explicit model for edema is proposed in
(Prastawa et al. 2003).
We simulate the amount of edema at each voxel, using a geodesic distance transfor-
mation (Soille 2003) starting from the tumor boundary. The basic idea is to constrain the
distance computation to remain within a subset of the image volume. We use a white matter
mask, because the edema is usually located in the white matter of the brain. Depending on
the resulting distance map we define a region of pure edema and of a mixture between pure
edema and normal brain tissue. This way, various degrees of edema dissemination can be
simulated. The amount of PV is scaled accordingly. Further PV effects that occur between
edema and tumor tissue at the boundary of the tumor are considered as well. The result-
ing edema probability mask is then added to the structure module as additional tissue class.
Suitable intensity values and noise level are again extracted from the associated patient data.
See Figure 5.13 for an example.
Unfortunately, the amount of edema is not only influenced by the distance to the tumor
boundary. Other aspects such as tumor infiltration should also be taken into account. Fur-
thermore, methods that account for preferred tumor dissemination pathways could provide
a more accurate basis for the tumor and edema growth, e.g., maps of the principal diffusivity
directions derived from diffusion tensor imaging.
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5.3.3. Modeling of Deformations Induced by Tumor Growth
An important aspect in generating a realistic phantom for brain tumors is to simulate the
deformation imposed by tumor growth. A fundamental assumption is that surrounding
brain tissue is pushed away from the tumor. In order to gain insight into the process of
tumor growth, mathematical modeling has become an increasingly important role and vari-
ous methods have been proposed.
We simulate the three-dimensional tumor growth using a physics-based model. Our ap-
proach is based on a linear elastic model that was previously used to capture shape changes
of the brain during neurosurgery (Ferrant et al. 2001; Rexilius et al. 2001). Since a rigid
model can be assumed for surrounding tissue such as the dura mater, the model is con-
strained at the boundaries of a brain mask generated by a watershed transform (Hahn and
Peitgen 2000), so that motion is restricted to areas inside the brain. Tumor growth is then
simulated from an initial start point. Thereby, a brain tumor object is placed at an arbitrary
position inside the brain with a given radial displacement u(d) = αd,α ∈ R+ in each di-
rection d ∈ R3. The center of gravity of the tumor object is used as point of origin. The
constraints for tumor and brain boundary are then introduced as external forces into the
elastic model defined in Equation 5.1 with material parameters E = 3kPa (Young’s moduls
measured in Pascal) and ν = 0.4 (Poisson’r ratio) as
E(u) =
1
2
∫
Ω
σ⊤ε dΩ −
∫
Ω
F⊤u dΩ . (5.1)
Ω image domain
σ strain
ε stress
F external forces
u displacement.
Similar parameters have been used for example by Ferrant et al. (2001). The computed
constraints for both, tumor and brain boundary are then introduced as external forces into
the elastic model. Thus, changes in the shape of the brain are modeled to result in an
equilibrium state of energy with a displacement u that minimizes the total potential energy
as defined in Equation 5.1.
The resulting equation is solved by a finite element approach (Zienkewickz and Tay-
lor 1987). We chose a structured mesh with a triangulation done using tetrahedra and linear
shape functions. To solve the resulting system of equations, we use a fast parallel implemen-
tation, which was already implemented as part of a nonrigid registration approach (Rexilius
et al. 2001).
Finally, an iterative tumor growth is applied as proposed in Equation 5.2. We start with
a deformation restricted to the boundary of a downsampled tumor shape (factor 5). The
center of gravity is placed at the same position as for the full-scale tumor, so that even brain
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Phantom Data Patient Data
Figure 5.13. Examples of different software phantoms with simulated edema compared to actual
patient data. (Left column) MR scan of a healthy volunteer with incorporated tumor object, (Right
column) MR scans of patients with a brain tumor.
structures very close to or even inside the full-scale object’s boundaries can be pushed away
from the tumor. The amount of displacement per iteration varies with the scale factor α as
defined above.
un(x) = un−1(x)+u(x+un−1(x)) . (5.2)
un−1(x) displacement at time point n
un−1(x) displacement at time point n−1.
The maximum deformation in the full-scale tumor size is set as stopping criterion for the
iteration process. The amount of displacement per iteration varies with the scale factor α as
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Figure 5.14. Summary of the developed brain tumor phantoms.
defined above. The associated parameter moduleMpgrowth is defined as follows:
Parameter Description (Mpgrowth)
H Tumor growth modeled by iterative linear elastic model
x Background data set and initial tumor shape
f Compute background deformations using Eq. 5.1 and Eq. 5.2
y Pixel-wise displacement map
5.3.4. Resulting Software Phantoms
Figure 5.13 illustrates the resulting software phantoms. Similar to the generated software
phantoms for MS lesions, we present a comparison of a patient MR with a brain tumor
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and a phantom data set. To evaluate the quality of these phantom data sets, we conducted
a visual assessment by two clinical experts. All four image data sets were shown to the
participants, i.e., the two patient and the two phantom data sets. The first example (top
row in Fig. 5.13) was clearly identified as tumor phantom. Especially the edema region
appeared to be too homogeneous. Nevertheless, one expert also rated the patient data as
possible software phantom. In the second example, the bottom row in Figure 5.13, both
experts rated the tumor phantom as potential patient data set. A summary of the phantom
and its major components is given in Figure 5.14.
5.3.5. Simulation of Contrast Enhancement Characteristics
In this section we add an additional parameter model to our brain tumor phantom that allows
the simulation of contrast agent enhancement characteristics. Since the focus in this work is
not on dynamic MRI, we merely provide exemplary results to showcase the flexibility and
potential of our approach.
Multi-compartment models are commonly used to describe the enhancement of macro-
molecular contrast agent particles in tumor tissue and thus are an important tool for com-
puter assisted analysis of dynamic MRI. We have used the Tofts&Kermode model to gener-
ate simulated perfusion data sets (Tofts and Kermode 1991). This enables us to combine the
prediction of contrast agent enhancement and a known ground truth for a quantitative anal-
ysis in simulated brain tumors. To apply the Tofts&Kermode model to the tumor phantom,
we generate maps of the artificial distribution of physiologic parameters: The permeability
of tissue and the extracellular volume fraction that is accessible for the contrast agent. Since
most of the active tumor tissue is usually located at the border of the tumor, we assume an
increase of the permeability from the center to the border. A very low permeability is as-
signed to necrotic tissue using the simulated amount at each voxel as a scaling factor. The
extracellular volume fraction is assumed to vary only slightly between 0.7 and 0.8. We set
a higher value for necrosis than for active tumor tissue. Finally, contrast enhancement is
simulated at a 0.5 minutes scan-interval from 0 minutes up to 15 minutes after injection of
contrast agent at a dose of 0.1mmol/kg. The associated parameter moduleMpenhancement is
Parameter Description (Mpenhancement )
H Enhancement characteristics can be simulated via Tofts&Kermode model
x Phantom data set with tumor object
f Tofts&Kermode model
y Pixel-wise enhancement characteristic over N time-steps.
Figure 5.15 (b) provides a color-coded visualization of the wash-in and wash-out of
contrast agent within the tumor region. The red area corresponds to active tumor, the blue
area to necrosis. The corresponding enhancement curves for different positions inside the
tumor are shown in Figure 5.15 (c). For example, the simulation of active tumor tissue (red
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(a) (b) (c)
Figure 5.15. Simulated enhancement characteristics. The imaging parameters are adapted to the
parameters of the real MR scan (T1w gradient echo, TE=5ms, TR=15ms, FlipAngle=30◦). (a)
Slice of phantom data set, (b) combined colorized visualization of wash-in and wash-out of con-
trast agent (red: active tumor, blue: necrosis) (c) relative enhancement curves for selected regions
inside the tumor.
curve) results in a rapidly increasing curve due to high values in the generated permeability
parameter map.
5.4. Discussion
Today, different software phantom approaches are available, and some have already been
discussed in the previous chapters. For example, evaluation of segmentation methods is
often based on artificial phantoms that consist of geometric primitives. Although such an
approach provides a reasonable tool in many cases, a dedicated validation of algorithms
using anatomical or other prior knowledge is not feasible, because these artificial phantoms
can only provide a very rough approximation of anatomy. Voxel phantoms such as the
BrainWeb phantom (Collins et al. 1998) on the other hand, enable a realistic representation
of anatomical structures, and have gained importance in medical image analysis. However,
only a small number of data sets are available for public use. The current BrainWeb data
consist of only one data set with T1-, T2-, and PD-weighted sequences. Twenty additional
data sets (only T1-weighted) are available based on the work of Aubert-Broche et al. (2006).
In this work, we develop hybrid phantoms that have proven to be an elegant way to
a flexible software phantom design (cf. Sec. 2.2.1). Our phantoms are well suited for
tasks such as algorithm development and evaluation, and some examples are given in the
upcoming chapter. We propose a phantom design based on the embedding of objects into
already available anatomical structures. The object design consists of several parameter
modules related to morphology and imaging parameters. Furthermore, our approach allows
for an extension to growth-induced deformations of objects. The background is based on
actual patient data or well-known software phantom data.
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Two phantoms are based on a manual object design. In Section 5.1, we developed MS
lesion phantoms consisting of a single tissue class from hand-crafted objects of typical le-
sion shapes. An extension of this approach is presented in Section 5.3 for brain tumors.
Besides a tumor class, we model edema as additional tissue class. Furthermore, object de-
formations affecting the background data are applied to model tumor growth. Nevertheless,
the actual tumor objects are still modeled by hand based on reference patient data. For both
applications, our software assistent introduced in Section 4.3 is used.
The phantoms described above provide a high degree of flexibility. However, generat-
ing a new phantom requires a long processing time and a large amount of manual work.
Therefore, we extended the above methods to a fully automatic approach for MS lesion
phantoms in Section 5.2. A statistical map of object positions and an automatic selection of
other parameters such as shape or volume enable the generation of an arbitrary amount of
phantom data sets. To the best of our knowledge, our approach represents the first method
of this type.
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6. Applications
After developing several brain lesion phantoms in the previous chapter, we now discuss how
such phantoms can be used to evaluate algorithms that frequently occur in clinical practice
and trials. We focus on MS lesions and brain tumor phantoms. Four different applications
are analyzed: First, we investigate the quality of visual assessment in MS lesion volumetry
(cf. Sec. 6.1). Based on a specially developed software assistant, a survey with more than
20 participants is carried out. Typical tasks are evaluated such as estimating volume change
between two lesion phantoms by pure visual inspection.
In Section 6.2, we then evaluate common methods for lesion volumetry including man-
ual tracing by three field experts plus voxel counting as well as two semi-automatic methods.
More than 50 phantom data sets are generated for this task. Furthermore, we perform an
intra-observer study, where all phantom data sets are repeatedly analyzing. Our results
demonstrate frequent problems with inter- and intra-observer reproducibility, and the im-
portance of an improved gold standard in lesion volumetry beyond voxel counting.
Finally, the use of phantoms for the evaluation of segmentation methods is discussed
in Section 6.3 and Section 6.4. Several algorithms ranging from manual to fully-automatic
are analyzed. The Dice similarity coefficient is used to compare the results with the ground
truth known from phantom data.
6.1. Visual Assessment in MS Lesion Volumetry
The change of lesion load on yearly T2-weighted MR scans of the brain is widely used in
clinical routine and clinical trials. Thereby, the expected change is estimated to be around
10% (Filippi et al. 1998). Today, common measurements are based on manual segmenta-
tion followed by voxel counting within the segmentation mask, or even by a simple visual
inspection of the available image data. But how reliable are such measurements, and what
are their chances and pitfalls?
In this section, we present a survey of a common quantitative measurement used in clin-
ical practice, namely pure visual inspection. Thereby, an assessment heavily relies on the
human eye to detect changes, which are then characterized in a qualitative way. To allow
for a more quantitative analysis, visual rating scales have been proposed in several medical
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disciplines. Nomori et al. (2005) compared visual assessment and a semi-quantitative anal-
ysis of fluorodeoxyglucose (FDG) uptake on PET for the evaluation of lung nodules. Three
grades were used to describe each nodule. A retrospective analysis of a visual grading from
unenhanced CT data for the diagnosis of 30% or higher of hepatic steatosis in living donor
liver transplantation candidates was proposed by (Lee et al. 2007). An overview of differ-
ent visual rating scales used for the analysis of anatomical and pathological white matter
changes in the brain is given in (Malloy et al. 2007).
In this section, MS software phantoms of different shape and volume are used to provide
a large range of different realistic data sets (cf. Chap. 4). Furthermore, the exact ground
truth is known for each modeled lesion. To this end, we developed a software assistant
that consists of several steps, comprising different tasks for the user. Each data set contains
exactly one lesion object that can be easily detected by the user.
6.1.1. The Software
The user interface consists of two parts: A viewing section and a description and question
section. To simplify the viewer handling, we provide several predefined zoom factors. Fur-
thermore, the number of visible slices per viewer can be interactively adjusted. Since we
are not interested in an evaluation of object detection, a region of interest is drawn around
a lesion. The lower part of the user interface in each step consists of a description of the
requested tasks as well as a short documentation of the current step and viewer functionality.
Additionally, a box with questions is given.
To participate in the survey, a user has to download the application from a website and
install it on her/his computer. A preamble serves to acquire some personal information
including age and sex as well as work experience (in years) and area of expertise (radiology,
neuroradiology, computer science, etc.). The results are stored in a separate structure that is
automatically returned as plain text by email after answering all questions.
Three different aspects are investigated, each consisting of at least two steps with differ-
ent lesion objects:
(1) Visual inspection.
The first part of the survey consists of five steps (S1–S5). In each step, a set of three
lesions are presented, and the user is requested to estimate their relative volumes.
In two steps the lesion objects have different shapes, whereas the three other steps
comprise a single shape. We asked for the largest/smallest lesion or if all lesions have
the same volume respectively. The questions are given as follows:
• Q1 : All lesions have equal volume?
Possible answers: yes, no
• Q2: Which is the largest lesion volume?
Possible answers: left, middle, right
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Figure 6.1. First part of the software assistant: Visual inspection.
• Q3: Which is the smallest lesion volume?
Possible answers: left, middle, right
Figure 6.1 shows an example of the corresponding user interface.
(2) Segmented mask volume.
In the second part of the survey, different segmentation masks are presented to the
user as overlay over a lesion object (two steps, S6–S7). Besides the above mentioned
interaction and viewing properties (zooming, etc.), the transparency of a segmentation
mask as well as its color can be adjusted to provide further flexibility. We asked for
the largest/smallest segmented mask volume as well as for the best fit of the true
lesion volume. The questions are given as follows:
• Q4: Which is the largest segmented mask volume?
Possible answers: left, middle, right
• Q5: Which is the smallest segmented mask volume?
Possible answers: left, middle, right
• Q6: Which segmented mask volume is closest to the true lesion volume?
Possible answers: left, middle, right
Figure 6.2 gives an example of the user interface.
(3) Lesion growth.
Finally, an examination of lesion growth and shrinkage has to be performed. Here,
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Figure 6.2. Second part of the software assistant: Segmented mask volume.
two lesion objects of different volume are presented to the user in each step (three
steps, S8–S10). The image in the left viewer is regarded as original data set, the other
image as follow-up data set. The questions are given as follows:
• Q7: Is a volume change visible between original data and follow-up data?
Possible answers: no volume change, volume shrinkage, volume growth
• Q8: Volume shrinkage in percent:
Possible answers: -5%, -10%, -25%, -30%, -40%, -50%, -75%, -100%
• Q9: Volume growth in percent:
Possible answers: 5%, 10%, 25%, 30%, 40%, 50%, 75%, 100%
An example of the user interface is given in Figure 6.3.
6.1.2. Results
Five women and 16 men participated in the survey. The average years of experience of
all participants was 4.93 (min= 0.5, max = 15). All of them already worked with medical
image analysis software before. The largest group of participants were experts in the field
of software development and research in medical imaging (19; 90.5%). Among them were
16 computer scientists, two mathematicians, and one physicist. Furthermore, 2 physicians
(radiology, neuroradiology) participated in the survey.
Twenty software phantom data sets including different lesion shapes and volumes have
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Figure 6.3. Third part of the software assistant: Lesion growth.
been developed for this study. The object volumes range between 0.05ml and 0.6ml. No
participant correctly answered all questions in the ten steps of the software assistant. Es-
pecially the lesion volume change between two data sets was often miscalculated. In the
following, we present the results of the three different tasks of this study.
(1) Visual inspection.
The first part of this study deals with the assessment of relative lesion volumes. Ei-
ther a single volume for all data sets or three different volumes are used, ranging from
0.05ml to 0.44ml. Thereby, for a step that contains different volumes, the volumetric
difference between lesion objects within one step is at least 10%, which is the ex-
pected change per year as described above. The underlying volumes as well as the
correct answers for each step are given in Table 6.1.
S1: Three different lesion shapes with equal volume are shown in this step. The
correct answers, i.e., equal volume for all three lesions, were given by nine
participants (42.9%).
S2: A single lesion shape is presented in all viewers. The largest and the smallest
volume were correctly estimated by 18 participants (80.7%). No participant
voted for an equal volume for all lesions.
S3: Again three different lesion shapes with equal volume are shown. Here, eight
participants (38.1%) gave the correct answer.
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Table 6.1. Ground truth for each step of task ’visual inspection’.
Step Volume (in ml) Questions
left middle right Q1 Q2 Q3
S1 0.1 0.1 0.1 yes – –
S2 0.36 0.12 0.25 no left middle
S3 0.36 0.36 0.36 yes – –
S4 0.4 0.44 0.36 no middle right
S5 0.05 0.05 0.05 yes – –
S4: The three viewers show a single lesion shape. The largest as well as the smallest
volume were correctly estimated by five participants (23.8%). Five participants
voted for an equal volume for all lesions.
S5: In this task, a single lesion shape with equal volume is presented. Most partici-
pants (19, 90.5%) voted for the correct answer.
(2) Segmented mask volume.
In the second part of this survey, segmentation masks are overlayed on the lesion
objects. A volume of 0.36ml is chosen in step 6, and a volume of 0.12ml in step 7.
See Table 6.2 for the underlying ground truth of the segmented mask volumes and the
correct answers.
Table 6.2. Ground truth for each step of task ’segmented mask volume’.
Step Lesion Volume Mask Volume (in ml) Questions
(in ml) left middle right Q4 Q5 Q6
S6 0.36 0.59 0.53 0.56 left middle middle
S7 0.12 0.26 0.20 0.23 left middle middle
S6: The largest mask was correctly identified by 13 participants (61.9%), the small-
est mask by only two participants (9.5%). Furthermore, nine participants (42.9%)
selected the correct mask volume closest to the true lesion volume.
S7: For this task, ten participants (47.6%) correctly identified the largest mask. The
smallest mask was correctly identified by no participant (0%). Nevertheless, 18
participants (85.7%) selected the correct mask volume closest to the true lesion
volume.
(3) Lesion growth.
The change of lesion volume between two data sets has to be estimated in the last part
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of the survey. Table 6.3 provides the true volumes as well as the requested growth
rates. Our results show that this last task has been the most difficult one.
Table 6.3. Ground truth for each step of task ’lesion growth’.
Step Volume (in ml) Questions
left right Q7 Q8 Q9
S8 0.4 0.6 Growth – 50%
S9 0.4 0.28 Shrinkage -30% –
S10 0.1 0.125 Growth – 25%
S8: Only two participants (9.5%) correctly estimated the volume growth. Two par-
ticipants (9.5%) estimated no volume growth at all. No one decided for a volume
shrinkage. Furthermore, no participant overestimated the volume growth (0%).
The mean estimated volume growth was 21.2% (min= 0%, max = 50%).
S9: The correct amount of volume shrinkage was estimated by one participant (9.5%).
No one underestimated the amount of shrinkage. Furthermore, no one estimated
a volume growth. Nevertheless, four participants (19.0%) estimated no volume
growth at all. The mean estimated volume shrinkage was -13.1% (min= 0%,
max = -30%).
S10: In this step, most participants (12; 57.1%) estimated no volume growth. One
participant selected the correct volume growth (4.8%). The mean estimated
volume growth was 3.8% (min= 0%, max = 25%).
6.1.3. Discussion
The survey has demonstrated the capabilities of our software phantoms. Typical drawbacks
of visual rating schemes have been identified. For example, only few participants were able
to correctly estimate the largest or smallest lesion, if three different lesion volumes were
shown. This also implies an overall low performance for a differentiation between different
segmentation masks. Furthermore, a comparison of the change in lesion volumes between
two data sets clearly revealed the importance of computer assistance for the quantitative
analysis of lesions. Although most participants were at least able to give the correct trend
in the data, i.e., growth or shrinkage, the volume change was typically underestimated.
6.2. Accuracy in MS Lesion Volumetry
Besides visual inspection of clinical data, a manual or (semi-)automatic assessment of the
volumetric lesion load often is used as an objective parameter. A fundamental issue is the
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accuracy of the calculated lesion volume because this can increase the impact of lesion vol-
umetry on diagnosis and therapy monitoring of the disease. Several methods have been
proposed to quantify lesion burden, ranging from manual tracing of each lesion by experts
to semiautomated and fully automated methods. A common method used in many clinical
trials that evaluate cancer treatments is the Response Evaluation Criteria In Solid Tumors
(RECIST) (Therasse et al. 2000), which uses a one-dimensional measurement of the tumor
size, the diameter, to approximate the volume. Molyneux et al. (1998) evaluate the perfor-
mance of manual outlining and a semi-automatic contour technique for the segmentation
of MS lesions from 16 patient data sets. The authors show that the semi-automatic method
results in a more robust quantification of the lesion load. A related approach is proposed in
(Ashton et al. 2003), where manual tracing is compared with two semi-automatic methods.
Nevertheless, both studies apply a simple voxel counting without considering PV effects
during volume calculation, i.e., the volume is computed as the number of voxels within a
segmentation mask multiplied by the volume of a single voxel (Clark et al. 1998; Joe et al.
1999; Kaus et al. 2001). An illustration of this method is shown in Figure 8.2.
The aim of this section is to introduce a new approach for the validation of MS lesion
volumetry. Because of the absence of a ground truth in patient data, we generate software
phantom data sets of MS lesions with known exact volumes (Rexilius et al. 2005).
Extensive experimental studies over a broad range of different lesions are carried out
manually by domain experts. Furthermore, a three-dimensional region growing combined
with voxel counting within the segmentation mask as well as a robust semi-automatic vol-
umetry approach based on Bayesian classification with explicit PV modeling are used for
comparison.
6.2.1. Software Phantoms for the Evaluation of MS Lesion Quantification
The software phantoms use in this study are developed based on the approach proposed in
Section 5.1. The images used as background in this study were acquired from a healthy
volunteer (a 28-year-old male) on a 1.5 T scanner (Magnetom Vision; Siemens, Erlangen,
Germany). The data-acquisition protocol contained axial and coronal PD-, T2-, and T1-
weighted images with an in-plane resolution of 0.449×0.449mm2 and a slice thickness of
3 mm, matrix of 512×512, and 34 axial and 51 coronal continuous slices, respectively. All
images were acquired in one session with head fixation and without table movement, such
that all data sets are perfectly aligned without visible motion artifacts.
The lesion objects are generated manually and placed at typical paraventricular posi-
tions in the white matter of the brain. To cover a variety of realistic-shaped MS lesions,
we generate three different lesion objects: a sphere-like lesion (L1), an ellipsoidal lesion
(L2), and an elongated lesion containing several deformations (L3). We did not use regular-
shaped cylinders or spheres because this would not lead to a realistic lesion appearance. A
3D surface rendering of these shapes is shown in Figure 6.4.
In addition to various shapes, six different lesion volumes are chosen: 0.05, 0.1, 0.2,
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Figure 6.4. Examples of software phantoms for MS lesions with different shapes and sizes. The
top row shows a slice of the resulting phantom in 2D, the bottom row shows the employed lesion
objects in 3D. (a) Sphere-like, (b) ellipsoidal, and (c) irregular shape containing several deforma-
tions.
0.4, 0.7, and 1.0ml, resulting in a total amount of 18 different lesion objects. The voxel size
for the largest volume (1.0 ml) was set to an isotropic voxel size of 0.05 mm, resulting in
8,000,000 voxels. Voxel sizes for the remaining volumes are calculated accordingly.
6.2.2. Setup for Manual Expert Analysis
Each data set is analyzed by three experts. In order to provide an intuitive but still powerful
tool for the manual analysis of the provided phantom data sets, we developed an application
with a graphical user interface based on the research and development platform MeVisLab
(MeVisLab 1.5 ). Therein, an expert is able to trace the boundaries of a lesion, shown as
overlay on the original slices. The actual volume is then computed using the voxel counting
approach. In addition to basic drawing functionalities, the user may adjust the lookup-table
and simultaneously view several neighboring slices. Furthermore, it is possible to change
between available sequences during outlining a lesion on one slice. Because we want to
analyze volumetric results and not the lesion detection task of different experts, only one
lesion is incorporated per data set.
6.2.3. Semi-Automatic Volumetry
Two semi-automatic measurement techniques are evaluated in this work. To provide results
corresponding to a popular method for the segmentation of MS lesions in clinical routine
and studies, a seeded region growing algorithm is used (Sonka et al. 1998). This technique
requires a user to place a "seed" within the lesion using a single mouse click. The region then
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successively grows and neighboring voxels are added to the region up to a certain intensity
threshold. A compact shape that does not deviate excessively between two neighboring
intensity thresholds is used to constrain the process. The lesion volume is computed by
voxel counting on the resulting mask similar to the manual approach.
The second algorithm combines a 3D marker-based segmentation and a bimodal his-
togram analysis with an explicit model for PV effects. Only the T2-weighted images are
considered due to their high lesion contrast. In a first step, a cuboid subvolume that contains
the entire lesion is selected and resampled in z-direction to an isotropic voxel size. Then,
an interactive watershed transformation is applied to generate an over-inclusive segmenta-
tion (Hahn and Peitgen 2000). Two different marker types are used. One include marker is
placed inside the lesion and up to five exclude markers are used to separate the lesion from
other hyperintense structures. The resulting region contains the complete object boundaries
including all voxels where PV effects occur.
In a subsequent step, the lesion is classified with a statistical parametric classification
algorithm, which are widely used in image analysis. The overall probability density function
(PDF) of a voxel is given by
P(i) = ∑
m∈T
P(wm)P(i|wm) , T = {background, lesion,PV} , (6.1)
P(i) M-component mixture density
wm underlying tissue class in the image
P(wm) mixing proportions
P(i|wm) component density of given tissue class wm
i observed value of a random vector (here: intensity value).
The weights or prior probabilities, P(wm), which act as scaling parameters of each class
PDF, are nonnegative quantities that sum up to one, i.e.,
0 ≤ P(wm) ≤ 1 (m= 1, . . . ,M)
and
M
∑
m=1
P(wm) = 1.
A Gaussian PDF (cf. Eq. 3.2) is assumed for the two pure tissue classes lesion and back-
ground.
Because of a typically small object size for MS lesions in the order of the slice thick-
ness and the complexity of tissue boundaries, partial volume (PV) voxels, i.e., a mixture
of pure tissue classes, is likely to occur. A common assumption for the modeling of par-
tial volume voxels is a uniform distributed linear mixture of pure tissues because mixture
voxels may consist of any fraction of pure tissue. This mixture model can be incorporated
directly into the clustering algorithm, and the extended classification process therefore can
6.2. Accuracy in MS Lesion Volumetry 99
be implemented computationally efficient. Model parameters for the partial volume tissue
class are defined as a convex combination of the model parameters of the two pure tissue
classes, as proposed in (Noe and Gee 2001). The intensity of a voxel is then determined by
a weighted sum of lesion tissue with intensity i1 and background tissue with intensity i2 as
υ = a1 i1 +(1−a1) i2 .
The corresponding PDF is again a Gaussian density function with parameters
µmix = aµ1 + (1−a)µ2 , (6.2)
σmix = a
2σ1 + (1−a)2σ2 .
The EM algorithm is applied to estimate appropriate parameters for each class (van Leemput
et al. 1999).
Finally, the object volume is computed by
V =
[
P(wlesion)+
P(wPV )
2
]
·Vvoxel ·N (6.3)
P(wlesion) computed weight for lesion object
P(wPV ) computed weight for partial volume region
Vvoxel voxel volume
N number of voxels in ROI.
Equation 6.3 assumes a symmetric PV distribution, so that only 50% of the computed weight
P(wPV ) are added to the total volume.
6.2.4. Results
We evaluated 54 phantom MR data sets generated from a brain scan of a normal volunteer
with exactly one MS lesion phantom per data set as described above. Lesion objects were
placed at typical paraventricular positions in the white matter of the brain. Eighteen dif-
ferent lesions were generated for this study, consisting of six different volumes (0.05, 0.1,
0.2, 0.4, 0.7, and 1.0 ml) for each of three generated lesion shapes (L1, L2, and L3). The
maximum diameters of the three lesion shapes are L1 = 75.4mm (L2 = 7.6mm, L3 = 7.2mm)
for the smallest lesions (0.05ml), and L1 = 713.5mm (L2 = 18.4mm, L3 = 19.3mm) for the
largest lesions (1.0ml). Each lesion phantom is incorporated into both, axial and coronal ori-
entations at corresponding positions. To simulate inter-examination variability with respect
to partial volume artifacts and apparent lesion size, an additional set of images is created by
randomly shifting each lesion in z-direction on the axial images.
The MS lesions were manually traced by three experienced raters using the software
assistant described above. Furthermore, the two semi-automatic volumetry approaches in-
troduced in the previous section were used for comparison. The required interactions for
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Figure 6.5. Results of manual and semi-automatic volume measurements in a boxplot. (a) Over-
all results calculated for each rater and algorithm separately. PVE refers to the semi-automatic
partial volume analysis. (b) Results for each available volume, i.e., experts 1 to 3 and both semi-
automatic approaches.
both algorithms were performed by Expert3.
Figure 6.5 (a) illustrates the overall error for each rater and the two semi-automatic
methods in percentage of the true volume in a boxplot. A detailed analysis for each vol-
ume is given in Figure 6.5 (b). The overall median overestimation as well as the median
overestimation computed for small lesions (<0.3ml) and intermediate lesions (>0.3ml) for
each method is shown in Table 6.4. It can be clearly observed that all experts overestimated
the true lesion volume, all to a comparable amount. The overall median overestimation for
manual evaluation of the three experts ranges between 42.9% and 63.2%. The variability
decreases with increasing volume size, because small changes already cause a significant rel-
ative error for small volumes. For small lesions the median overestimation over all experts
is 73.2%, and 45% for intermediate lesions. No significant shape effect has been observed.
Similar results are obtained using the semi-automatic region growing approach com-
bined with voxel counting. Here, the overall median overestimation is 46.3%. The semi-
automatic approach with dedicated PV modeling, on the other hand, provides far more ac-
curate results with a low error margin especially for intermediate lesions. Here, the overall
median overestimation is 0.4%. Especially the deviation from the median is much smaller
than for both voxel counting based methods.
To evaluate the intra-observer variability, repeatability analyses of the axial phantom
data sets for each method were carried out by one rater, assessing each data set ten times.
Figure 6.6 and Table 6.5 show the mean and the variance of the measured volumes. The
manual approach was found to be highly variable especially for small lesions, whereas both
semi-automatic methods provide a high reproducibility.
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Table 6.4. Median overestimation of computed lesion volume for each expert and the two semi-
automatic volumetry methods; #data sets: n = 27 (small and intermediate lesions), n = 54 (total).
Median Overestimation (%)
Small Intermediate
Method Lesion Lesion Total
Manual, expert 1 87.7 57.2 63.2
Manual, expert 2 58.3 35.5 42.9
Manual, expert 3 78.0 47.0 52.9
Region growing 66.5 31.6 46.3
Partial volume analysis 7.3 -0.9 0.4
Table 6.5. Systematic error and intra-observer variability trials for all proposed methods, assessing
each data set (n = 18) ten times.
Mean Error ± SD (%)
Small Intermediate
Method Lesion Lesion
Manual, expert 3 91.4 ± 32.3 56.5 ± 17.0
Region growing 81.1 ± 2.8 38.4 ± 1.6
Partial volume analysis 14.7 ± 1.0 1.3 ± 0.4
6.2.5. Discussion
Manually outlined contours can provide a good estimation of visible lesion boundaries, al-
though results may vary depending on the experts’ common training. However, volumetric
results using the common gold standard based on voxel counting within the segmentation
mask show massive overestimation with poor interobserver and intraobserver reproducibil-
ity, even for lesions of intermediate size. Here, the partial volume effect is the largest source
of systematic error. The computed volumetry results clearly depend on lesion size because,
for small lesions, relatively more voxels are affected by partial volume.
This also has direct impact on the accuracy of other voxel-counting based methods, and
one cannot expect significant improvement for these methods in general. Moreover, the
negative effect on total lesion load measurements becomes evident. In this work, a common
region-growing algorithm was used as an example. Our results show median overestimation
similar to the manual approach, even if the semiautomatic method has a slightly lower error.
However, a higher degree of automation could improve the reproducibility of the method
and reduce the amount of training needed for inexperienced observers.
To accurately compute lesion volumes, algorithms with a model for partial volume ef-
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Figure 6.6. Results of an intra-observer study for all proposed methods, assessing each axial data
set ten times. ( ⋄, manual analysis; , region growing; ◦, PV analysis).
fects have to be taken into account. The proposed partial volume analysis method is robust
for intermediate and large lesions.
Although correlation between MRI and clinical findings remains difficult, volumetric
analysis of the lesion load has become an important issue and an active research field. How-
ever, analysis of the common gold standard in MS lesion volumetry among three experts
shows a large median overestimation. The overall maximum was approximately 200% for
one expert. An intraobserver study also showed large variability, even for a single rater. No
manual tracing underestimated or met the true volume.
Similar results were obtained for a semiautomatic approach based on region growing.
Although this method generates reproducible lesion segmentations, the actual volumetry is
still based on voxel counting and thus is error prone. Because accuracy is an important
factor for the clinical relevance of a method, results clearly indicate the importance of an
improved gold standard in lesion volumetry beyond voxel counting. New measurements
that accurately address partial volume artifacts are likely to correspond better to clinical
findings. Therefore, our phantoms can provide a basis for comparison and testing of current
and new approaches.
6.3. Segmentation of MS Lesions
Prior to a quantitative analysis of volumetric lesion load as discussed in the previous section,
detection and segmentation are important pre-processing steps for diagnosis and treatment
monitoring of MS lesions. An extensive description of lesion segmentation methods includ-
ing both semi-automatic and automatic algorithms can be found in (Mortazavi et al. 2012).
To evaluate a lesion segmentation method, using patient data and associated manual seg-
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mentations, which serve as a surrogate ground truth, is a common approach. However, a
large data pool is required to account for major anatomical variations and pathologies. Fur-
thermore, exact measurements of parameters such as the volume of an imaged organ are not
possible with patient data sets. Today, only few data sets that include both patient data plus
manual expert segmentations are freely available for the community. An exception for ex-
ample is the Lesion Segmentation Challenge workshop at the MICCAI conference (Styner
et al. 2008).
Instead of another patient data set with unknown ground truth, we propose software
phantoms for this task in this section. In Section 6.3.1, manual and semi-automatic methods
are tested. A fully automatic approach is evaluated in Section 6.3.2.
6.3.1. Manual and Semi-Automated Segmentation
The Algorithms
Two algorithms are analyzed that were already used in Section 6.2. The first method is a
manual expert segmentation. Here, a domain expert interactively outlines the lesion bound-
ary. The second algorithm is a semi-automatic region growing, where a seed is manually
placed within the lesion as starting position.
Results
To evaluate the two segmentation approaches, we use the same lesion phantoms that were
proposed for lesion volume estimation (cf. Sec. 6.2). A total number of 18 phantom MR
data sets is analyzed. For each data set (MS brain scan of normal volunteer), one MS lesion
phantom is placed in the white matter of the brain. Three different lesion shapes were
generated and six different lesion volumes are chosen for each shape (0.05, 0.1, 0.2, 0.4,
0.7, and 1.0ml) resulting in 18 different lesion objects.
To measure the overlap of the segmentation results with our ground truth, the Dice simi-
larity coefficientDSC(A,B)= 2|A∩B|/(|A|+ |B|), (A=AlgorithmResult,B=GroundTruth)
is used (cf. also Sec. 8.2). Since both segmentation algorithm compute a binary lesion mask,
we calculate the overlap only for ground truth voxels with ≥ 50% lesion probability.
Table 6.6 gives the results for all phantoms. The expert segmentation usually resulted
in lower overlap values compared to the semi-automatic region growing algorithm, inde-
pendent of the segmented lesion. The values for the manual segmentation range between
0.58 and 0.90 and for the region growing approach between 0.61 and 0.96. Note, that a
value of DSC = 0.7 is generally regarded as good segmentation. Similar to the volumet-
ric lesion analysis, the computed similarity measure increases with increasing volume size.
No significant shape effect is observed. For small lesions (<0.3ml), the mean similarity is
DSCmanual = 0.75 and DSCrg = 0.78 respectively, while for intermediate lesions the mean
values increase to DSCmanual = 0.84 and DSCrg = 0.88.
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Table 6.6. Comparison of segmentation algorithms (manual segmentation, semi-automatic region
growing) to ground truth using the Dice similarity coefficient (DSC). For the phantom ground
truth data, only voxel with ≥ 50% lesion probability are included.
DSC (%)
Method 0.05ml 0.1ml 0.2ml 0.4ml 0.7ml 1.0ml
Spherical Object
Manual 0.85 0.84 0.78 0.83 0.86 0.90
Region growing 0.95 0.85 0.81 0.84 0.88 0.85
Ellipsoid Object
Manual 0.87 0.75 0.58 0.85 0.85 0.84
Region growing 0.91 0.69 0.61 0.89 0.96 0.81
Deformed Object
Manual 0.76 0.68 0.61 0.81 0.81 0.82
Region growing 0.80 0.70 0.69 0.83 0.95 0.87
6.3.2. Automated Multi-Spectral Segmentation
The Algorithm
After evaluating two segmentation algorithms that require user interaction, we now analyze
a fully automatic approach. We use the lesion segmentation algorithm proposed by van
Leemput et al. (2001), which has become quite popular within the medical imaging com-
munity. A search for citing papers on IEEE Xplore returned 121 documents (performed on
November 6th, 2014). Furthermore, the source code is freely available for download from
the EMS website (EMS ).
The algorithm performs an intensity-based segmentation frommultispectral MR images.
Each voxel is classified into one of four healthy tissue classes (white matter, gray matter, csf,
and other). Spatial information for each tissue type is incorporated using a Markov random
field (MRF). Moreover, MR field inhomogeneities can be corrected. Finally, MS lesions are
detected as outliers that are not well explained by a model for normal brain MR images.
Results
We apply the same parameters as proposed on the EMS website (EMS ) in Section "Addi-
tional intensity and contextual constraints." An overview of parameters and corresponding
values is given in Table 6.7. The computed mask contains a value for lesion probability at
each voxel.
The reference data used in this work consist of twenty patient data sets (Styner et al.
2008) with manually segmented lesions acquired on a 3T MR scanner. The data-acquisition
protocol includes T1-, T2-, and FLAIR-weighted images. The T1-weighted data are used
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Parameter Value
Modalities T1,T2,PD
Order of Bias Field Polynomial Model 4
Type of Polynomial 3D
Mahalanobis Threshold 3
MRF yes
Intensity Constraints iT2 ≥ gmT2
Lesion Tissue wm (white matter)
Other Outliers no
Table 6.7. Parameters and values of the evaluated segmentation approach proposed by van Leemput
et al. (2001) (EMS).
as input for the initial brain extraction algorithm and the global and local B-spline registra-
tion. The resulting lesion position map is computed from approximately 500 lesions with a
volume range of 0.001ml to 4.38ml (mean=0.25ml). See Section 4 for more details.
Sixteen lesion phantoms have been generated with a total lesion load (TLL) ranging
from 1.12ml to 7.18ml. Therein, we developed six phantom pairs that only differ in the
texture model (Data3,...,Data8), which is varied from homogeneous to inhomogeneous (cf.
Sec. 5.2). Furthermore, four additional phantoms were generated without this restriction
(2x homogeneous, 2x inhomogeneous). See Table 6.8 for an overview.
Again the Dice similarity coefficient (DSC) is used to compare the segmentation results
with our ground truth. An illustration of the algorithm results is given in Figure 6.7. Since
the ground truth as well as the computed lesion mask contain a voxel-wise lesion proba-
bility, we threshold the values before computing the overlap measure. Only values with a
lesion probability of ≥ 50% are used. The average similarity measure for phantoms with
homogeneous lesions ismean(DSChomogen) = 0.67 (min= 0.57,max= 0.77). For phantoms
with inhomogeneous lesions this value is reduced to mean(DSCperlin) = 0.49 (min = 0.35,
max= 0.55). Even more, no result for the homogeneous phantoms is lower than any result
for the inhomogeneous phantoms. The largest difference is 0.23.
One reason for the low segmentation overlap for inhomogeneous lesions is the incor-
rectly computed amount of lesion tissue by the EMS algorithm. This results in a larger
lesion mask compared to the underlying ground truth. See Figure 6.8 for a visualization.
The yellow area, i.e., the voxels with ≥ 50% lesion probability, is much larger for homoge-
neous lesions (cf. Fig. 6.8 (b)) than for inhomogeneous lesions (cf. Fig. 6.8 (d)).
Besides the segmentation overlap, our phantom also enables a comparison of the total
lesion load. Instead of using only voxels with ≥ 50% lesion probability, the whole lesion
mask is used. The last rows in Table 6.8 give the total lesion load for homogeneous and
textured lesions computed by the EMS algorithm (TLL-EMS). The mean overestimation
for homogeneous lesions is 161%. For textured lesions, it is 224%.
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HOMOGENEOUS LESIONS
Data1 Data2 Data3 Data4 Data5 Data6 Data7 Data8
TLL (ml) 3.76 5.08 2.06 3.28 3.20 2.66 7.18 5.19
DSC 0.66 0.68 0.71 0.77 0.57 0.65 0.70 0.61
TLL-EMS (ml) 6.57 8.00 4.21 5.60 5.84 4.92 13.52 11.05
LESIONS WITH TEXTURE
Data1 Data2 Data3 Data4 Data5 Data6 Data7 Data8
TLL (ml) 2.18 2.86 1.12 2.03 2.13 1.70 4.50 4.60
DSC 0.49 0.52 0.51 0.54 0.35 0.51 0.55 0.43
TLL-EMS (ml) 4.91 6.04 3.29 4.39 4.90 3.92 9.21 7.73
Table 6.8. (1st row) Total lesion load (in ml) of lesion phantom (TLL); (2nd row) Dice similarity
coefficient (DSC) to compare the computed segmentation overlap with the ground truth; (3rd row)
Total lesion load computed by segmentation method (TLL-EMS, in ml).
6.3.3. Discussion
Segmentation of MS lesions in brain MR image data is an important step towards diagnosis
and patient follow-up, and has been widely investigated in recent years. Several algorithms
ranging frommanual to fully automatic have been proposed. Evaluation of these approaches
is usually performed with both phantom as well as real patient data sets. Phantom data are
especially used to detect algorithmic errors in early development stages.
A major point of criticism of phantoms is their overall data quality. Most phantoms have
only a very limited anatomical and pathological variability and are thus not as challenging
as patient data. This behavior can also be observed with our data: The computed values
using our phantoms are about 33.7% to 41.5% higher compared to the values reported in
(van Leemput et al. 2001) for patient data sets.
Nevertheless, a phantom-based evaluation is an excellent tool especially in early algo-
rithmic development stages, since each phantom can be adapted to the specific needs of the
developer. We have shown that changing parameters can yield lesion objects with increased
complexity. In this work, the object structure is modified. The resulting in inhomogeneous
lesions provide a more challenging task for the segmentation algorithm with a lower seg-
mentation overlap measure and a higher volume overestimation. Furthermore, the values
now differ only by 7.2% compared to the values by Leemput et al. reported on patient data
sets.
6.4. Segmentation and Quantification of Brain Tumors
In this section, we use our brain tumor software phantoms for the evaluation of a segmen-
tation and quantification approach that has become popular in the field of cancer therapy
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Figure 6.7. Phantoms with segmentation result overlay. The associated T1- and PD-weighted
images used for segmentation are shown in Figure 5.10. Red: algorithm result (van Leemput et al.
2001) with ≥ 50% lesion probability, yellow: phantom data with ≥ 50% lesion probability.
(a) (b) (c) (d)
Figure 6.8. Comparison of segmentation results for homogeneous and inhomogeneous lesions. (a)
Homogeneous lesions; (b) segmentation overlay on (a); (c) inhomogeneous lesions; (d) segmen-
tation overlay on (c). Red: algorithm result (van Leemput, Maes, Vandermeulen, Colchester, and
Suetens 2001), yellow: phantom data. Only voxels with ≥ 50% lesion probability are used.
monitoring, namely OncoTREAT (Bornemann et al. 2007).
OncoTREAT facilitates a semi-automatic segmentation of different lesion types in CT
data sets including lung nodules, enlarged lymph nodes, and liver metastases. Furthermore,
a segmentation of brain metastases in MR scans included in the software prototype. The un-
derlying algorithm combines an initial seeded region growing and an automatic morpholog-
ical refinement to exclude adjacent structures with similar gray values. A detailed descrip-
tion can be found in (Kuhnigk et al. 2006). Since this approach requires a rather compact
lesion appearance, a new method has been proposed for the segmentation of ring-enhancing
tumors by Bornemann et al. (2007), which has shown to result in a more appropriate seg-
mentation for many cases especially of brain metastases. In addition to the different seg-
mentation tools, a fully automatic volumetry is implemented within OncoTREAT. For brain
tumors, the software assistant uses a voxel counting approach, i.e., the volume is calculated
as the number of voxels within the segmentation mask multiplied by the voxel volume.
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Figure 6.9. Segmentation results of software phantoms Case1 and Case2 using OncoTREAT. From
left to right: Slice of T1 post contrast, 2D tumor segmentation overlay, and tumor segmentation
in 3D.
Table 6.9. Evaluation of OncoTREAT results for all data sets using the Dice similarity coefficient.
Overlap1: ≥ 50% tumor tissue in reference segmentation mask, Overlap2: > 0% tumor tissue in
reference segmentation mask
Case 1 Case 2 Case 3 Case 4 Case 5
Overlap1 0.90 0.88 0.96 0.89 0.94
Overlap2 0.90 0.87 0.94 0.87 0.91
6.4.1. Results
Five data sets are analyzed representing different tumor shapes, locations, and sizes (Case1,
Case2, ..., Case5). T1-weighted post contrast MR image data of a healthy volunteer are used
as background, obtained from a clinical 1.5T scanner (Siemens Magnetom Vision, Siemens,
Erlangen, Germany; 256x256 matrix; 1.0mm3 isotropic voxel size). Case1 shows a rather
homogeneous tumor shape that is composed only of active tumor. The tumor objects in
Cases2 to Case5 contain a model for active tumor tissue and necrosis. Furthermore, in
Case3 the amount of necrotic tissue is scaled to 50%. See Figure 6.9 and Figure 6.10 (left)
for an example of each data set. The volume and the overlap statistics for all data sets are
computed from the combination of both tissue types.
Table 6.9 shows the resulting similarity values for each tumor phantom. For comparison,
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Figure 6.10. Segmentation results of software phantoms Case3, Case4, and Case5 using On-
coTREAT. From left to right: Slice of T1 post contrast, tumor segmentation overlay in 2D, and
tumor segmentation in 3D.
we used two different reference segmentations: The number of voxels with ≥ 50% tumor
tissue in the segmentation mask, and the number of voxels with > 0% tumor tissue. All
cases show a high degree of overlap for both reference segmentation masks. The mean
Dice similarity coefficient is DSCmean = 0.92 using a manual segmentation as reference,
and DSCmean = 0.90 for the ground truth reference. The segmentation results also show a
good visual correspondence with the underlying ground truth (cf. Fig. 6.9 and 6.10).
Besides an evaluation of the segmentation overlap, we also calculated the tumor vol-
ume as well as the volumetric error (cf. Table 6.10). OncoTREAT uses the voxel counting
approach as already delineated above, which is still the gold standard in medical image quan-
tification. The resulting volumetric error ranges between -17.24% and 5.263%. Especially
Case4 and Case5 underestimate the volume by more than 10%. Here, the segmentation al-
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gorithm does not include the whole tumor due to necrosis and PV voxels, which has already
resulted in a lower overlap value (cf. Table 6.9).
Table 6.10. Estimated tumor volume and volumetric error for all data sets using the approach
implemented in OncoTREAT.
Case Ground Truth Volume Error
(in ml) (in ml) (in %)
Case1 2 1.951 -2.450
Case2 8 8.421 5.263
Case3 25 25.771 3.084
Case4 25 20.690 -17.240
Case5 25 22.234 -11.064
6.4.2. Discussion
Data quality was already discussed as important issue in the previous section. The computed
similarity coefficients for our phantoms have very high values, ranging between [0.87−
0.96]. Again, we conclude that our phantoms are not as challenging as typical patient data
sets. It is interesting to note that the similarity coefficient is slightly lower using all voxels
with > 0% tumor tissue, especially for large tumors. Here, an important factor are PV
effects at the tumor boundary. Furthermore, our software phantoms consist of areas at the
tumor boundary that have a higher amount of necrosis, resulting in a lower gray value. Both
characteristics yield in a set of voxels that are difficult to identify as tumor tissue on the data
set by the segmentation algorithm, and thus are missing in the final tumor mask.
Despite the very accurate segmentation, the tumor volume is not estimated correctly
using the voxel counting approach. Similar results were already obtained for the MS lesion
phantoms in the previous sections. For the brain tumor phantoms, the inhomogeneous object
appearance leads to a volumetric underestimated in most cases.
7. Conclusion Part I
In this chapter, we discuss the main objectives related to phantom development and our
contributions.
How to develop phantoms for medical image analysis?
A phantom is an artificial object with known properties used to test certain aspects of an
algorithm within a chosen application domain (cf. Chap. 2). Based on this definition, we
can derive several requirements for phantom development in medical image analysis.
The first step towards developing a phantom is to decide what kind of phantom is re-
quired for the considered task. Therefore, we started our investigation in this work with
a general overview of design approaches and proposed a categorization scheme that par-
titions software phantoms into three categories: stylized phantoms, voxel phantoms, and
hybrid phantoms. We focus on hybrid phantoms, which provide a separation between ob-
ject and background. Based on the knowledge of the underlying application domain and the
phantom type, we can focus on the actual design in the next step.
In Chapter 4, we proposed a formalization consisting of three main parts: The design
of a suitable object, the design of a related background, and the incorporation of one or
more of these objects into the background. Each part of a phantom is based on certain
hypotheses and parameters. Therefore, the next step of the phantom design is to choose
and to model the relevant parameters. In Chapter 3, we provided a detailed examination
of parameters used in phantom development. To help the user in the selection process, we
proposed a classification into four groups, each modeling a certain aspect of a phantom.
The parameters are selected based on the examination of work in the field of medical image
analysis. For example, segmentation algorithms make assumptions about the underlying
models for typical parameters such as the volume or the gray value. The shape or the volume
of an anatomical or pathological structure are also important markers for diagnosis and
therapy monitoring. Furthermore, the selected imaging parameters are commonly used in
quality assurance (QA) programs of MR scanners. After modeling all required parameters,
we can combine them to our final phantom.
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What are the benefits of our approach?
Modular Design. In this work, we aim at a new approach for modular phantom design
based on a set of components. To this end, we formalized the overall development process
in Chapter 4, which is an essential step towards reusing components in a software assistant.
This yields a flexible standard of the required processing steps and encourages devel-
opers to thoroughly investigate all aspects of a phantom before starting the actual design
process. Moreover, it provides a straightforward description of phantoms when only lim-
ited knowledge about the design process is available. For this task, we developed a template
data sheet that is used throughout this thesis. For example, we used it in Part II to initiate
a discussion with experts about our phantoms. The template turned out to be an efficient
basis for our discussions.
Parameter Reuse. Besides a phantom description, our implemented parameter mod-
ules can also be easily changed without affecting other modules. For example, a different
object shape does not change the underlying model for intensity values. This eventually
saves time, e.g., through reuse of parameter models for new phantoms, and helps to elimi-
nate the risk of design errors. Several parameter models such as noise or volume developed
for MS lesion phantoms were later reused to develop our brain tumor phantoms. Moreover,
new parameters can be added. For example, the brain tumor phantoms used the MS lesion
phantoms as basis and extended them by additional modules such as tumor growth.
Similar to parameter reuse, our design process also allows to develop different classes of
phantoms with varying complexity by simple parametric manipulations of one parameter. In
this work, we developed two sets of phantoms with equal object positions, shapes, etc., but
with different object texture. Thereby, our design process allows to change the texture model
without affecting other parameters such as noise. The results have been used to compare
how a segmentation algorithm is affected by modifications of the input data. A comparable
analysis is not possible with patient data sets. Different appearances for a single object are
usually not available or need to be acquired over a long time period. Moreover, such follow-
up scans require scanner and imaging parameters equal to the initial data, which might not
always be feasible.
To the best of our knowledge, this is the first approach towards a comprehensive descrip-
tion of the phantom design process in medical image analysis. Thereby, a controlled and doc-
umented construction of parameter models and phantoms provides an excellent overview of
the underlying parameters and assumption.
Software Assistant. Using our component-based phantom design, we introduced an
interactive software assistant that provides an easy-to-use tool for phantom development
(cf. Sec. 4.3). In this work, we used the software assistant to develop the manual phantoms
proposed in Chapter 5. The development time for each phantom is reduced from hours to a
few minutes depending on the number of objects per phantom. Different implementations
are available, for example to generate a suitable object shape. Furthermore, a set of ten
pre-defined shapes is already available.
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Fully Automatic Phantom Design. Besides the above mentioned manual approach,
we also proposed a fully automatic method for phantom design. Thereby, the component-
based design helps us to concentrate on the automatization of one parameter at a time. In-
stead of following the common design approach and of developing the one best phantom,
we introduced a method to automatically generate a large set of phantoms. The majority
of our parameter models are based on actual patient data such as lesion shape and position.
This way, our approach allows us to capture the variability encountered in clinical practice.
Furthermore, our design process enables a large applicability of the resulting phantoms as
well as of the individual parameter models. In other words, the development of a parameter
model should start with an analysis of the already available feature pool.
Phantom Diversity. Our modular design approach introduces new perspectives for
a broad range of phantoms in medical image analysis as described above. However, some
limitations remain. First of all, we focused on hybrid phantoms. Although this enables a
practical separation between object and background design, incorporating an object into this
background must be possible. Furthermore, we focused on background consisting of volun-
teer or patient images. Therefore, we can only cope with pathological structures added to
the underlying data. This will lead to rather compact object shapes in most cases. Modeling
other structures such as whole organs, e.g., the heart or the liver, is not yet possible. An ex-
tension to this approach could be a brain phantom. In this case the background is generated
from a patient or volunteer data set, where the brain tissue is cropped out algorithmically,
leaving only the skull. The object then consists of brain structures such white matter, gray
matter and fluid, which is incorporated into this cavity.
Two clinical applications were analyzed more closely in this work, namely the analy-
sis of Multiple Sclerosis (MS) lesions and of brain tumors. The quality of each phantom
is visually confirmed by an expert, even if this can only give a hint of the actual quality.
Nevertheless, further applications with different modalities such as CT are possible as well.
For example, the analysis of lung nodules and hepatic lesions, or coronary artery plaque
detection in angiographic images. A validation including a measure of the overall phantom
quality as well as the quality of each module will be the focus of Part II in this work.
Ground Truth for Applications. Besides different phantom types, modalities, etc.
our phantom design approach covers the evaluation of a wide range of algorithms that occur
in clinical practice and trials. An evaluation study for each algorithm was proposed in
Chapter 6. For example, an extensive analysis of MS lesion volumetry over a broad range
of different lesions is performed in Section 6.2. Our results clearly show the importance
of an improved gold standard in lesion volumetry beyond voxel counting. A similar study
would not have been possible with patient data sets.
Furthermore, we evaluated an algorithm proposed by van Leemput et al. (2001). Lesion
segmentation and volumetry results were compared with the phantom ground truth data.
Both approaches show that our inhomogeneous lesions provide a more challenging task with
a lower segmentation overlap measure and a higher volume overestimation. An analysis of
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the computed lesion mask showed that the computed lesion probability at each pixel is too
high for low-contrast lesion pixels.
Part II.
Phantom Validation
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8. Validation in Medical Image Analysis
An important aspect of any development in medical imaging is a thorough analysis of the
underlying assumptions and the modeled parameters with respect to their quality. Especially
the validity of a method needs to be demonstrated, having considerable impact on its value to
the user, and no model should be accepted before it has passed elaborate testing. Moreover,
the level of confidence in a method increases, as it passes more tests. The purpose of
this chapter is to give an overview of validation in medical image analysis. We discuss
current concepts and provide a general overview of terms and definitions. Furthermore,
we introduce prominent validation approaches for common fields of application including
image segmentation and quantification. Thereby, phantoms used as reference data play an
important role.
8.1. Principles and Definitions
Validation is characterized by an iterative process to demonstrate the compliance of a method
with a set of given criteria. A method has to pass elaborate testing before it is accepted.
Thereby, the level of confidence increases with the number of passed tests. In contrast to
the verification of a system that ensures that a method is built right, i.e., that it includes
all required parameters, validation determines that the right method is built. Thereby, val-
idation does not give an answer to the question ’is the method correct?’, since a system
specification is rarely precise, and it is impossible to test a method under all possible events.
Therefore, no method is ever 100% accurate. Instead, validation ensures the degree of re-
quired accuracy for its underlying purpose, which can vary from one application to another.
As a consequence, this also implies the exact knowledge of a methods’ objectives before it
can be validated. For example, a segmentation algorithm may have been validated for use
in brain tumor segmentation. However, this does not necessarily enable a valid use for the
analysis of liver tumors. In this work, we use a definition of validation similar to that given
by the American Institute of Aeronautics and Astronautics (1998):
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Today, most algorithms are accompanied by some kind of validation study, and several
examples are given in this chapter. A key criterion is that a method must model the clini-
cal setting, i.e., a validation should consist of a broad spectrum of actual clinical use cases
(Gee 2000). A number of publications focusing on this aspect have been proposed as well,
each suggesting a slightly different method with its own terminology (Buvat et al. 1999;
Jannin et al. 2006; Udupa et al. 2006). Nevertheless, a widely accepted approach is not
yet available. Besides algorithm development in a research setting, commercial products
should especially follow a rigorous validation process. For example, the Food and Drug Ad-
ministration (FDA ) provides general principles for the management and control of software
validation in medicine. In their guidelines, validation is used to assure software quality by
assessing the fulfilled requirements.
In order to assess the degree of compliance with the underlying purpose of a method,
e.g., the above mentioned validation of clinical use cases, validation metrics are an invalu-
able aspect, and we will provide a broad overview of used measures in the upcoming sec-
tions. Each application has its own set of examined parameters, depending on the required
level of validation, e.g., early development stage vs. late stage. For example, methods
used in segmentation and quantification are discussed in Section 8.6. Therein, validation
parameters consist of overlap ratios between the analyzed algorithm and the ground truth.
Nevertheless, several other parameters often have to be considered as well, including com-
putation time or susceptibility to errors. The availability of common data sets and reference
algorithms used as benchmark for comparison are also important contributing factor to an
effective validation.
8.2. Phantom-Based Validation
Both physical and software phantoms are used for validation purposes. Thereby, the com-
plexity of the applied phantom depends on the considered application as well as on the
current stage of the development process. Simple geometric phantoms such as a square
or a sphere are often used during initial development and evaluation phases (Noe and Gee
2001). More complex phantoms are applied in later stages. Unfortunately, phantom devel-
opment is also a challenging task, and we already analyzed several issues in the previous
chapters. For example, anatomical and pathological structures and organs are highly vari-
able with respect to their appearance, size, or shape. Moreover, each parameter requires an
application-specific modeling, and modifying one parameter also affects others.
Besides their advantages and weaknesses, an explicit analysis of the quality of phantoms
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is still missing. In other words: ’Why does a phantom represent an adequate validation
approach for a certain method?’ In Section 2.3, we introduced a rather simple validation
approach based on a qualitative analysis with fuzzy terms (good, average, low). Although
this method yields a general categorization (cf. also Sec. 3.4), an in-depth analysis of a
phantom is infeasible. Today, only few validation approaches are used for phantoms in
medical imaging. A common strategy uses visual inspection and expert knowledge about
anatomical or pathological structures. (Tofts et al. 1997; Segars et al. 2001; Suryanarayanan
et al. 2005). Other publications propose a validation based on visual comparison with
patient data sets or with images from literature (Pupi et al. 1990; Tofts et al. 1997; Prastawa
et al. 2005). However, a method that provides a systematic analysis of the accuracy and
precision of a phantom is not available, and some phantoms are even proposed without any
validation. Furthermore, several phantoms have only a very limited parameter distribution.
For example the popular BrainWeb phantom is created from a single individual (Collins et al.
1998). To this end, we propose a new phantom validation approach in the next chapter.
8.3. Validation without Phantoms
If a phantom is not available, one has to resort to other sources that allow validating a
method. A number of approaches have been proposed, and each technique has its own
pros and cons. We roughly distinguish between methods that are either based on expert
knowledge or on all sorts of databases.
8.3.1. Expert Validation
An approach particularly suited for early development stages of a new method is the so-
called face validation. Therein, field experts are asked if the results of a method are reason-
able. Face validation provides a quick and rather informal validation. To give an example,
a physician’s opinion is a suitable way to determine the quality of a new segmentation algo-
rithm during its conceptual phase. It allows for the identification of gross errors such as an
under-segmentation or a leakage into adjacent structures. Unfortunately, accurate measure-
ments are difficult to perform with the human eye, leaving the computer as supplementary
tool. A further potential uncertainty can result from inferior visualizations. Moreover, repro-
ducibility is often limited. For example, we performed a study to evaluate visual assessment
in MS lesion volumetry in Section 6.1.
A related approach to obtain expert knowledge is to perform a comparison to other
(valid) methods that have been proposed for the same application, and that are used as
expert knowledge instead. This enables an overview of similar algorithms and provides
information about important parameters. For example, Hagemann et al. (1999) extract
appropriate elasticity constants for a physically-based registration algorithm of the head
from a comprehensive literature study. In their work, the mean value calculated from nine
different publications finally serves as an estimate of the correct values.
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Another way to incorporate expert knowledge into the validation process is based on
manual measurements such as manual segmentation of anatomical structures. An overview
of related approaches is given in Section 8.6.1.
8.3.2. Databases
Another validation approach is the use of image data and associated segmentations from
databases. Thereby, gathering appropriate image data and acquiring segmentations also
requires expert knowledge. Nevertheless, this knowledge differs from expert validation as
discussed above since it is rather used to assemble the data. Today, several public research
resources are available in different fields of medical image analysis such as computer aided
detection of calcifications in mammograms. A well-known initiative is the Visible Human
Project that was established in 1989 to build a digital library of volumetric image data
(Spitzer et al. 1996). The public domain data sets consist of complete, anatomically detailed
representations of the human body based onMR and CT scans as well as cryosection images
of male and female cadavers.
One of the most popular databases for the evaluation of methods in mammography
was introduced by Karssemeijer (1993), containing 40 digitized film-screen mammograms
of different clinically relevant cases with associated ground truth. Another, much larger,
public database is the Digital Database for Screening Mammography (DDSM), maintained
by the University of Florida. The DDSM database contains approximately 2.500 studies
(Heath et al. 1998).
In the field of lung cancer detection, a cooperative effort known as the Lung Image
Database Consortium (LIDC) was launched in year 2000 to construct a database that con-
tains CT scans from both diagnostic and screening studies (Armato et al. 2004). Various
information are stored for each data set in addition to the actual image data including tech-
nical scan parameters, patient information, and nodule features (McNitt-Gray et al. 2007).
The assessment of lesion boundaries is based on manual outlining performed by expert ra-
diologists.
A related project is the Reference Image Database to Evaluate Response (RIDER) that
was initiated in 2004 (Armato et al. 2008). This initiative provides a web accessible public
database of images for different organ systems. Currently, RIDER consists of a CT image
archive of lung cancer subjects collected longitudinally over the course of treatment. An
important aim of this project is the assembly of so-called validated data sets. This includes
expert measures such as RECIST as well as associated meta-data including radiologist anno-
tations. Furthermore, RIDER is intended to provide standardized methods for the evaluation
of algorithms. To this end, a set of training and test data sets will be established.
An open and freely accessible database related to Alzheimer’s Disease has been devel-
oped as part of the Alzheimer’s Disease Neuroimaging Initiative (ADNI). The database
includes 200 elderly controls, 400 individuals with mild cognitive impairment, and 200
individuals with Alzheimer’s disease. See Mueller et al. (2005) for an overview of the
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initiative.
Besides databases for a specific modality or a specific body part, approaches focusing
on the underlying image analysis task have been proposed as well. A synthetic database
for the validation of brain image registration and segmentation methods is proposed in (Ens
et al. 2009), including image data from 50 patient MR scans (T1-weighted) as well as a
labeled brain atlas and an averaged multi-patient brain atlas. The database is generated in
a three-step process: The first step consists of a linear transformation to register all data
sets to the same coordinate system. In the second step, a non-rigid registration scheme
with an elastic regularization is applied to match the labeled atlas data to the data of the
average atlas. Additionally, three different methods are used to obtain a registration from
the atlas scan onto each of the 50 patient MR data sets. The last step applies the computed
deformation fields to transform the labeled atlas data to each patient data set. The resulting
deformation fields can be used as basis for the validation of registration approaches. The
labeled data sets can be used to evaluate segmentation methods. A major drawback of this
approach is the lacking definition of the correct deformation field. Each registration method
produces a slightly different deformation and each has its eligibility. However, the right
deformation is still unknown. Furthermore, only an indirect and thus less accurate labeling
of the patient data is available with this approach.
8.4. Gold Standards
Today, most studies compare the quality of a method with some kind of reference. Such
a gold standard is presumed to contain the correct result (the ground truth) or be at least
close to it. For example, segmentation methods typically use manually outlined image data
(cf. Sec. 8.6.1). Therefore, establishing an appropriate gold standard is an essential task for
validation. In the previous section we already described different types of gold standards.
One approach is the use of phantoms since they allow direct access to the modeled param-
eters (cf. Sec. 8.2). Depending on the underlying application, the ground truth can also be
based on manual segmentations or a database consisting of patient data. If no ground truth
is available, other methods are required that serve as gold standard. Examples include the
STAPLE algorithm by (Warfield et al. 2004) or a comparison by field experts (cf. Sec. 8.3).
But what makes a reliable gold standard? In a seminal paper, Lehmann (2002) proposes
five attributes that should be considered:
1. Reliance: The development must follow an exactly determined and reproducible pro-
tocol.
2. Equivalence: The generated data must be equal to real-life data w.r.t. all important
parameters.
3. Independence: The resulting data must rely on a different procedure than that to be
evaluated.
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4. Relevance: An evaluated algorithm must be self-reproducible, i.e., robust to parame-
ter changes.
5. Significance: The number of gold standard images used for evaluation must be suffi-
ciently large.
Based on this characterization, Lehmann (2002) then defines a reference standard as fol-
lows:
Reference Standard Fulfilled Criteria
Gold Standard (1),(2),(3)
Silver Standard (1),(2) or (1),(3)
Plastic Standard otherwise
Properties (4) and (5) are used to define a meaningful evaluation of an image processing
algorithm.
In Chapter 2 we defined similar requirements for the design of phantoms, namely suit-
ability, flexibility, and correctness. Based on our classification, a ’perfect’ phantom – and
thus a good gold standard – should fulfill these three requirements. Especially suitability
and flexibility overlap with the attributes that are needed for the gold standard definition
by (Lehmann 2002). Particularly equivalence, i.e., the quality of the considered parameters.
Nevertheless, the definitions of reliance and independence deviate from our requirements:
Although we agree to an exactly determined and reproducible protocol (reliance), phantom
design can still include a great amount of manual work, which is explicitly prohibited by
Lehmann. Furthermore, independence between training and test data is a crucial aspect
during algorithm validation, but should have less importance for phantom design.
In conclusion, we believe that the parameters used by (Lehmann 2002) provide an ex-
cellent approach to characterize a reliable gold standard, and to our knowledge this is to
date the only attempt to provide a unified classification scheme for this task. However, the
three features are somewhat mixed with the task of algorithm validation. The work rather
provides an upper bound for a gold standard, and a phantom that meets our requirements is
already sufficient.
8.5. General Approaches
After introducing general principles of validation, we now focus on actual methods used in
medical image processing. These approaches include general frameworks as well as more
specific tasks such as the validation of visual assessment and segmentation. In this section,
we provide a survey of methods that are concerned with a standardization of the overall
validation process regarding terminology and methodology: Some papers are related to
algorithm evaluation (Buvat et al. 1999), or discuss the validation of algorithm performance
(Gee 2000). Other papers focus on the validation process itself (Jannin et al. 2006).
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Fryback and Thornbury (1991) analyze the efficacy of diagnostic imaging. They pro-
pose a hierarchical model outlining the contribution of diagnostic imaging to the patient
management process. Six levels are distinguished: (1) Technical efficacy, (2) diagnostic ac-
curacy efficacy, (3) diagnostic thinking efficacy, (4) therapeutic efficacy, (5) patient outcome
efficacy, and (6) societal efficacy. Additionally, typical measures for analyses are provided
for each level. For example the analysis of ROC curves (Level 2: diagnostic accuracy ef-
ficacy) or the number of cases in which an image is judged helpful to making a diagnosis
(Level 3: diagnostic thinking efficacy). An important aspect of the presented hierarchy is
that demonstrating the efficacy on a lower level is necessary, but not sufficient, to assure
efficacy at higher levels. For example, the quality of scanner parameters (Level 1: technical
efficacy) has to be assessed before a diagnosis of the resulting patient data can be evaluated
(Level 2: diagnostic accuracy efficacy).
Buvat et al. (1999) propose a hierarchical approach to algorithm evaluation. They
apply the six levels of efficacy defined by Fryback and Thornbury (1991) to the evaluation
of medical image processing. Level 1 is related to validation or feasibility studies of a
method; level 2 is associated with the method accuracy by measuring its performance; level
3 measures whether a method helps a clinician; level 4 evaluations determine that a method
provides information, which contributes to the appropriateness of patient management; level
5 efficacy corresponds to how a method affects patient outcome; level 6 efficacy is related
to the benefit of a method for the society.
Buvat et al. (1999) also present a generic evaluation model (GEM) that identifies re-
quired components and provides guidelines for evaluation studies. The main components
include an abstract aim, a context, and a hypothesis. The abstract aim results from the
method to be assessed and the level of evaluation. The context defines the underlying envi-
ronment in which a method is evaluated. It also includes the components required to define
the evaluation protocol. Finally, the hypothesis is related to tests performed within a con-
text to extract information about the abstract aim. A detailed description including further
components required during an evaluation process are given in the paper.
An approach that introduces a model to describe the main components used for valida-
tion procedures in medical imaging is proposed by Jannin et al. (2006). It presents one
of the few more recent general validation methods in medical image analysis. The model
focuses on level 1 and level 2 efficacy. As an example, a relation of these levels to image
registration is given. Therein, level 1 efficacy is associated with performance criteria of
an algorithm, whereas level 2 efficacy is related to an evaluation at clinically meaningful
anatomical or pathological structures. The validation process model is related to the evalua-
tion model of Buvat et al. (1999), where a clinical context is specified as well as a clinical
objective, i.e., a hypothesis. The validation process aims at testing this hypothesis. Jannin
et al. (2006) base their model on the evaluation of data sets and input parameters, given
a reference method that estimates the ground truth. Thus, the model provides a detailed
description of common reference-based validation scenarios. An illustration is given in Fig-
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Figure 8.1. Overview of reference-based validation model presented in (Jannin et al. 2006).
ure 8.1. Besides a detailed description of the process model, Jannin et al. also provide a
checklist of components that should be included when reporting a validation study. The pre-
sented model is validated on the basis of 38 papers that include validation studies. Results
are summarized in a database and are accessible via a website (VMIP ).
An approach that is not only related to algorithm validation, but to the whole develop-
ment process is presented by Thacker et al. (2008). In their work, the authors propose
a characterization of algorithms based on the analysis of representative tasks in computer
vision including feature detection, stereo vision, or face recognition. Moreover, measuring
structural differences in medical images is examined. Central aspects of algorithm perfor-
mance evaluations are extracted, resulting in a set of key questions such as ’how is testing
currently performed?’, ’is there a data set for which the correct answers are known?’, or
’are there data sets in common use?’. Answering these questions during the development
and evaluation of an algorithm is stated to be an important step towards validation.
8.6. Applications
After introducing rather general approaches to validation in medical image analysis, the
following sections cope with specific applications.
8.6.1. Segmentation
Segmentation of medical image data is a crucial task for the analysis of normal and patho-
logical processes, where small changes can already be of paramount importance. Today a
vast amount of different methods is available for various applications and levels of automa-
tion, ranging from manual outlining to fully automatic segmentation. Many approaches
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have also been proposed for the validation of these methods. See for example (Udupa et al.
2006) and references therein. However, a widely accepted performance measure is not yet
established, making it still difficult to compare two different segmentation methods.
In order to provide a systematic evaluation framework, several authors proposed a cat-
egorization of segmentation algorithms into different classes. Zhang et al. (2008) propose
a categorization into two major categories: subjective and objective evaluation methods.
Thereby, a subjective evaluation is related to visual inspection by a human observer as al-
ready described in Section 8.3.1. Further categories are supervised and unsupervised meth-
ods, where supervised refers to the use of a ground truth image, and unsupervised can do
without one. Udupa et al. (2006) present an evaluation framework consisting of five compo-
nents: (F1) a specification of meaningful metrics of efficacy, (F2) real life image data, (F3)
reference segmentations (ground truth) (F4) a number of available standard segmentation
algorithms, (F5) a software incorporating evaluation methods and segmentation algorithms.
In their work, an application is determined by three entities:
T : A task.
B: A body region.
P: An imaging protocol.
Each realization of these entities presents a specific application domain 〈T,B,P〉, and a
general statement or a comparison between different application domains cannot be made.
Due to the required reference data (component F3), the work of Udupa et al. can be assigned
to the category of supervised evaluation methods.
Despite the difficulties to evaluate a segmentation algorithm, most paper provide at least
some kind of analysis. Especially applications, where public databases or software phan-
toms are available, play a pioneer role. For example, a comparison of different brain tissue
segmentation methods is performed in (Cuadra et al. 2005; Hahn et al. 2004). Another
evaluation of seven algorithms for the same task is presented in (Bouix et al. 2007).
Unfortunately, a comparison of different algorithms is often difficult as most of them are
not freely available, and a re-implementation is time-consuming or often even not possible.
A more promising approach is to provide a public database with training and test cases
where the ground truth for the test data is not publicly available. This way, a research group
does not have to release their algorithms to the community. Another approach, that has
become popular in the past years, is to arrange an on-site competition of several research
teams during a conference. At the MICCAI conference 2007, the first ’Grand Challenge’
workshop was held, attributed to the comparison of liver segmentation methods. A summary
can be found in (Heimann et al. 2009). Several subsequent workshops for other organs and
pathologies such as head or MS lesion segmentation have been carried out since.
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Similarity Measures for Supervised Evaluation
Several metrics have been proposed to measure the similarity of two sets of segmented vox-
els. Two commonly used measures based on the regional overlap are the Jaccard Similarity
J (Jaccard 1912) and the Dice coefficient DSC (Dice 1945), given as
J(S,T ) =
|S∩T |
|S∪T | (8.1)
DSC(S,T ) =
2|S∩T |
|S|+ |T | (8.2)
J Jaccard similarity measure ∈[0,1]
DSC Dice similarity coefficient ∈[0,1]
|.| stands for the number of elements
S set of voxels segmented by algorithm 1
T set of voxels segmented by algorithm 2 (or ground truth).
Both coefficients are equal to zero if the voxel sets S and T cover disjoint regions, and one
if they are identical. Thereby, the Dice coefficient is always larger than the Jaccard metric,
except at 0 and 1. Furthermore, both values are related by the functionDSC= 2J/(J+1). A
value DSC > 0.7 is often reported to indicate ’excellent agreement’ between segmentations
(Zijdenbos et al. 1994).
A drawback of such measures is that they only consider the number of overlapping vox-
els and do not take into account their positions. To this end, Pichon et al. (2004) proposed a
generalization of these global overlap measures, using the distance between the segmented
voxels to the ground truth, defined as:
d(x) =


0, x ∈ S∩T
mins∈S ‖x− s‖, x ∈ T \S
mint∈T ‖t− x‖, x ∈ S\T
(8.3)
d resulting distance measure
x voxel ∈ S∪T
S set of voxels segmented by algorithm 1
T set of voxels segmented by algorithm 2.
The mean value and the standard deviation over all voxels with a distance of d > 0 are
used to measure the segmentation error. Furthermore, the error distance of the worst f%
voxels is used. A related approach is presented by Crum et al. (2006). Here, the authors
introduce a fuzzy multilabel overlap value plus an associated error measure based on the
overlap distance.
Besides using one specific approach for evaluation, some authors have proposed to cal-
culate the quality of a segmentation method based on a combination of different measures.
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Moretti et al. (2000) derive several evaluation criteria based on the BrainWeb software
phantom for the analysis of brain tissue segmentation methods. This includes overlap ra-
tios and a distance map from the object’s contour. Furthermore, a distance histogram as
well as derived features such as the mean and the standard deviation are computed from
the distance map. Gerig et al. (2001) developed a tool for validation and comparison of
object segmentation. The tool uses several algorithms, again including overlap ratios and
distance measures. Both 2D cross-sections with label overlay as well as 3D visualizations
are available to illustrate differences between algorithms, or between an algorithm and the
gold standard. The tool is freely available from the web.
While the above methods provide a separate analysis for each measure, Cardenesa et al.
(2009) propose a multidimensional evaluation technique. To this end, a vector of different
similarity measures is assembled and the overall similarity is defined as the l2-norm of this
vector. Moreover, a principal component analysis (PCA) is applied to allow for a dimen-
sionality reduction and a 2D visualization of the results.
Similarity Measures for Unsupervised Evaluation
As described above, unsupervised methods work without any reference image. Zhang et al.
(2008) analyze 16 evaluation methods used in the field of computer vision applications. For
example, intra-region metrics such as texture metrics measure the texture uniformity, assum-
ing that a ’smoother’ image is preferred. Other metrics use differences between regions, e.g.,
the inter-region color difference. A third class of measures is related to shape information.
Furthermore, a combination of all three classes is presented.
In the field of medical imaging, unsupervised methods have become popular with the in-
troduction of the STAPLE (simultaneous truth and performance level estimation) algorithm
by Warfield et al. (2004). The algorithm allows for an evaluation of a set of segmentations
by simultaneously estimating performance parameters (sensitivity and specificity) and the
hidden true segmentation for each voxel, based on an expectation-maximization (EM) al-
gorithm. STAPLE can also be used to estimate a reference image. Thereby, the algorithm
computes the highest consensus between segmentations, which is typically assumed to be
close to the ground truth. Details of the algorithm can be found in (Warfield et al. 2004).
Bouix et al. (2007) propose the Williams Index as efficient alternative to the STAPLE
method. Considering a set of r raters and a similarity s(Xi,X j) between rater i and j, e.g.,
the Jaccard similarity measure, the Williams Index for rater i is defined as
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Figure 8.2. Current gold standard in medical image quantification: The voxel counting approach.
WIi =
(r−2)
r
∑
j 6=i
s(Xi,X j)
2
r
∑
j 6=i
j−1
∑
k 6=i
s(X j,Xk)
(8.4)
WIi Williams’ Index for rater i
r number of raters
Xi set of voxels segmented by rater/algorithm i.
If this index is greater than one, it can be concluded that rater i agrees with the other raters
at least as much as they agree with each other. In their work, Bouix et al. (2007) found
similar results for this measure compared to the STAPLE algorithm.
8.6.2. Quantification
Today, validating quantification methods is largely based on the comparison with results
from domain experts. We therefore term these approaches supervised similar to the cate-
gories used for segmentation evaluation. Unsupervised methods on the other hand, i.e., a
validation without a reference standard, are rather uncommon. One approach could be to
perform a reproducibility study, where an object is quantified several times. However, this
can only provide information about the precision of an algorithm and not about its accuracy.
Similar to image segmentation, a ground truth is often difficult to obtain especially for
small objects such as tumors, and a ’surrogate’ ground truth has to be used. The voxel
counting method (cf. Fig. 8.2) represents the current gold standard for validation, where the
ground truth is defined by counting the number of voxels from an expert’s hand labeling. A
common issue with this approach is that human observers are known to be quite variable
during manual segmentations. Furthermore, partial volume effects are not accounted for.
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8.7. Discussion
Validation is gaining growing attention in medical image analysis. Today, several work-
shops at major conferences also focus on this topic, e.g., the ’Grand Challenge’ workshops
at the MICCAI conference. Other works include application-specific frameworks (Gedamu
et al. 2008; Neumuth et al. 2009) as well as specific tasks such as segmentation (Udupa
et al. 2006). However, these are typically not used by research groups different from those
of the initial authors. Moreover, validation is rarely the main objective in current publica-
tions, but often regarded as an add-on to the development of a new method. Exceptions
from literature include procedures suggesting a standardization of the validation process.
For example, validation protocols have been presented by Buvat et al. (1999) or Jannin et al.
(2006). Unfortunately, a widely accepted method is not yet available.
In this chapter, we have given an overview of current validation concepts in medical
imaging. Each application has its own set of validation methods. Nevertheless, we propose
a common classification into supervised and unsupervised methods for each application,
where supervised refers to a validation based on some reference image. In addition to
this categorization, we determined different approaches to validate a method, including
validation methods using a phantom and validation methods without a phantom.
If no phantom with known ground truth is available, databases are a common alterna-
tive. Thereby, associated segmentations of anatomical structures such as brain tissue classes
serve as a surrogate ground truth, and this approach is the gold standard for many applica-
tions. A major issue when using databases is the continually evolving technology used to
create the data. For example, changes in acquisition protocols, e.g., due to a larger field
strength, or new imaging sequences will result in a different set of data in clinical practice.
A database used for training and evaluation will have to adapt to these changes, which can
result in a huge effort and financial burden. Another issue is the required sample size of
the database. If the sample size is too small, an algorithm will adapt to the data and not
be able to generalize to new data sets (Gee 2000). A potential solution could be a public
repository where data can be freely submitted. However, data sets from different sites can
have a different quality, e.g., different amount of imaging artifacts, and merging these data
in one database could make the evaluation of algorithms even more challenging. Moreover,
databases consisting of patient data do not provide ground truth for many parameters such
as the volume or the shape of an imaged organ.
Expert knowledge is another validation approach which does not require a phantom. It
is especially useful during early development stages of a method. Unfortunately, expert
knowledge is subjective and often not reproducible, and also consensus meetings with sev-
eral experts can not provide a ground truth.
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Validation of Phantoms
In addition to the methods discussed above, phantoms provide an excellent basis for valida-
tion. Because the ground truth of the modeled parameters is known exactly, they provide a
convenient approach compared to other data that can merely act as surrogate ground truth
such as manual segmentations of patient data. Furthermore, the development of phantoms
can concentrate on important features of a method, and each application requires its own
type (cf. Chap. 2). For example, physical phantoms are often used for quality assurance
of medical devices, whereas software phantoms often present a more flexible alternative for
algorithm validation.
Today, phantoms are used for many applications in medical imaging. However, devel-
oping a phantom can be time-consuming and cost-intensive, and only few are freely or
commercially available. Similar to an expert segmentation of a patient data set, the quality
of the underlying ground truth is now in the hands of the phantom developer. Moreover, the
representativeness of the modeled parameters for the targeted application has to be consid-
ered during the design process. Therefore, validating a phantom is particularly important.
Lessons Learned
To summarize, important characteristics of validation in medical image analysis are as fol-
lows:
1. Validation is application-dependent.
2. Validation is an iterative process.
3. Each validation step increases the confidence in a method.
4. It is often impossible to validate all aspects of a method.
5. Sufficient data are essential for the success of validation.
In the next chapters, we propose different approaches to validate a phantom.
9. Validation of Phantoms
Phantoms have become a widely accepted tool for validating new algorithms and imaging
equipment. Nevertheless, an objective evaluation of the accuracy and precision has not
been proposed yet, and most approaches are based on an ad hoc design. In the first part
of this chapter, we recapitulate major challenges of phantom validation and identify a link
to the overall requirements for phantom development already addressed in Chapter 2. Our
approach enables the validation of a single phantom as well as the comparison of different
phantoms.
To assess the phantom quality, we then propose a novel iterative validation approach.
Each iteration consists of a separate validation method that increases or decreases the confi-
dence in the phantom. For example, one applications is a user-study to analyze the detection
performance of lesion phantoms. Furthermore, the effect of parameter changes is investi-
gated. Thereby, we propose a new method based on a multi-criteria decision making tech-
nique, the so-called Analytic Hierarchy Process, to select a parameter of high importance.
Our overall validation approach consists of three major steps: method selection, method
validation, and finally phantom validation. Two attributes are considered, namely the suit-
ability of a method and its correctness. A validation function is proposed that combines
both parameters. An example application will be used in the next chapter to evaluate our
approach.
9.1. General Approach
An important characteristic of a phantom is the availability of an exactly known ground
truth for the modeled parameters. Therefore, it is widely used as gold standard, i.e., as
a reference used to analyze a method. But how to validate a phantom? In Chapter 8 we
defined validation as the degree to which a model is a sufficiently accurate representation of
reality from the perspective of its intended uses. Applied to phantoms, validation assesses
the degree a phantom is an adequate reference for the targeted application. Unfortunately, a
proper analysis of phantoms is difficult, and often only the developer of a phantom is able
to fully understand and test it. Current validation approaches are often based on an expert-
based visual comparison with patient data sets or with data from literature. A systematic
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analysis has not been proposed yet.
An important step towards phantom validation is to identify the underlying challenges.
A first step is to determine core features that need to be examined for successful phantom
validation. In Chapter 8, we analyzed validation approaches and provided an overview of
methods commonly used in medical imaging. This eventually led us to a summary of the
most important characteristics in Section 8.7. These results are now applied to the process
of phantom validation. The three most relevant aspects are:
1. It is often impossible to validate all aspects of a phantom. (Correctness)
A key issue for the validation of phantoms is a commonly lacking parameter correct-
ness. Although the ground truth might be available for some parameters, the correct
model and an appropriate parameter distribution for all parameters are often difficult
to obtain or not known at all. Therefore, phantoms can only act as a surrogate ground
truth, and the simplified model might not be suited for the underlying task. For ex-
ample, pathological structures such as tumors have a high variability, and surgical
resection would be required to determine the true appearance.
2. Validation is application-dependent. (Suitability)
Each application requires its own phantom and many examples were given in the
previous chapters. For instance, a phantom used to analyze contrast enhancement
characteristics is different from one used to evaluate a segmentation algorithm. Even
a phantom used for one algorithm might not be suited to evaluate another. The chal-
lenge is to identify the relevant parameters for an application. Eventually, this will
also lead to a different validation procedure for each application.
3. Sufficient data are essential for the success of validation. (Flexibility)
Developing a physical phantom can require a large manual effort depending on the
modeled structure. Even for the more flexible design process of software phantoms,
generating a distribution of different models is time-consuming. For example, con-
sider building an adequate model of the gray matter of the brain for a large amount of
phantoms. Therefore, only a small number of phantoms or even a single exemplar is
typically used during algorithm evaluations in medical image analysis.
To summarize, validating a phantom requires methods that assess three general properties,
namely correctness, suitability, and flexibility. Thereby, correctness and flexibility are re-
lated to the analyzed phantom, whereas suitability is related to the targeted application. The
same parameters were already addressed as general requirements for phantom development
in the first background chapter of this work (cf. Fig. 2.1).
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Table 9.1. Scale used to characterize the correctness and suitability of a module. Intermediate
values between two levels (2,4,6,8) do not get a separate naming.
Explanation poor low average high very high
Value 1 2 3 4 5 6 7 8 9
9.2. Processing Steps
A simple validation approach could be to let an expert directly assign a value between zero
and one, with one being a phantom of high quality. Unfortunately, expert knowledge is
subjective and often not reproducible. In order to derive a more sophisticated approach, let
us have a look at the phantom design process. In Chapter 3, we started with an analysis
of the parameters typically required for phantoms. For each relevant parameter, we then
developed an appropriate model. Finally, the generated lesion objects are incorporated into
a given background.
In this work, we propose a novel phantom validation method that is derived from this
design process. For this approach we evaluate a number of methods (Method Selection)
with respect to their quality and relevance for the targeted application (Method Validation).
The final phantom validation is then determined as a combination of all methods (Phantom
Validation).
Step 1: Method Selection
The first step of our algorithm is an in-depth analysis of the targeted application. In this step,
a setM= {M1,M2, ...,MN} of methods is selected. Furthermore, the importance (suit :M→
[0,1], suit(Mi) = s) is determined for each considered criteriaMi.
The values are calculated via an expert validation, which provides a quick and informal
approach. However, expert decisions are based upon multiple subjective criteria and are
heavily affected by accumulated experience. Moreover, expert decisions are based upon
multiple criteria and are heavily affected by accumulated experience. in which several ex-
perts work together towards common recommendations. A related approach is the compar-
ison with information extracted from published work. A more detailed overview can be
found in Section 8.3.
In this work, we propose a set of qualitative criteria given in fuzzy terms: poor, low,
average, high, very high. The corresponding function values are integral numbers from 1
to 9. Thereby, the values 1,3,5,7, and 9 are associated with one of the criteria given above,
while the other values (2,4,6,8) characterize intermediate levels (cf. Tab. 9.1). Finally, the
results are normalized by the function fexpert(z) = z/9.
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Table 9.2. The main processing steps of the phantom validation process.
Step 1. Method Selection
Determine the set of relevant methods and quantify their suitability.
Step 2. Method Validation
Define measures for each method based on the functions corr and suit.
Step 3. Phantom Validation
Compute an overall validation measure or a ranking of available alternatives.
Step 2: Method Validation
Besides the relevance of a method, the quality of the computed results is another important
aspect. Therefore, the second validation step determines the correctness of a method and
combines both parameters within a validation function. The correctness is defined similar
to the suitability by a function corr :M→ [0,1], corr(Mi) = c. Another approach could be
to use a comparison with reference data. However, adequate reference data are difficult to
obtain. For example, the correct shape of a complex object such as the white matter can
only be estimated from patient data.
The third attribute to be tested is the flexibility. For example, a module that is very
difficult to develop and requires substantial manual work could result in an overall lower
validation value than a module that does not require a difficult development process. Unfor-
tunately, estimating the amount of flexibility is difficult. Moreover, even a module that is
difficult to create can still be of a high quality, so that this attribute should only be consid-
ered as a minor factor during module validation. In fact, we do not include the flexibility
parameter during phantom validation.
The validation function vMi : M×M → [0,vmax], vMi(c,s) = v combines the suitability
and correctness values. Important features of this function can be summarized as follows:
We aim at a multiplicative aggregation of all validation functions in the phantom validation
step (cf. Tab. 9.2), so that a value v = 1 represents a somewhat neutral result. To this
end, methods with low suitability (suit ≪ 1) should result in values close to one. In other
words, there is no need to heavily weight unimportant methods, independent from their
correctness. On the other hand, an important method that is not correctly modeled should
result in a low value v≪ 1, reducing the confidence in the phantom. Finally, important and
correctly modeled methods should result in a value v > 1, i.e., we increase the confidence
in the phantom. Table 9.3 provides a summary of these features. Based on these properties,
we propose a module validation function given by
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Table 9.3. Summary of general features of validation function v.
1. Not required criteria do not affect the validation result (v(c,0) = 1, c ∈ [0,1]).
2. Important and correctly modeled criteria get a high value (v(1,suitmax) = vmax).
3. Important and not correctly modeled criteria get a low value (v(0,suitmax) = 0).
4. v(c,s)> 1 enhances the confidence in the phantom.
5. v(c,s)< 1 decreases the confidence in the phantom.
v(c,s) =
vmax
suitmax
· s · c− 1
suitmax
· s+1 (9.1)
v Module validation function
c Measure of module correctness (corr(Ci) = c)
s Measure of module suitability (suit(Ci) = s)
vmax Maximum value of v
suitmax Maximum module suitability.
The function proposed in Equation 9.1 reaches its maximum value vmax for methods with
a maximum relevance and correctness. Due to the normalization function used in Step 1
(Method Selection) f (z) = z/9, we select vmax = 3 as an arbitrary value within the range
1< vmax < 9. The maximum input suitability is given by suitmax ∈ [0,1].
The function is derived using the following steps: Taking into account the first and third
item in Table 9.3, we initially define a linear function between v(0,0) = 1 and v(0,suitmax) =
0 as
v1(0,s) = 1− 1
suitmax
· s, v1 ∈ [0,1] .
From the first and second item in Table 9.3 we then derive a second linear function between
v(1,0) = 1 and v(1,suitmax) = vmax given by
v2(1,s) = 1+
vmax−1
suitmax
· s, v2 ∈ [1,vmax] .
The proposed module validation function finally results from linear combination of a point
in function v1 with a corresponding point in v2. See Figure 9.1 for a visualization.
Step 3: Phantom Validation
The last step combines all validation functions vMi , resulting in an overall measure for the
analyzed phantom. The multiplicative aggregation results in
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Figure 9.1. Visualization of the validation function introduced in Equation 9.1. The underlying
functions v1 and v2 are plotted as dashed line (see text for a description).
vphantom(P) =
N
∏
i=1
vMi(P) (9.2)
vphantom Phantom validation function
P Analyzed phantom
vMi Validation function for moduleMi, i= 1, . . . ,N.
A value of vMi > 1 denotes an improved phantom confidence. Thus, evaluating many correct
and relevant methods will result in a large value for vphantom. On the other hand, a single
method with vMi ≪ 1 is sufficient to greatly reduce the overall phantom validation result.
If the goal is a comparison of different phantoms, the result can also be a ranking of
the available alternatives. Thereby, the aim is to evaluate a set of alternatives describing a
separate phantom. The best alternative should receive the highest value.
9.3. Iterative Phantom Validation
Phantom validation is an iterative process that requires several steps to reach a reasonable
confidence level. In other words, not only one but several methods should be used to validate
a phantom, each increasing or decreasing the confidence. Unfortunately, a proper analysis
of phantoms is difficult.
In this section, we introduce an iterative phantom validation approach that combines the
results of several separate validation methods to an overall measure of the phantom quality.
In Chapter 10 we will discuss these methods in the context of MS lesion phantoms.
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9.3.1. Fusion of Parameter Validations
The first method introduces a direct analysis of the phantom based on an expert analysis.
The suitability of this method is given by the expert’s experience. The correctness value,
i.e., the phantom quality, is calculated by fusing the validation of all parameters to a single
measure. Two features need to be investigated for each parameter: suitability and correct-
ness.
The Analytic Hierarchy Process
We introduce a validation approach, that allows for an explicit analysis of the relationships
between modules. The proposed method is based on the so-called Analytic Hierarchy Pro-
cess (AHP). AHP is a multi-criteria decision making technique developed by Thomas L.
Saaty (Saaty 1977; Saaty 1990). It has become one of the most widely applied tools for a
variety of decision situations, e.g., for ranking a set of alternatives or for making the best
choice from a number of options. Instead of analyzing all parameters at once, the AHP
approach uses pairwise comparisons, which has demonstrated in studies to be an efficient
and accurate approach.
A literature review including several areas of applications such as engineering, gov-
ernment, or education can be found in (Vaidya and Kumar 2006). A review focusing on
healthcare and medical decision making based on AHP is given in (Liberatore and Nydick
2008). The authors investigate 50 articles, classified into seven categories such as diagnosis,
therapy/treatment, or project and technology evaluation and selection.
The AHP approach starts by sorting out all parameter modules that are not important for
the targeted application. The definition of a hierarchy of different levels is an essential as-
pect of the AHP. Thereby, modules of an upper level are only influenced by modules of the
adjacent lower level. Based on this hierarchy, the suitability of the remaining modules is ex-
amined. A frequently used method in psychology is to use pairwise comparison, since it has
turned out to be easier and more accurate to choose between two elements than simultane-
ously between all available alternatives. The AHP uses the same approach. In other words,
a pairwise comparison is performed of (1) all object modules and of (2) all background
modules. Then, the two parameter sets are averaged, meaning that we weight the object and
background design equally important. Finally, the resulting values are normalized.
The comparisons of object and background modules can each be organized into a matrix.
For N modules, this yields an N×N matrixC with
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C =


c11 . . . c1 j . . . c1N
. . . . . . . . . . . . . . .
ci1 . . . ci j . . . ciN
. . . . . . . . . . . . . . .
cN1 . . . cN j . . . cNN


, (9.3)
C Comparison matrix for N modules
ci j Matrix entry delineating the comparison between element i and j.
The matrix has the following properties:
• ci j > 0, i, j = 1, . . . ,N.
• ci j = 1/c ji, i, j = 1, . . . ,N.
• ci j = 1, i= j.
Before we now derive the actual module suitability from C as proposed in the AHP
approach, we need to define an adequate judgment scale. The AHP commonly uses a ratio
scale consisting of values from one to nine (Saaty 1990) as given in Table 9.4. A value of
one denotes two modules of equal importance, whereas nine indicates the highest suitability
difference between two modules. A description for all values of this scale is given in Table
9.4.
To give an example, let us consider a phantom developed to evaluate liver segmentation
algorithms. Thereby, we define the object contrast to be more important than the position
parameters, and parameters modeling processes will be much less important. The corre-
sponding matrix entries are then: cimg,pos = 3, cpos,proc = 7, cimg,proc = 7. The resulting
matrixM will then be
C =


1 3 7
1/3 1 7
1/7 1/7 1

 .
After assembling the comparison matrix C, we can compute the suitability for all mod-
ules at a given hierarchy level. The AHP derives the weights for each module from an
eigenvalue analysis ofC
C · p= λmax · p (9.4)
C Comparison matrix (cf. Eq. 9.3)
λmax Maximum eigenvalue
p Eigenvector (priorities) corresponding to λmax.
The eigenvector p corresponding to the largest eigenvalue of V , normalized by dividing by
its sum (i.e., ∑Ni=1 pi = 1), contains the suitability for each module. If all modules have equal
importance, the resulting matrix V is singular and the maximum eigenvalue is λmax = N. In
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Table 9.4. The 1−9 fundamental scale as defined in (Saaty 1990).
Intensity Definition Explanation
of importance
1 Equal importance Two activities contribute equally
to the objective
3 Moderate importance Experience and judgment moderately
favor one activity over another
5 Strong importance Experience and judgment strongly
favor one activity over another
7 Very strong importance An activity is strongly favored and
its dominance demonstrated in practice
9 Extreme importance The evidence favoring one activity is
of highest possible order of affirmation
2,4,6,8 Intermediate values
this case, each module gets a suitability value of 1/N. Besides the normalization of the
priorities, a further normalization can be performed across various hierarchy levels. Such
a composition eventually leads to a global suitability measure of each parameter module,
reducing the complexity of upcoming validation steps. For our example above, the resulting
suitability measures are pimg = 0.633, ppos = 0.3043, pproc = 0.0627.
An interesting feature of the AHP is that it provides an inherent consistency analysis
of the performed pairwise comparisons, i.e., of the comparison matrix of a certain level,
and thus a quality measure of the determined judgments. A consistency index CI has been
proposed by Saaty (1977), which is related to the eigenvalue analysis described above.
CI =
λmax−N
N−1 (9.5)
CI Consistency index
λmax Largest eigenvalue
N Dimension of comparison matrixM.
A further normalization of this index can be applied, resulting in the so-called consistency
ratio CR. This value is computed as the ratio of the consistency index CI and a random
index RI
CR=CI/RI (9.6)
CR Consistency ratio
CI Consistency index
RI Random index.
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Table 9.5. Random indices RI as calculated in (Saaty 1977).
n 3 4 5 6 7 8 9 10
RI 0.58 0.9 1.12 1.24 1.32 1.41 1.45 1.49
The random index RI is commonly defined by averaging the CI values of 500 randomly
filled comparison matrices based on the AHP fundamental scale (cf. Tab. 9.4). See (Saaty
1990) for a detailed discussion. Table 9.5 shows the values for RI for matrices of order three
to ten as given in (Saaty 1977). A high CR value corresponds to a low matrix consistency,
and the entries, i.e., the comparisons, should be reevaluated. Consistency ratios of less than
0.1 are usually considered acceptable. A ratio of CR = 1 characterizes inconsistent and
rather random value selection.
Method Validation
To summarize, the AHP approach computes the degree of suitability for all object and back-
ground modules. The next step is now to integrate our results into the validation method.
Since the sum of all AHP values is equal to one, we normalize each value by dividing it
by the largest output. This way, the most relevant parameter receives suitparam = 1. The
second feature for a parameter, the parameter correctness, is assigned via an expert analysis.
The resulting overall phantom correctness is then defined as the minimum of all parameter
validations
corrphantom =min(∀vparam) .
Equation 9.1 is used to calculate the result of each validation function vparam. In other
words, we choose the lowest combination of correctness and suitability normalized over all
parameters. The input values for this validation method are then
Suitability suit = expert experience ∈ [0,1]
Correctness corr =min(∀vparam)
9.3.2. Number Of Parameters
The next validation method is extracted from our development process. Each phantom mod-
els a certain amount of object and background parameters. Assuming that a larger number
of modeled parameters results in a better phantom, this value is an adequate validation step.
Since this approach does not include any statement about the quality of the modeled parame-
ters, we set the importance of this approach to be only moderate (suit = 4/9), i.e., we select
a value between ’low’ and ’average’. The correctness is calculated as ratio of the number of
modeled parameters and the number of relevant parameters for the targeted application. To
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summarize, the input values for the method validation (Step 2) are
Suitability suit = 4/9
Correctness corr = (#modeled params) / (#relevant params)
9.3.3. Lesion Detection Performance
Another interesting approach is to analyze the object detection performance compared to
patient data sets. Here, the user is asked to identify phantom objects in a patient data set
that contains similar objects. Unfortunately, this approach does not give any information
about the background used in the phantom data sets. It can also only be used in patient
data with more than one object. Therefore, we choose the importance of this approach to
be moderate (suit = 6/9). The correctness should be derived from the computed detection
performance.
Suitability suit = 6/9
Correctness corr = derived from detection results
9.3.4. Segmentation Overlap Measures: Phantom vs. Patient Data
Phantoms have become a widely accepted tool for the evaluation of segmentation algo-
rithms. They have a known ground truth and provide a good alternative to the analysis of
patient data sets. A good phantom should be able to predict the performance of an evalu-
ated algorithm on patient images never seen before. Comparing the segmentation results for
phantoms and patient data sets is thus a good way to derive the phantom quality.
An important assumption of this approach is that all relevant parameters are modeled.
Nevertheless, a poor parameter model can still result in an unrealistic phantom with compa-
rable segmentation overlap. Nevertheless, we believe that this approach is suited to evaluate
the quality of a phantom, and therefore assign suit = 7/9. The reference values can be ex-
tracted from publications related to the segmentation algorithm or from own investigations,
i.e., from segmentation of own patient data sets. The correctness values are estimated from
the segmentation overlap using the Dice similarity coefficient.
Suitability suit = 7/9
Correctness corr = comparison of segmentation overlap
9.3.5. Effect of Parameter Changes
Changing the complexity or the value range of a parameter has an effect on the resulting
phantom quality. For example, a wrong object position will reduce the applicability of the
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phantom. One way to test the effect of parameter changes is to compare the segmentation
overlap for different parameter settings with those of patient data. Therefore, we believe
that this approach is well suited to act as an indirect measure of phantom quality and assign
suit = 8/9.
Our aim for this validation method is to compare phantom pairs where certain parame-
ters are changed to some extent. Therefore, we want to use a parameter with high impor-
tance. The Analytic Hierarchy Process introduced in Section 9.3.1 is used for this task. An
important assumption of this approach is that all relevant parameters are modeled.
Suitability suit = 8/9
Correctness corr = comparison of segmentation overlap
9.4. Discussion
A good phantom should be able to predict the performance of an evaluated algorithm on
images never seen before. In other words, if the phantom is useful, the evaluated algorithm
should produce comparable results for both phantom data and patient data. In this chapter,
we introduced a novel phantom validation approach. We associate the overall requirements
for phantom development given in Chapter 2 with those of phantom validation. Furthermore,
our approach is closely related to the phantom development process proposed in Chapter 4.
Our validation approach supports the design process of these hybrid software phantoms
already at the initial development phase by an analysis of the required parameters. We
propose a method based on a multi-criteria decision making technique, namely the Analytic
Hierarchy Process. An important aspect of this method is the use of pairwise comparisons,
where each module is compared to all other modules within the same group. This way,
dependencies between modules are explicitly modeled. In contrast, two important modules
will both receive a high suitability value if analyzed separately.
The AHP method uses an expert analysis of the phantom. This method requires user
involvement as well as expert knowledge of the underlying problem domain. Increasing the
number of modules also increases the required pairwise comparisons. Analyzing an object
including all modules introduced in this work results in 12 ∗ 11/2 = 66 comparisons, i.e.,
N(N−1)/2 comparisons. Although this is a significantly higher number compared to a sin-
gle evaluation of each parameter, we gain an explicit assessment of module dependencies.
Comparison with Related Work
Current phantom validation approaches are based on a visual comparison with patient data
sets or apply some expert knowledge for evaluation (cf. Sec. 8.7). Nevertheless, at least
some related work can be found that goes beyond these fairly subjective methods.
In Section 8.5, we reviewed several methods that propose a standardization of the overall
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validation process. Even though these methods focus on the validation of image processing
algorithms, some characteristics are also important for phantom validation. The work by
Jannin et al. (2006) introduces a general validation concept (cf. Fig. 8.1). In their work,
the authors propose a checklist of roughly 30 components that need to be observed when
reporting a validation study. These parameters include the clinical context or the method
to be validated. Similar to our approach, Jannin et al. (2006) aim at a formalization of
the validation process. Furthermore, they also emphasize the application dependency of
validation and delineate the clinical context and the method to be validated as important
parameters. However, the authors propose a reference-based process, i.e., the underlying
validation data is already known. In our work, we start one step earlier and focus on the
analysis of the underlying reference data instead.
Another approach related to phantom validation is the analysis of ground truth data
in medical image processing. In Section 8.4, we discussed the work by Lehmann (2002),
who proposed five attributes that should be considered for any appropriate gold standard:
reliability, equivalence, independence, relevance, and significance. Although this approach
provides an interesting attempt towards a classification scheme for reference data, it is not
accompanied by an objective measurement for the proposed attributes. Therefore, only a
descriptive analysis can be performed, reducing the overall reproducibility between different
raters.
Iterative Validation
Validation is an iterative process that requires several steps to reach a reasonable confidence
level (cf. Sec. 8.7). Furthermore, it is application-dependent. In this work, we propose a
novel iterative validation approach consisting of several evaluation methods. Each method
increases or decreases the confidence in a phantom. Our validation approach is divided into
three steps: method selection, method validation, and phantom validation (cf. Tab. 9.2).
For each validation method phantom-related measures (correctness) and application-related
measures (suitability) are analyzed. To combine these two measures, we proposed a valida-
tion function (cf. Eq. 9.1). The same function is used for all investigated methods.
In the last step of our validation approach, all validation methods are combined to a final
measurement for the analyzed phantom. Our goal is an approach where the phantom quality
is expressed in a single value. This allows for a straightforward comparison of different
validation results among several raters or among different phantoms. We aim at a function,
which ensures that unimportant methods have only a limited influence independent from
their correctness. Important methods on the other hand can heavily increase or decrease
the confidence in the phantom. To this end, we propose a multiplicative aggregation of all
validation functions.
Based on the iterative fusion proposed in this chapter and the chosen validation methods,
we believe that our approach allows for an estimation of the phantom quality. Thus, a highly
rated phantom will be able to predict the performance on patient data. To the best of our
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knowledge this is the first method of this type. Given a phantom we can evaluate to what
degree this phantom is appropriate for a certain application, and also assess if one phantom
is better suited than another. Moreover, phantom developers and users are supported in
analyzing advantages and drawbacks of a phantom in more detail. This was also found
useful for our own phantom development in the first part of this work and justifies the
additional effort of the proposed validation approach. The next chapter will provide a more
detailed analysis on the basis of a validation of our MS lesion phantoms.
10. Validation of MS Lesion Phantoms
In the previous chapter, we proposed a new phantom validation approach based on an it-
erative analysis. Each iteration consists of a separate validation method, which increases
or decreases the confidence in the phantom. In this chapter, we apply our approach to the
validation of our MS lesion phantoms proposed in Chapter 5.
Five validation methods are analyzed. For example, we perform an expert-based analy-
sis of the phantom quality. The Analytic Hierarchy Process is used to derive the suitability
of all required object parameter modules. Another validation method carries out a user-
study to analyze the detection performance of lesion phantoms. Furthermore, the effect of
parameter changes is investigated. For each step, a short description of the underlying data
and a discussion of the results is provided.
10.1. Fusion of Parameter Validations
The first validation method is a direct analysis of the phantom. We use an expert validation
for this method. A detailed description of this validation method is given in Section 9.3.1.
The suitability is defined as the expert’s experience. In our case, two raters performed the
analysis our MS lesion phantoms. Both with several years of expertise in medical image
analysis.
The correctness value, i.e., the phantom quality, is calculated by fusing the validation
of all parameters to a single measure. Again, two features need to be investigated for each
parameter: suitability and correctness. Since our focus in this work is on hybrid software
phantoms, only the lesion object is analyzed. Nevertheless, an additional validation is con-
ceivable that also includes the background.
To analyze the parameter modules of our phantoms, the first step classifies the parameter
modules into the binary categories relevant and negligible. Modules that have no effect
on the targeted application are sorted out. A consensus meeting was held to decide on
the remaining parameters. The resulting comparison matrix consists of the following nine
modules: shape, structure, volume, topology, contrast, noise, resolution, PV effects, and
uniformity. All object parameters are modeled in our approach. Since the sum of all AHP
values is equal to one, we normalize each value by dividing by the largest output. This way,
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Table 10.1. Expert analysis for each parameter. The suitability values are calculated via the AHP
approach described in Section 9.3.1. All parameters are normalized to [0,1].
Parameter Suitability Correctness
Rater1 Rater2 Rater1 Rater2
Shape 1.0 1.0 0.78 0.67
Structure 1.0 0.99 0.78 0.67
Volume 0.38 0.41 0.78 0.78
Topology 0.67 0.67 0.89 0.78
Contrast 0.81 0.85 0.78 0.89
Noise 0.33 0.28 0.89 0.89
Resolution 0.10 0.09 1.0 1.0
PV effects 0.29 0.36 0.78 0.89
Uniformity 0.09 0.06 0.78 0.89
the most relevant parameter receives suitparam = 1 (cf. Tab. 10.1).
The second feature, the parameter correctness, is assigned via an expert analysis. The re-
sults of this evaluation are also given in Table 10.1. The values for correctness and suitability
are then used as input for the validation function (cf. Eq. 9.1), resulting in a value vparam for
each parameter module. Finally, the overall phantom correctness for the current validation
method is defined as the minimum of all parameter validations, i.e., corr =min(∀vparam).
Evaluation
Both experts rated their experience to be ’high’ (suit = 7/9). The correctness values are
extracted from the analysis of the parameter modules. Therein, the computed values are
approximately the same for both raters. Four parameter modules get assigned high suit-
ability values of over 65%, namely shape, structure, topology, and contrast. Furthermore,
all modules got assigned a correctness value larger then five, i.e., better than average. The
resulting overall phantom correctness, defined as the minimum of all parameter validations,
is corr = 0.78 for Rater1 and corr = 0.67 for Rater2.
Rater1 Rater2
Suitability suit = 7/9 suit = 7/9
Correctness corr = 0.78 corr = 0.67
The validation results are for Rater1 v= 2.04, and for Rater2 v= 1.78.
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The first step of the AHP-based validation described above extracts all relevant modules and
sorts out the rest. Assuming that the amount of modeled parameters directly corresponds
to the phantom quality, we can derive a phantom validation approach. Similar to the AHP-
based validation presented above, only the lesion objects are analyzed.
Evaluation
In Section 10.1, we extracted nine relevant parameters. All of them are modeled in our phan-
tom approach. See also Figure 5.9 for an overview. Because we calculate the correctness
as ratio of the number of modeled parameters divided by the number of relevant parameters,
our phantom receives the highest value corr = 1.
An advantage of this approach, compared for example to the comparison of segmen-
tation results, is that the phantom does not necessarily have to be available. A list of all
modeled parameters is sufficient. Therefore, we investigated related work on MS lesion
phantoms and carried out a similar parameter analysis. The phantom by Tofts et al. (1997)
models five parameters resulting in v = 1.30, which is a decrease by 35.1% compared to
our approach. The work of Melhem et al. (2003) models eight parameters. The validation
result decreases by 8.7% to v= 1.74.
The resulting values for our validation function are
Suitability suit = 4/9
Correctness corr = 9/9
The validation result for our approach is v= 1.89.
10.3. Lesion Detection Performance
The next method to assess the phantom quality, is a human observer study. Therein, the
detection performance of lesion phantoms in patient data sets with several real MS lesions
is investigated. To carry out the study, we developed a software assistant with an intuitive
graphical user interface. It consists of a viewer showing the current image data as well
as a simple parameter panel to select the current lesion type. Two different marker types
are available. A ’lesion’ marker is used for real lesions and a ’phantom’ marker for lesion
phantoms. Six data sets from different patients were analyzed (Case1, Case2, ..., Case6).
Two to three MS lesion phantoms were incorporated in each MR scan at different positions
in the white matter (T2-weighted, matrix 256×256, 3mm slice thickness). The size and
intensity values were adjusted to match the real MS lesions in the underlying patient data.
Only two different object shapes were used for all data sets. To reduce the detection task for
each participant, only the lesions on one slice had to be detected. Nevertheless, the raters
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Table 10.2. Results of human observer study averaged over six patient data sets with included lesion
phantoms.
Rater1 Rater2 Rater3 Rater4
Sensitivity (in %) 27.27 23.08 23.08 38.46
Specificity (in %) 67.57 86.00 81.13 56.10
were able to slice through the whole data set, whereas the slice to be rated was highlighted
by a rectangle.
Two physicians (Rater1, Rater2) as well as two computer scientists with considerable
experience in computational neuroimaging (Rater3, Rater4) participated in the study. All
raters were blinded in the number of real MS lesions and lesion phantoms. All used the same
computer and monitor devices to carry out the detection task. Figure 10.1 (c)-(f) show the re-
sulting marked lesions for each expert (Case6). The corresponding ground truth is presented
in Figure 10.1 (b). The raters correctly marked 26.9% (min= 23.08%,max = 38.46%) of thir-
teen lesion phantoms. The overall sensitivity was 27.97%, the overall specificity 72.70%.
No significant differences were found in the resulting detection rate of all four raters. The
values for each participant is separately given in Table 10.2.
Evaluation
The results clearly show the plausibility of our software phantom design approach with
respect to clinical image data. A broad range of software phantoms can be generated that
are indistinguishable from actual MS lesions for a human observer. The ability to correctly
identify lesion phantoms, i.e., the sensitivity, is very low for all four raters (<30%), even
though we only used two different object shapes. Three out of four raters were not able to
correctly mark more than 25% of all lesion phantoms. Only Rater4 had a slightly better
overall detection rate of approximately 40%. However, the corresponding specificity of this
rater is very low (56.10%). All participants suspected several real MS lesions to be lesion
phantoms (cf. Fig. 10.1). Therefore, we assign a high correctness of corr = 8/9 to this
validation approach.
Suitability suit = 6/9
Correctness corr = 8/9
The validation result for this approach is v= 2.11.
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(a) (b) (c)
(d) (e) (f)
Figure 10.1. Lesion detection performance using a patient data set with additional lesion phantoms
(Case6). (×, real MS lesions (yellow); +, lesion phantom (green)). (a) Slice of original image
data with incorporated lesion phantoms, (b) ground truth, (c)-(f) Rater1–Rater4.
10.4. Segmentation Overlap Measures: Phantom vs. Patient
Data
In this validation step, we propose an evaluation of phantom quality using results of an
adequate segmentation method. We apply the lesion segmentation algorithm proposed by
van Leemput et al. (2001), which has become quite popular within the medical imaging
community with more than 100 citing papers on IEEE Xplore. It is also freely available
and therefore well suited as a reference method for comparison. See also Section 6.3.2 for
a more detailed overview of the parameter settings. The segmentation results are shown in
Table 6.8 (upper table).
Evaluation
To evaluate this validation step, we need to compare our results with those calculated on
patient data. In (van Leemput et al. 2001), segmentations of 20 low-resolution patient
data sets with an in-plane resolution of 0.9×0.9 and 5 mm slice thickness were performed.
Furthermore, three data sets with a slice thickness of 2.4 mm are analyzed. Expert segmen-
tations are used as reference. The best DSC value in the paper is max(DSC) = 0.45 for the
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low-resolution data sets and max(DSC) = 0.51 for the high-resolution data sets.
Similar results were recorded by García-Lorenzo et al. (2011). In their work, the authors
used the EMS method to segment ten patient data sets (in-plane resolution 0.97× 0.97,
3 mm slice thickness) with a total lesion load (TTL) ranging from 1.0 ml to 47.7 ml. Again,
a manual expert segmentation is used as reference ground truth. The calculated DSC values
have a large range of [0.31,0.77] with a mean value of mean(DSC) = 0.56.
Our results are mean(DSC) = 0.67 with min(DSC) = 0.57 and max(DSC) = 0.77. In
other words, our mean values differ from those of García-Lorenzo et al. (2011) by 16.4%.
Furthermore, our max values differ from those of van Leemput et al. (2001) by 41.5% for
the low-resolution data and by 33.7% for the high-resolution data. A moderate correctness
is therefore selected for this approach (corr = 6/9). Nevertheless, we believe that this
approach is suited to evaluate the quality of a phantom and assign suit = 7/9. The values
for our validation function are given by
Suitability suit = 7/9
Correctness corr = 6/9
The validation result for this approach is v= 1.77.
10.5. Effect of Parameter Changes
Changing the complexity or the value range of a parameter has an effect on the resulting
phantom quality. For example, a wrong object position will reduce the applicability of the
phantom. One way to test the effect of parameter changes is to compare the segmentation
overlap for different parameter settings with those of patient data. Therefore, we believe
that this approach is well suited to act as an indirect measure of phantom quality and assign
suit = 8/9.
An important assumption of this approach is that all relevant parameters are modeled.
Nevertheless, a poor parameter model can still result in an unrealistic phantom with com-
parable segmentation overlap. Our aim for this validation method is to compare phantom
pairs where certain parameters are changed to some extent. Therefore, our goal is to select
a parameter of high importance. We choose the structure parameter for the subsequent eval-
uation, since it got assigned a high suitability value in the AHP analysis in Section 10.3 by
two experts.
To assess the effect of parameter changes on the phantom quality, we use the same ap-
proach presented in the previous section. First, all phantoms are segmented with the MS
lesion segmentation algorithm proposed by van Leemput et al. (2001). The Dice similarity
coefficient computed from segmentation mask and ground truth is used to evaluate the re-
sults. The calculated values are then compared with segmentation results from real patient
data.
In Section 6.3.2 we generated 16 phantoms from two different parameter setups. The
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first set consists of a homogeneous lesion structure and was already used in the previous
section. The second set includes inhomogeneous lesions using a parametric model to change
the lesion texture (cf. Sec. 5.2). The resulting overlap measures and the total lesion load for
each data set is given in Table 6.8 (lower table).
Evaluation
Changing the lesion structure to an inhomogeneous texture model has a large effect on
the segmentation results. Because of the more complex lesion appearance, we expect a
decrease in the overlap measure. In fact, the mean overlap measure decreases by 26.8% to
mean(DSC) = 0.49 (min(DSC) = 0.35, max(DSC) = 0.55). Compared to the patient data
results of van Leemput et al. (2001), the max values now differ only by 7.2%. We can
further evaluate the effect of adding lesion texture using a Wilcoxon matched pairs signed-
ranks test. The test results indicate that a significant difference exists between lesions with
and without our texture model at the p≤ 0.05 significance level. Therefore, this validation
approach receives a high correctness value of corr = 8/9.
Suitability suit = 8/9
Correctness corr = 8/9
The validation result for this approach is v= 2.48.
10.6. Result of Phantom Validation
After analyzing each validation method separately, the final phantom quality is computed
by fusing all results as described in the previous sections. In this work, we analyzed five
different validation methods. All results have a value v> 1 and thus increase the confidence
in our phantom. The overall phantom validation value is
vphantom = vexpert1 · vexpert2 · v#params · vdetect · vsegm · vchangeParam
= 2.04 · 1.78 · 1.89 · 2.11 · 1.77 · 2.48
= 63.71
To understand how to interpret the validation result, we compare it with those of a
slightly different phantom. Let us assume, that the object structure is not generated by the
proposed texture model, but by a checkerboard pattern. In other words, only one parameter
model is changed. This will still increase the lesion complexity and result in a lower overlap
measure for the applied segmentation approach as described in Section 10.5. The low object
quality will be detected by an expert validation. For the given example, we select a low
correctness value of corrparam = 1/9 for both experts. The phantom validation proposed
in Section 10.1 will then be v = 0.48 (v = 0.48) instead of v = 2.04 (v = 1.78). This will
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decrease the result of the iterative phantom validation by 93.7% to vphantom = 4.03. Even
if only one expert assigns a low rate, e.g., Rater1, the result will decrease by 76.5% to
vphantom = 14.98.
If the new phantom is evaluated by different raters, interobserver variability is difficult
to avoid. Nevertheless, our approach is able to detect the reduced phantom quality using
the method described in Section 10.1. Rating the parameter correctness between ’poor’ and
’low’ with corrparam= 2/9 instead of 1/9 for both raters will decrease the resulting phantom
value by 84.1% to vphantom = 10.13. An even higher value for both raters (corrparam =
3/9), i.e., a ’low’ correctness, will still reduce the phantom validation value by 72.4% to
vphantom = 17.57.
10.7. Discussion
Phantom validation is an iterative process in which several steps are required to reach a
reasonable confidence in a phantom. In the previous chapter, we introduced five different
validation methods for this task that were applied to the analysis of our MS lesion phantoms
in this chapter. The final phantom quality is computed by fusing the results of all methods.
All methods increased the confidence in our lesion phantoms, i.e., all validation results have
a value greater than one.
The first method performed an expert validation, analyzing all object parameters. Our
approach goes beyond a simple visual rating of a phantom by only looking at it. Instead, we
provide an explicit analysis of the relationships between parameter modules based on the
Analytic Hierarchy Process, which has become a widely applied decision making technique.
Our method uses pairwise comparisons of parameters, which has been demonstrated in
studies to be an efficient and accurate approach. Two raters performed the validation for our
MS lesion phantoms.
In another validation method, we analyzed the effect of object parameter changes. Again,
the AHP approach is applied to select a parameter with high importance. The developed
phantoms are then used to analyze a well-known MS lesion segmentation algorithm pro-
posed by van Leemput et al. (2001). The resulting overlap measure for the lesion mask
is compared with segmentation results from patient data. Results from published work of
two different research groups are used for comparison. Our results indicate that it is worth
developing complex parameters, that better reflect the challenges of related patient data.
Our validation yields a single value for the phantom quality, that directly depends on the
number of validation methods. However, the result of our iterative approach does not have
an upper bound. Adding the result of a new method to our current evaluation in Section 10.6
will change the overall validation and increase or decrease the confidence in our phantom.
Thereby, the methods analyzed in this chapter provide a good starting point. To the best of
our knowledge, this is the first time a phantom is analyzed to this extent.
Establishing an absolute value for ’good’ phantoms is complex because it requires de-
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velopers to thoroughly evaluate their own phantoms and many experts to review the results
of each validation method. Our approach provides a formalized process for phantom val-
idation, which is an important step in this direction. Using our method, different raters
should be able to obtain related results. Our approach can be easily extended by new vali-
dation methods to a point where the output value has reached a level, at which the phantom
is considered to be sufficiently validated. Moreover, the multiplicative combination of all
validation methods has the benefit that even a single method with high suitability and low
correctness is sufficient to greatly decrease the built up confidence in a phantom.
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11. Conclusion Part II
In this last chapter, we reflect the main challenges of phantom validation and our contribu-
tions in this field. The thesis is completed with a discussion of future work.
Why is an analysis of the phantom quality required?
To reach clinical acceptance, and to fully understand a method, dedicated evaluation strate-
gies are required. Today, most algorithms are accompanied by some kind of validation
study, where the quality of a method is compared with some kind of reference. Therefore,
establishing an appropriate gold standard, that is presumed to contain the correct result (the
ground truth) or be at least close to it, is an essential task. Phantoms provide an excellent
basis, because the ground truth is known for all modeled parameters.
Nevertheless, tools that analyze the phantom quality are largely unknown. In Chapter 8,
we reviewed methods that have been proposed for the validation of image processing algo-
rithms. Several methods use a reference database consisting of patient scans or phantoms.
However, only few are actually available for research groups other than the initial devel-
opers. Our approach starts one step earlier and focuses on the analysis of the underlying
reference data.
A characteristic of validation methods in medical image processing – also important for
phantom validation – is a formalized and reproducible analysis. Today, the most common
phantom validation approach is a visual assessment by a field expert, which provides a quick
and informal method. However, expert knowledge is subjective and often not reproducible.
To analyze the quality of a phantom, we need standardized tools that demonstrate the
advantages and drawbacks of a phantom for the targeted application. For example, a bad
phantom with wrong object intensity values can heavily effect the output of a segmentation
algorithm and reduce the relevance of the calculated results. Furthermore, methods that
enable a ranking of different phantoms for the same application are required.
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What are the benefits of our phantom validation?
Link to Phantom Design. In this work, we proposed a novel phantom validation method
that is closely related to the design process (cf. Chap. 9). Therein, models for the rele-
vant parameters of an object are developed and the results are incorporated into a given
background. To support this process already early in the design phase, our phantom valida-
tion starts with an analysis of the required parameters. We proposed a method based on a
multi-criteria decision making technique, namely the Analytic Hierarchy Process. The AHP
approach uses pairwise comparisons of parameters, which has demonstrated in studies to
be an efficient and accurate approach. It allows for an explicit analysis of the relationships
between modules. This way, phantom developers and users are supported in analyzing ad-
vantages and drawbacks of a phantom in more detail, which was also found useful during
development in this work. For example, the computed importance values were used in our
automatic phantom design proposed in Chapter 5 to focus on the relevant parameters.
Iterative Process. Besides the evaluation of relevant parameters for phantom design,
an assessment of the actual phantom is required. Validation is an iterative process that
requires several steps to reach a reasonable confidence level. In this work, we proposed
a novel iterative approach consisting of several evaluation methods. The methods can be
analyzed independent of one another, so that a new method does not have to take previous
validation results into account. Our overall phantom validation approach is divided into
three steps: method selection, method validation, and phantom validation. Each method
increases or decreases the confidence in a phantom through an analysis of the method’s
quality and its relevance for validation.
Phantom Quality Measurement. Our goal is to express the phantom quality by
a single value, which enables a straightforward comparison of different validation results
among several raters or among different phantoms. After selecting the validation methods,
an analysis of their suitability and correctness is performed. We proposed a validation
function that combines these two features for each validation method (cf. Eq. 9.1). The last
step of our approach then combines all validation methods to a final measurement.
Our validation process ensures that unimportant methods have only limited influence in-
dependent from their correctness. Relevant methods on the other hand can heavily increase
or decrease the confidence in the phantom. To this end, we propose a multiplicative aggre-
gation of all validation functions. Methods with low suitability result in values close to one,
whereas the output of the validation function is larger than one for important and correctly
modeled methods.
Applications. The result of our iterative validation approach does not have an upper
bound. Instead, each new method adds further information about the phantom and thus
changes the validation value. Thereby, the computed result of our approach provides a good
starting point for subsequent validation methods. Furthermore, it enables a comparison with
other phantoms that carry out the same methods.
Five validation methods have been proposed in Chapter 9. These methods were then
157
applied in Chapter 10 for the validation of our MS lesion phantoms. All methods increased
the confidence in our phantoms. For example, we compared the segmentation overlap com-
puted for phantom data with those from patient data using the same algorithm. Furthermore,
we analyzed the effect of object parameter changes. Similar to supporting the initial phan-
tom design phase, the Analytic Hierarchy Process is used to select a parameter with high
importance. Our results show that it is worth developing complex parameters, that better
reflect the challenges of related patient data.
In Section 10.5, we compared our results with those of a phantom where only one
parameter is modified. Our validation helped to detect a major change in phantom quality.
A comparison with phantoms that did not use the same validation methods is also possible
if the applied methods have the same relevance.
Standardization of Validation. Our long term goal is a standardization of phantom
validation. The iterative approach proposed in this work provides a formalization of the
validation process, and the applied methods have shown the capabilities for validation. This
way, a phantom that is considered to have a good quality by our approach can enhance the
clinical acceptance of evaluation studies for new algorithms in medical image analysis.
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Future Research
This thesis has given insights into phantom development and validation and has presented
several new ideas. Nevertheless, several extensions of our work are conceivable.
Phantom Development
In Part I of this work, our focus was on the development of software phantoms. A future
direction could be to put more emphasis on the automatic design of phantoms. An ad hoc
solution that develops a phantom from single patient data set should no longer be needed.
Large databases are required to do sufficient testing of an algorithm. Our automatic ap-
proach allows to parametrically generate not only tens, but hundreds of phantoms. To this
end, families of phantoms should be developed categorized into imaging, normal, and patho-
logical variability encountered in clinical practice. Since our approach uses patient data to
capture this variability, additional data are required.
Another future work of our phantom design is to focus on further imaging modalities
such as CT or PET. This will particularly require the development of new parameter modules
such as a new object noise model. Furthermore, currently missing parameter modules could
be added for additional flexibility. New applications within new areas of medical image
analysis is another interesting topic. An example is the evaluation of registration methods
using phantoms.
Our current phantom design approach covers hybrid software phantoms, which limits
the possible objects and thus the clinical applications. An extension of our approach to the
automatic development of data sets where the modeled object is an organ, e.g., the heart or
the liver, is of great interest. A reasonable software phantom that allows for modeling of
parameters within a range extracted from patient data is currently not available.
On-site competitions of several research teams during a conference have become popu-
lar in the last years, e.g., the Grand Challenge workshops at the MICCAI conference. An
interesting extension of the current patient data used for training and testing are phantoms.
For example, a segmentation challenge using our data sets could add new insights into both
the tested algorithms as well as the underlying phantom data.
Phantom Validation
An important aspect of our current validation approach is the user involvement. We rely
on rater decisions, which includes some inherent and inevitable subjectiveness. A common
method to overcome this issue is a consensus meeting of several experts. For example,
Sloane et al. (2003) used seven development stages with different participants to assess
the criteria required to purchase specific clinical equipment within an AHP-based approach.
Furthermore, the competence of each expert is important. Tsyganok et al. (2011) conclude
that the individual expertise of a rater can be neglected for large groups of more than 50
persons. On the other hand, for relatively small groups, expert competence should be taken
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into consideration. A different approach could be to remove the manual rating from the vali-
dation process. For example, a distance function measuring the similarity between phantom
data and a database with a sufficient amount of reference data could be used to compute the
correctness of a parameter model.
Besides the already proposed features, several additional parameters could be consid-
ered for validation such as the required time and costs to develop a phantom. Another re-
lated factor is the amount of manual processing required to assemble a phantom. Although
such parameters can affect the development process, they should not change the overall
phantom quality and are therefore not considered in this work.
Future work will extend our approach by new validation methods to a level where the
confidence in our phantom is determined as sufficient. To demonstrate the wide applicability
of our validation, we also plan to investigate phantoms from other groups. Thereby, data
availability is an important topic for both phantom development and validation. Today, only
few data sets are available or are widely accepted in medical image analysis. A step towards
this goal are public data sets within a database plus an easy-to-use web interface. This
would allow other researchers to upload their phantoms as well as their validation results
for an already available phantom. Additionally, it would allow selecting a suitable phantom
for evaluation studies. Thereby, our validation approach can provide a common basis for
comparisons. Furthermore, determining the required modules and their suitability provides
an excellent platform for discussions.
In Chapter 4, we proposed a formalization of the phantom design process and developed
a template that can be used to provide an easy-to-use phantom description. A similar ap-
proach could also be beneficial for phantom validation. In this case, the description contains
not only the output of the overall validation. Also, all validation steps are included with a
short description and the values and meanings for suitability and correctness.
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